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Abstract
 
Background: The nutritional status of HIV-infected children is reported to be poor. Diarrhoea 
and acute respiratory infections tend to be more common and severe in HIV-infected children 
than in uninfected ones. Deficiencies of micronutrients may result in poor growth and 
increased risk of diarrhoea and respiratory infections. Micronutrient deficiencies are common 
in HIV-infected
 
children. The poor growth, diarrhoea and respiratory infections seen in HIV-
infected children may be partly due to micronutrient deficiencies. The studies in this thesis 
had two main objectives: (1) to evaluate the effect of short-term (during hospitalization) and 
long-term (6 months) multi-micronutrient supplementation on episodes of diarrhoea and 
respiratory infections in HIV-infected children who are not yet on antiretroviral therapy 
(ART), and (2) to assess the effects of long-term multi-micronutrient supplementation on 
appetite and growth performance of HIV-infected who are not on ART.
 
Methods and results: Four studies were conducted. Initially a cross-sectional study was 
performed in which the duration of hospitalization, weight, length, micronutrient status and 
appetite of HIV-infected children admitted with diarrhoea or pneumonia was compared with 
the results of HIV-uninfected children. Duration of hospitalization was 2.8 days (52%) longer 
in HIV-infected children. Appetite as measured by amount of test food eaten (g per kg body 
weight)
 
was 26% poorer in HIV-infected children. Mean length-for-age Z-scores were lower 
in HIV-infected children; there was no difference in level of wasting.
 
       
Subsequently multi-micronutrient supplementation studies were performed, one short-
term and two long-term studies. The effect of supplementation on the duration of 
hospitalization in HIV-infected children with diarrhoea or pneumonia was assessed in the 
short-term study. One long-term study assessed the supplement's impact on growth and 
frequency of episodes of diarrhoea and of pneumonia in HIV-infected children. The other 
evaluated the effect of the supplement on the appetite of these children. The supplement 
contained vitamins A, B complex, C, D, E and folic acid, and the minerals copper, iron, 
selenium and zinc at levels based on recommended dietary allowances. 
 
       
In the short-term supplementation study HIV-infected children aged 4-24 months who 
were hospitalized with pneumonia or diarrhoea received the supplement or a placebo until 
discharge from hospital. The duration of hospitalization was 1.7 days (19%) shorter in the 
supplement group.
 
       
Long-term multi-micronutrient supplementation improved the weight-for-age and weight-
for-height Z-scores
 
of HIV-infected children aged 4-24 months by 0.4 over the 6-month 
period. There was no improvement in stunting. Children in the supplement group had 
substantially fewer episodes of respiratory symptoms per month than the placebo group (0.66 
± 0.51) per month vs (1.01 ± 0.67) (P < 0.05) and marginally fewer episodes of diarrhoea per 
month (0.25 ± 0.31) vs (0.36 ± 0.36) (P = 0.09). There was no effect on CD4 lymphocytes. 
Long-term supplementation with micronutrients had benefits on the appetite of HIV-infected 
children aged 6-24 months as well. Improvements in amount of test food eaten over the 6-
month period were much higher among children who received the supplement (4.7 ± 14.7 
g/kg body weight) than the changes in those who received the placebo (-1.4 ± 11.6
 
g/kg body 
weight). 
 
Conclusion: Multi-micronutrient supplementation reduces the duration of diarrhoea and of 
pneumonia and incidence of diarrhoea and of respiratory symptoms in HIV-infected children 
who are not yet on ART. Multi -micronutrient supplementation also improves appetite and 
weight in these children but not height. The results of these studies indicate that multi-
micronutrient supplementation should be considered in HIV-infected infant and young 
children who have not commenced ART.  
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INTRODUCTION
 
 
In spite of numerous advances that have been made in relation to the treatment and indeed the 
prevention of HIV infection in children, it remains a major problem among children in sub-
Saharan Africa. It is estimated that there were 2.5 million children worldwide living with HIV 
at the end of 2009, 2.3 million of them in sub-Saharan Africa (UNAIDS, 2010). The mortality 
and morbidity associated with HIV infection in children is quite high; the number of child 
deaths due to HIV in 2009 is estimated to be 280 000 (UNAIDS, 2009).
 
HIV infection is 
thought to be a cause in 42%
 
of under-5 child deaths in South Africa, in 2004 (Statistics South 
Africa, 2006). Common clinical manifestations in HIV-infected children include severe 
malnutrition and diarrhoea and respiratory infections (Pol et al.
 
2007). Micronutrient 
deficiencies are common among children in developing countries (Micronutrient Initiative, 
2004), but these deficiencies are even more common and more severe among HIV-infected 
children (Semba & Tang 1999). Micronutrient deficiencies on their own are associated with 
poor growth and increased susceptibility to diarrhoea and respiratory infections (Semba & 
Tang 1999). The research that is described in this thesis focuses on two major issues. The first 
is the impact of short and long-term multi-micronutrient supplementation on episodes of 
diarrhoea and respiratory infections in HIV-infected children. The second issue is the effect of 
long-term multi-micronutrient supplementation on appetite and growth performance of HIV-
infected children.  
 
       
In this chapter, a summary of what is known on the nutritional status of HIV-infected 
children is discussed. Subsequently, the rationale for multi-micronutrient supplementation in 
HIV-infected children will be elucidated, followed by a discussion on the public health 
relevance of such supplementation in the South African setting. At the end of the chapter the 
objectives of the thesis research will be described and the outline of the thesis explained.  
 
 
HIV-infected children and their nutritional status
 
 
Failure to thrive has been a prominent feature of paediatric HIV since the early cases were 
observed (Arpadi, 2000), and it's thought to be an indicator of HIV disease progression 
(Arpadi, 2005). There is also a strong association between micronutrient deficiency,
 
poor 
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growth and
 
HIV disease progression (Semba & Tang, 1999). In this section therefore we shall 
briefly discuss the magnitude of HIV disease in children, followed by the growth performance 
(weight and height) of HIV-infected children and the micronutrient status of these children. 
 
 
Magnitude of HIV disease in children
 
The number of children under 15 years living with HIV worldwide in 2009 was estimated to 
be 2.5 million, and 90% of these children were in sub-Saharan Africa (UNAIDS, 2010). The 
number of children younger than 15 years infected with HIV in South Africa was estimated to 
be 280 000 (UNAIDS, 2010). In terms of new infections with HIV it is estimated that there 
were 430 000 children younger than 15 years worldwide who were newly infected with HIV 
in 2008, and 90% of
 
them were in Sub-Saharan Africa (WHO, 2010). In South Africa the 
number of children under 14 years of age who were newly infected with HIV in 2006 was 
approximately 64 000 (Dorrington et al.
 
2006). Over 90% of HIV infections in children are 
due to mother-to-child transmission (WHO, 2010).     
 
       Infection with HIV has a major impact on the admission of children to South African 
hospitals (Rabie et al. 2007), and the infection has changed  the profile of paediatric admission 
diagnoses and has increased the mortality rate of hospitalized children (van Deventer et al. 
2005). A South African academic hospital reported that approximately 60% of children 
admitted were HIV-infected (Pillay et al.
 
2001). A
 
survey that reviewed the mortality in 16 
South African hospitals showed
 
that approximately 48% of the deaths of children admitted to 
these hospitals were related to HIV infection (Patrick & Stephen, 2008).
 
       
HIV infection is thus a major problem among South African children; therefore 
interventions that can mitigate its effects are crucial.
 
  
Growth performance of HIV-infected children
 
Poor nutritional status, pneumonia and diarrhoea have been noted as
 
the most common causes 
of death in HIV-infected children (Patrick & Stephen, 2008). Slow weight gain and poor 
linear growth are common manifestations of paediatric HIV infection (Chantry et al. 2003). A 
strong inverse relationship between the rate of growth and the degree of HIV viral replication 
has been reported (Arpadi et al. 2000).  
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The postnatal growth of HIV-infected children, as measured by weight-for-age and 
length-for-age has been observed to be poorer than that of HIV-exposed but uninfected 
children; this has been observed in both developed and developing countries (Isanaka et al. 
2009). A study that prospectively followed children born to H IV-infected mothers in 11 
European countries revealed that infected children had poorer growth (in terms of both weight 
and height) compared to uninfected children (Newell et al. 2003). The prevalence of moderate 
to severe underweight and stunting among HIV-infected Indian children was noted to be 63% 
and 58%, respectively (Padmapriyadarsini et al.
 
2009). Similarly, the prevalence of 
underweight and stunting was shown to be significantly higher in HIV-infected Ugandan 
children than in uninfected ones (Nalwoga et al.
 
2010).  Impairment in weight-for-age and 
length-for-age has been detected as early as 3-4 months after birth (Isanaka et al. 2009).
 
The 
weight and height impairment seems to worsen with increasing age (Arpadi, 2005; Newell et 
al. 2003).
 
 
Micronutrient status of HIV-infected children 
Micronutrient deficiencies have been shown to be more severe in HIV-infected children, 
compared to uninfected children, and several micronutrient deficiencies often coexist (Eley et 
al.
 
2002a; Eley et al.
 
2002b). In a study that measured the concentrations of vitamins A, B6, 
B12, E and folic acid,
 
zinc and copper in stable antiretroviral naïve HIV-infected South 
African children whose median age was 25 months, 62% had two or more deficiencies of 
these micronutrients (Eley et al.
 
2002a). Zinc deficiency was also found to be frequent among 
HIV-infected Ugandan children; where it was observed that two thirds of untreated (with 
antiretroviral therapy (ART)) children were zinc deficient (Ndeezi et al.
 
2010). Anaemia and 
iron deficiencies
 
have also been noted to occur frequently in stable HIV-infected children; in 
a group of HIV-infected South African children, 73% were anaemic and 45% of all anaemic 
children were iron depleted (Eley et al.
 
2002b). A review by Singhal and Austin (2002) 
indicated that deficiencies of vitamins B2, B6, B12, E and folic acid are common in HIV-
infected persons. 
 
Role of micronutrients in the immune system
 
Zinc deficiency affects both non-specific and specific immunity. Deficiency of zinc results in 
epidermal cell damage, and damage to the linings of the gastrointestinal and pulmonary tracts 
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has been observed during zinc deficiency (Finamore et al. 2008; Prasad, 2007). Deficiency of 
zinc also affects other mediators of non-specific immunity, such as polymorphonuclear 
leucocyte and natural killer cell function (Finamore et al. 2008; Prasad, 2007). The cytokines 
interleukin-1, interleukin-2 (IL-1, IL-2) and interferon-ã have been reported to be suppressed 
during zinc deficiency (Prasad, 2008). Zinc deficiency results in decreased T and B 
lymphocyte concentrations and depressed T and B lymphocyte functions, and decreased 
CD4+:CD8+ ratios are also seen (Prasad, 2007; Prasad, 2008). Zinc is an antioxidant and its 
role in modulating oxidative stress has been recently recognised (Prasad, 2008). Children with 
low plasma zinc levels have been observed to have an increased risk of episodes of diarrhoea 
and acute respiratory infections compared to children with normal plasma zinc levels, and 
zinc deficiency is thought to result in a substantial disease burden among children less than 5 
years of
 
age (Fischer Walker et al. 2009).
 
       
Vitamin A plays an important role in maintaining the structural and functional integrity of 
mucosal epithelial cells and this is essential in preventing microbial invasion (Mehta & Fawzi, 
2007). Loss of integrity of the epithelial lining of mucous membranes in vitamin A deficient 
persons explains the close association with increased susceptibility to gastrointestinal and 
respiratory infections (Mehta & Fawzi, 2007). Indeed it has been indicated that children with 
mild vitamin A deficiency are at increased risk of both diarrhoeal and respiratory disease 
(Nojilana et al. 2007). The functions of vitamin A include increasing the levels of acute phase 
reactants in response to infection, regulating monocyte function, improving the cytotoxicity of 
natural killer cells and increasing total lymphocyte, especially the CD4 counts (Mehta & 
Fawzi, 2007). 
 
       
Impairment of cell mediated immunity has been described in iron-deficient humans 
(Kumar & Choudhry, 2010). Iron deficiency has been demonstrated to reduce the bactericidal 
effects of neutrophils (Bhaskaram, 2002). Other immunological abnormalities that have been 
observed with iron deficiency include impaired natural killer cell activity, reduced production 
of macrophage inhibitor activity, depression of T-lymphocyte numbers, defective T-
lymphocyte induced proliferative response, impaired interleukin-2 production by lymphocytes 
and impairment of delayed cutaneous hypersensitivity (Kumar & Choudhry, 2010). On the 
other hand, iron is essential for both the child and the invading pathogen (Ianotti et al.
 
2006), 
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but iron binding proteins such as transferrin and lactoferrin inhibit bacterial growth by making 
iron unavailable to the pathogens (Oppenheimer, 2001).          
 
       
Micronutrients such as vitamin C, vitamin E, selenium, copper and riboflavin are 
powerful antioxidants and antioxidant deficiencies have been found to adversely influence the 
cytokine profile of host T cells (Bhaskaram, 2002). Vitamin B -6 deficiency is associated with 
reduced lymphocyte proliferation and antibody production, while neutrophil function is 
reduced with vitamin B12 deficiency (Dreyfuss & Fawzi, 2002). Riboflavin deficiency 
impairs the ability to generate humoral antibodies in response to antigens
 
(Fawzi et al.
 
1999). 
Vitamin E is known to influence the functions of T and B cells, as well as phagocytes (Semba 
& Tang 1999). Vitamin C deficiency has been associated with both B and T cell lymphocyte 
dysfunctions (Fawzi et al.
 
1999). Selenium deficiency inhibits neutrophil function, the 
cytotoxicity of T lymphocytes and natural killer cells, and it also inhibits antibody production 
(Dreyfuss & Fawzi, 2002).  
 
       
There are many potential causes of poor nutritional status (growth performance and 
micronutrient status) in HIV-infected children, and these include reduced dietary intake, 
increased nutrient losses and increased nutrient requirements.  
Reduced dietary intake 
Decreased oral intake in HIV-infected children results  from various causes including anorexia 
(loss of appetite), dysphagia (difficulty in swallowing) and odynophagia (painful swallowing 
(Semba & Tang, 1999). Loss of appetite has been reported to be common among HIV-
infected children (Heikens et al. 2008). The loss of appetite is probably a major contributor to 
the decreased dietary intake. The dysphagia and odynophagia may be caused
 
by
 
oro-
pharyngeal candidiasis which is a frequent finding in HIV-infected children (Singh
 
et al. 
2003).
 
Increased nutrient losses
 
Malnutrition can result from increased nutrient losses as a result of chronic vomiting, 
diarrhoea and malabsorption. Malabsorption has been noted to be more common in HIV-
infected children and is associated with advanced HIV disease and higher degrees of 
malnutrition (Densupsoontorn
 
et al. 2009). Diarrhoea and malabsorption of fats and 
carbohydrates appear to be common in all stages of HIV infection (Semba & Tang, 1999). 
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Malabsorption of fat probably results in reduced absorption of fat-soluble vitamins such as A, 
D, E and K.  
 
Increased nutrient requirements
 
The utilization of nutrients (including micronutrients) is thought to be increased in HIV-
infected children (Duggan & Fawzi, 2001). The increased utilization is partly related to the 
metabolic effects of cytokines released and inflammation associated with HIV infection 
(Keusch & Farthing, 1990). Catabolism of stored nutrients is necessary for the provision of 
energy and substrates required for the increased protein synthesis of the normal host response 
to infection (Keusch & Farthing, 1990). 
 
       
It has been postulated that total energy expenditure is increased in children with HIV, and 
this may be secondary to increases in resting energy expenditure
 
(REE). REE (adjusted for fat 
free mass) has been reported to be increased in HIV-infected adults when compared to 
uninfected ones (Fitch et al. 2009). In a study conducted in American children, the mean REE 
was lower in HIV-infected children than in uninfected children, however, the mean REE/kg of 
body weight was significantly higher among HIV-infected children (Henderson et al. 1998). 
A higher energy expenditure implies an increase in requirements of nutrients.      
       In summary, the nutritional status of HIV-infected children has been noted to be poor in 
terms of weight, height and micronutrients. The causes of the poor nutritional status include 
poor food intake (which is partly related to appetite), malabsorption and increased 
requirements of nutrients.
 
 Relationship between micronutrient levels and HIV infection
 Deficiency of micronutrients and HIV infection are both individually associated with immune 
deficiency and HIV infection itself results in micronutrient deficiency. The deficiency of 
micronutrients in HIV-infected children is partly related to poor dietary intake (poor appetite, 
mouth sores etc), malabsorption of nutrients (including micronutrients) and increased 
requirement of nutrients. The resultant micronutrient deficiency will further suppress 
immunity and will accelerate the progression of HIV disease. This will increase susceptibility 
to infections (including diarrhoea) even more, with additional loss of micronutrients. This 
vicious cycle is well described in the review by Semba and Tang (1999).
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It has thus been noted that deficiencies of micronutrients are common in HIV-infected 
children, and that these children commonly lack multiple micronutrients. Furthermore, these 
micronutrients play an important role in the immune system thus their deficiency is likely to 
increase susceptibility to infections.
 
  
Rationale for multi-micronutrient supplementation in HIV-infected children
 
 
People in the developing world show deficiencies of not just one micronutrient, but of several 
key micronutrients including
 
vitamins A, B2, B12, and folic acid, iron and zinc 
(Micronutrient Initiative, 2004). The most prevalent micronutrient deficiencies include 
vitamins A, B2, B12, D and E, and iron and zinc; deficiencies of these micronutrients often 
occur together due
 
to a low intake of animal source foods (Allen
 
et al.
 
2009; Murphy & 
Allen, 2003). HIV-infected children have been shown to have multiple micronutrient 
deficiencies (Eley et al.
 
2002a; Eley et al.
 
2002b). In view of the fact that micronutrient 
deficiencies commonly occur as concurrent deficiencies of several micronutrients, it is 
considered that the deficiencies should be addressed simultaneously (Gross et al.  2005).  
       A number of studies have assessed the effects of multi -micronutrient supplementation  on 
growth and duration and number of episodes of diarrhoea and of pneumonia in children. Most 
of these studies were performed in children who were not HIV-infected, however, a large 
number of the children were undernourished, and as previously stated HIV-infected children 
tend to be undernourished. These studies may thus be relevant for HIV-infected children. 
While there is a number of studies that have looked at the effects of multi-micronutrient 
supplementation, a larger number of studies assessed the effects of a single micronutrient. 
When deciding which micronutrients should be included in a multi-micronutrient supplement, 
it is useful to assess the effects of individual micronutrients on these children as well. 
 
 
Effects of micronutrient
 
supplements
 
on appetite
 
Deficiency of zinc has been associated with taste disturbances and poor appetite (Ueda et al. 
2006; Chen
 
et al. 2000). It is also thought that zinc levels may have an effect on serum leptin 
(a hormone involved in the regulation of appetite) concentrations (Kwun
 
et al. 2007). 
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Supplementation with zinc was shown to improve the appetite of zinc deficient patients with 
cystic fibrosis (Van Biervliet et al.
 
2008). 
 
       
Iron deficiency is also thought to be associated with poor appetite (Isguven et al.
 
2007), 
and iron supplementation might improve appetite. Indeed the appetites of Zanzibari school 
children
 
were improved by
 
supplementation with iron (Stoltzfus et al.
 
2004).  
 
       
Supplementation with a multi-micronutrient (containing vitamins A, B1, B2, B3, B5, B6, 
B12, C, D, E and folic acid and zinc, iron, copper, iodine, manganese, chromium, selenium 
and molybdenum) for six weeks did not improve the appetite of children in Benin (a country 
with low HIV prevalence) (Dossa et al. 2002). Adding more iron to the afore-mentioned 
supplement did not improve the appetite of Beninese children (Dossa et al. 2001).
 
       
The benefits of multi-micronutrient supplementation on appetite have not been clearly 
established, and as far as we know there is no published study that assesses the effects of 
multi-micronutrient supplementation on appetite of HIV-infected children. We therefore 
decided to design a study that assesses the effect of multi-micronutrient supplementation on 
the appetite of HIV-infected children.   
 
Effects of micronutrient supplements on growth  
Zinc, vitamin A and iron deficiencies are known to be associated with impaired growth 
(Brown et al. 2002; Umeta et al. 2003; Melikian et al. 2001; Isguven et al. 2007). Zinc 
supplementation may significantly improve growth in prepubertal children (Brown et al. 
2002). Supplementation with iron for six months to a group of malnourished Indian children 
resulted in significantly higher gains in weight and in height compared to children who were 
given a placebo (Abdelrazik et al. 2007). Multi-micronutrient supplementation (vitamins A, 
B1, B2, B3, B6, B12, C, D, E and folic acid, and zinc, copper, iodine and iron) was shown to 
be beneficial for growth in Vietnamese children (Hop
 
et al. 2005). Likewise supplementation 
with a multiple micronutrient (containing vitamins A, B1, B2, B3, B6, B12, C, D, E and K, 
and folic acid, zinc, copper, iodine and iron) improved length-for-age in stunted HIV-
uninfected South African children, compared to children given vitamin A alone or zinc with 
vitamin A (Chhagan et al. 2010). However, multiple micronutrient supplementation had no 
effect in on the linear growth of another group of South African children (HIV status not 
indicated) (Smuts et al. 2005).          
 
                                                                                                                                         
                                    
                                                                                                                                                                                                    
18
 
 
 
Effects of micronutrient supplements on diarrhoea
 
Diarrhoea has been reported to be significantly more frequent and more severe among HIV-
infected than among
 
uninfected children
 
(Humphreys et al. 2010). Certainly, diarrhoeal 
disease has been noted as
 
the second
 
most
 
common admission diagnosis among HIV-infected 
South African children (van Deventer et al. 2005). 
 
       
The aetiology of HIV-related diarrhoea is multi-factorial and is thought to include 
opportunistic gut infections (due to suppressed immunity) and intestinal dysfunction (Janoff 
& Smith, 2001; Keusch & Farthing, 1990). HIV infection itself has a major impact on the 
structure and function of the alimentary tract, and the virus has been found in the intestinal 
mucosa and may directly lead to intestinal symptoms (Keusch & Farthing, 1990). The 
transactivating peptide (Tat), which is produced by the HI virus, is thought to play a primary 
role in pathogenesis of diarrhoea in HIV-infected patients (Canani et al. 2007). Tat stimulates 
active fluid secretion into the gut lumen and inhibits
 
fluid absorption at the intestinal level 
(Canani et al. 2003; Canani et al. 2006). 
 
       Zinc supplementation in children with acute diarrhoea has been shown to reduce the 
duration of diarrhoea, stool output and the risk of prolonged diarrhoea (Bhatnagar et al. 2004). 
The beneficial effects of zinc treatment on the duration of diarrhoea have been summarised in 
the review by Hoque and Binder (2006), and are thought to include the following: (a) 
improved absorption of water and electrolytes by the intestines, (b) faster regeneration of gut 
epithelium, (c) increased levels of enterocyte brush-border enzymes, and (d) an enhanced 
immune response leading to an increased clearance of the pathogen/s responsible for 
diarrhoea from the intestines. Zinc has also been shown to have an inhibitory effect against 
HIV-related Tat protein induced secretory diarrhoea thus directly limiting a specific 
mechanism of HIV-related diarrhoea (Canani et al. 2006). Supplementation with zinc also 
seems to reduce the incidence and severity of diarrhoeal episodes in children (Bhandari et al. 
2002). A
 
reduced incidence of diarrhoea was observed in zinc supplemented
 
HIV-infected 
South African children (Bobat et al.
 
2005).  
 
       
Vitamin A supplementation seems t o be associated with protective effects in HIV-
infected children with diarrhoea. The risk for severe watery diarrhoea has been observed to be 
lower in HIV-infected children supplemented with vitamin A (Mehta & Fawzi, 2007). 
                                                                                                                             
Chapter 1
                                                                                                                             
            
Introduction
 
                                    
                                                                                                                                                                                                    
19
 
 
 
Vitamin A supplementation was associated with a trend towards decrease in persistent 
diarrhoea among HIV-infected Ugandan children (Semba et al. 2005).  
 
       
Similarly, supplementation with a multi-micronutrient was shown to reduce the incidence 
of diarrhoea in stunted HIV-uninfected children (Chhagan et al. 2009). Another study on the 
other hand revealed no effect on diarrhoeal frequency or severity in HIV-infected and 
uninfected South African children who received a multi-micronutrient (Luabeya et al.
 
2007).  
 
           
Effects
 
of micronutrient supplements on pneumonia
 
The HIV epidemic has markedly increased the incidence and severity of childhood 
pneumonia in developing countries and approximately 90% of HIV-infected children will 
develop a respiratory illness during the course
 
of their HIV disease (Graham, 2003; Graham, 
2007). The incidence of pneumonia has been shown to be more common in HIV-infected than 
in uninfected children
 
(Madhi et al. 2000). Respiratory diseases are the major cause of 
morbidity and mortality in HIV-infected children (Graham, 2003). A
 
study conducted in 
Johannesburg, South Africa, indicated that although the prevalence of HIV-1 infection is 5% 
among children younger than 5 years; children in this age group accounted for 45% of those 
hospitalized and 85% of those who died as a result of severe pneumonia (Madhi et al. 2000).      
       Supplementation with zinc may be beneficial in reducing the duration of pneumonia 
(Brooks et al. 2004), but this is not a consistent finding (Bose et al. 2006). A meta -analysis 
concluded that zinc supplementation reduces the risk of respiratory illness (Aggarwal et al. 
2007).       
 
       
While some studies have suggested that vitamin A may reduce the duration of non -
measles pneumonia (Julien et al. 1999), a meta-analysis indicated that there is no evidence 
that high-dose Vitamin A
 
(  100 000IU for infants and 00 000 IU for children older than 1 = = 2
year)
 
improves recovery from pneumonia in developing countries (Brown & Roberts, 2004). 
 
       
Consumption of milk fortified with
 
multi-micronutrients reduced the incidence of 
pneumonia in Indian children, compared to children who received the same milk without 
fortification (Sazawal et al. 2007). Conversely, multi-micronutrient supplementation had no 
effect on the incidence of pneumonia in either HIV-infected or uninfected South African 
children (Luabeya et al.
 
2007).      
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Multi-micronutrient supplementation seems to improve growth in stunted children, and 
may be of benefit in improving appetite and reducing diarrhoea and respiratory infections in 
children. Investigating the impact of multi-micronutrient supplementation in HIV-infected 
children in relation to these outcomes would be worthwhile. In view of the various effects of 
micronutrients, a multi-micronutrient supplement
 
is likely to be more beneficial in HIV-
infected children than a single micronutrient. Such a supplement should at least include the 
following micronutrients; vitamins A, B2, B12, D and E, and iron and zinc. Deficiencies of 
these micronutrients are often usually associated with a diet that is low in animal source foods 
(Allen
 
et al.
 
2009). In the long-term it is probably better to correct micronutrient deficiencies 
through an improved diet rather than supplementation with tablets. However, animal source 
foods tend to be expensive and are thus not easily affordable by poor communities. Therefore
 
supplementation may be the more practical option
 
in the short
 
to medium-term. This is 
especially
 
so
 
when one notes that HIV-infected children are often seen at health care centres 
at regular intervals and the supplements can thus be easily distributed from these centres.   
 
 
Public health importance of multi-micronutrient supplementation in HIV-infected  
children 
 
Supplementation with micronutrients is likely to reduce the duration of and number of 
episodes of diarrhoea and respiratory
 
tract infections in HIV-infected children. 
Supplementation might also improve the appetite and growth of these children. When one 
considers the fact that the most common complications seen in HIV-infected children are poor 
growth and undernutrition, respiratory tract infections and diarrhoea,
 
it becomes clear that an 
intervention that attenuates these problems is highly relevant.   
 
       
It is recognised that the mainstay of treatment in HIV-infected children is anti-retroviral 
therapy. In South Africa, antiretroviral therapy (ART) was generally not available to patients 
in the public sector (which serves the overwhelming majority of South Africans) when the 
present studies were conceived. The South African government made a decision to provide 
ART in the public sector during the latter period of 2003 and the treatment began in April 
2004. However, in spite of this a large number of HIV-infected children in sub-Saharan 
Africa are still not on ART. South Africa has the largest (in absolute numbers) ART 
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programme in Africa. Despite this fact, it was estimated that the proportion of HIV-infected 
children on ART in South Africa w as 10% in 2007 (UNAIDS, 2008). By the end of 
November 2009 there were 86 270 children on ART in South Africa ,
 
out of the 280 000 HIV-
infected children at the same time (UNAIDS, 2010). 
 
       
Therefore even in the era of expansion of the ART programme, mul ti-micronutrient 
supplementation remains an important part of the management of HIV-infected children.
 
 
Objectives of studies reported in this thesis
As outlined above HIV-infected children have a poor nutritional status as indicated by 
anthropometric indices and micronutrient levels. These children are also prone to diarrhoeal 
disease and acute respiratory infections. Micronutrient deficiencies on their own may cause 
immune suppression and also increase the risk of diarrhoea and respiratory infections. 
Children with micronutrient deficiencies are also more likely to have poor growth and poor 
appetite. 
 
       The main objective of the research presented in this thesis was to study whether 
micronutrient supplementation improves growth performance, morbidity (specifically 
diarrhoea and acute respiratory infections) and appetite in HIV-infected young South African 
children.          
       
We started by performing a cross-sectional study where we compared the nutritional 
status, duration of hospitalisation and appetite of HIV-infected children who were admitted to 
hospital with diarrhoea and pneumonia and that of HIV-uninfected children admitted with the 
same diagnoses. This was done to confirm that HIV-infected children would have a poorer 
appetite and nutritional status and that their duration of hospitalization would be longer. The 
outcomes of the cross-sectional study suggested that these two groups of children were 
different; hence assessing them separately might
 
be appropriate. However, there was a 
reasonable number of trials that have assessed the effects of multi-micronutrients in HIV-
uninfected children. As previously stated, ART had recently been introduced in South African 
public hospitals when the study was performed (thus there were few children on ART).  We 
thus decided to assess the short-term and long-term (over 6
 
months) effects of multi-
micronutrient supplementation only in HIV-infected children who were not yet on ART. 
 
We thus formulated the following hypotheses. 
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Short-term multi-micronutrient supplementation would reduce the duration of an acute 
episode of pneumonia or diarrhoea in HIV-infected children.
 
 
Long-term multi-micronutrient supplementation
 
would improve the growth 
performance and reduce the number of episodes of diarrhoea or pneumonia
 
in HIV-
infected children.
 
 
A multi-micronutrient supplement over a long-term would improve the appetite of 
HIV-infected children.
 
  
 
Outline of thesis
 
 
In Chapter 2 the
 
nutritional status, appetite and duration of hospitalisation of HIV-infected 
young children is compared with that of uninfected children. Chapter 3 focuses on the effect 
of short-term multi-micronutrient supplementation on the duration of hospitalisation in HIV-
infected young children hospitalised with diarrhoea or pneumonia. In Chapter 4 we assessed 
whether long-term daily multi-micronutrient supplementation would improve the growth 
performance and reduce the number of episodes of diarrhoea or pneumonia in HIV-infected 
young children. Chapter 5 describes the effect of long-term multi-micronutrient 
supplementation on the appetite of HIV-infected young children and the levels of appetite 
regulating hormones. Finally, in Chapter 6 the main findings of this dissertation, nutritional 
aspects of children on ART and suggestions for future research are discussed.
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Abstract
 
Human immunodeficiency virus (HIV)-infected children generally show poor growth. 
Episodes of diarrhoea and pneumonia in HIV-infected children are thought to be more severe 
than in HIV-uninfected children. The objective of this study was to compare duration of 
hospitalization, appetite and nutritional status of HIV-infected children with that of uninfected 
children. A cross -sectional study was performed on children (2-24 months) admitted with 
diarrhoea or pneumonia to the university hospital. Children were tested for HIV, and the 
duration of hospitalization was noted for 192 children. Follow-up for blood analysis (n = 154) 
and appetite measurement (n = 50) was performed
 
4-8 weeks after discharge. Appetite was 
measured as ad libitum intake of a commercial infant cereal using highly standardized 
procedures. Hospitalization (in days) was significantly longer in HIV-infected children; 
among children admitted with diarrhoea (5.9 ± 1.9 vs 3.8 ± 1.5) (mean ± standard deviation)
 
and with pneumonia (9.3 ± 3.0 vs 6.1 ± 2.1). Serum zinc, iron and transferrin concentrations, 
and haemoglobin levels were significantly lower in HIV-infected children compared with 
uninfected children. Appetites [amounts eaten (g) per kg body weight] of HIV-infected 
children were significantly poorer than those of HIV-uninfected children (18.6 ± 5.8  vs 25.2  ± 
7.4). The eating rates (g min- 1) of HIV-infected children were also slower (17.6 ± 6.2) vs 10.1 
± 3.7). Mean Z-scores for length-for-age were significantly lower among HIV-infected 
children compared to HIV-uninfected children. Weight -for-length Z-scores were not 
significantly different. In summary, HIV-infected children had a 52% longer duration of 
hospitalization and a 26% lower appetite.
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INTRODUCTION
 
 
It is estimated that in 2006 there were 36 million people infected with the human 
immunodeficiency virus (HIV) worldwide; 24 million of these infected people were in Sub-
Saharan Africa (UNAIDS 2007). The number of HIV-infected persons in South Africa is 
estimated at 5.4 million,
 
of whom approximately 294 000 are children under
 
15 years 
(Dorrington et al. 2006). Infection with HIV has had a major impact on the admission of 
children to South African hospitals (Zwi et al. 2000). In one of South Africa's academic 
hospitals,
 
approximately 60% of children admitted were HIV-infected (Pillay et al. 2001). 
The commonest admission diagnosis among HIV-infected South African children is reported 
to be pneumonia, followed by diarrhoea (van Deventer et al. 2005). 
 
       
The duration of hospitalization may be longer in HIV-infected children compared with
 
uninfected children. An evaluation of a database that accounted for approximately 73% of  all 
US hospital discharges of children in 2000 indicated that HIV-infected children had a 
significantly longer mean duration of hospitalization (7.8 days  vs 3.9 days), when compared 
with HIV-uninfected children (Kourtis et al. 2006). In a group of children who were younger 
than 5 years and were admitted to a tertiary hospital in Johannesburg, South Africa, those who 
are HIV-infected had an average 33% longer hospital  stay  than uninfected children (Meyers et 
al. 2000). HIV-infected children, who were admitted to a hospital in Cape Town, South 
Africa,
 
with pneumonia had an average 33% longer duration of hospitalization when 
compared with HIV-uninfected children (Zar et al. 2001). In yet another group of children 
who were admitted with diarrhoea to a hospital in Johannesburg, South Africa, it was noted 
that the median duration of hospital stay was 8 days for HIV-infected children, as opposed to 
3 days for HIV-uninfected children (Johnson et al. 2000). HIV-infected children from 
Durban, South Africa had a slightly longer duration of hospitalization than uninfected 
children; the difference approached but did not reach statistical significance (Pillay et al. 
2001).
         
       
Persistent anorexia (loss of appetite) has been reported to be common among HIV-
infected children (Heikens et al. 2008). In fact, loss of appetite was reported to be a common 
symptom in a group of HIV-infected Indian children, being reported in 59% of these children 
(Pol et al. 2007). Reduced energy intake is known to be common among HIV-infected people. 
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Indeed, a study conducted in England on HIV-infected men concluded that reduced energy 
intake was the prime determinant of weight in HIV associated wasting (Macallan et al. 1995). 
Loss of appetite is an important cause of reduced food intake. Oropharyngeal and oesophageal 
candidiasis are common with HIV infection and may lead to dysphagia (difficulty in 
swallowing) and odynophagia (painful swallowing) (Semba & Tang 1999). These problems 
also contribute to the poor food intake that occurs in these children. 
 
       
The nutritional status in terms of weight,
 
height and micronutrient status of HIV-infected 
children is reported to be poor compared
 
with
 
uninfected children. A study that followed up a 
group of children born to HIV-infected mothers in 11 centres in eight Europeans countries 
showed that between 6 and 12 months of age, uninfected children grew an estimated 1.6% and 
6.2% faster in height
 
and weight respectively, than infected children (The European 
Collaborative Study 2003). In Rwanda, where children born to HIV 1-infected and uninfected 
women were followed for 36 months, it was noted that the mean Z-scores for weight-for-age 
and height-for-age were lower among HIV-infected children compared with
 
uninfected 
children (Lepage et al. 1996). The assertion that HIV-infected children have a poor 
micronutrient status is supported by a study that showed that approximately 60% of stable 
(antiretroviral naïve) HIV-infected children from Cape Town, South Africa, had multiple 
micronutrient deficiencies (Eley et al. 2002a). HIV-infected adults from the Free State 
province in South Africa were shown to be deficient in several micronutrients (van Staden et 
al. 1998).   
 
       
Micronutrients are thought to play a role in infectious diseases, in particular diarrhoea and 
pneumonia. They are also thought to be important in growth and appetite. Deficiencies of zinc 
and vitamin A are associated with increased r isk of diarrhoea and respiratory infections 
(Bloem et al. 1990; Bahl et al. 1998). Micronutrient deficiencies, in particular of zinc,
 
have 
been associated with stunting and poor appetite (Umeta et al. 2000). Iron deficiency is also 
associated with poor appetite (Lawless et al. 1994). 
 
       
HIV-infected children are thus more likely to have longer hospital stays and poorer 
appetites than uninfected children. Children with HIV infection are also likely to have poor 
growth and micronutrient status. The increased duration of hospitalization and poor appetites 
may be influenced by the poor nutritional status that is thought to be common in these 
children. 
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Antiretroviral therapy (ARV) was not available in South African public hospitals when 
the study was designed, and even at the conclusion of the study, only a modest number of 
patients were on ARVs. However, there is evidence that ARVs have an influence on the 
duration of hospitalization of HIV-infected children. This is supported by a retrospective 
study that was conducted in Italy that showed that the duration of hospitalization was longer 
in HIV-infected children who did not receive ARV compared to those who received the 
therapy (Resino et al. 2006). It was therefore decided to exclude children who were on ARVs. 
 
       
The objective of the study was to compare duration of hospitalization, appetite and 
nutritional status of HIV-infected children with that of uninfected children.  
 
 
SUBJECTS AND METHODS 
 
 
Subjects and study area 
 
The study was conducted between August 2004 and March 2005. The subjects were children 
aged 2 months-2 years who were admitted with diarrhoea and/or pneumonia to the Dr George 
Mukhari hospital (previously GaRankuwa hospital), the teaching hospital for the Medunsa 
campus of the University of Limpopo. This government owned peri-urban hospital is about 35 
km north-west of Pretoria, the capital city of South Africa. The subjects were mainly from the 
townships surrounding the hospital. More than 80% of the patients who visit the hospital have 
no medical insurance and attend state-owned clinics and hospitals. Children under 6
 
years of 
age are not required to pay for hospital visits. Children admitted with acute lower respiratory 
tract infection (pneumonia) or acute diarrhoea were recruited to take part in the study. 
 Exclusion criteria
  
All children who had received vitamin or mineral supplements in the past 2
 
months were 
excluded. As we were assessing the length of hospitalization
 
in children with acute 
pneumonia or diarrhoea,
 
it was decided to exclude children whose pneumonia or diarrhoeal 
episode was longer than 72 h on admission.
 
Children with pneumonia and respiratory failure,
 
i.e. hypoxia on supplemental oxygen,
 
were not included.
 
Children who had both diarrhoea 
and pneumonia were also excluded.
 
Any child who was on ARV
 
was not eligible for 
inclusion.
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Study design
 
A cross sectional study was performed. The subjects were enrolled on admission or within 24 
h of admission. At enrolment, the following information was obtained: age, gender, body 
weight and length. The HIV status of all the subjects was determined (after counselling and 
informed consent) using the enzyme linked immunosorbent assay (ELISA) method in 
children older than
 
18 months, and by polymerase chain reaction (PCR) (Gene Amp 2400, 
Applied Biosystems, Foster City, CA, USA) in those younger than 18 months who had a 
positive ELISA. Children who had a documented previous positive HIV test result were not 
retested. 
 
       
It was scheduled to enrol a total of 200 children i.e. 100 HIV-infected and 100 HIV 
uninfected. The treatment was as per standard hospital care, as determined by the attending 
physician. Children with diarrhoea were assessed for dehydration, and the dehydration was 
corrected over 24 h if there was hypernatraemia, or if the age was 3 months or less; otherwise 
rehydration was performed over 6 h. Diarrhoea was defined as the passing of three or more 
loose stools per day (Al-Sonboli et al. 2003), and pneumonia as a period during which a child 
was reported to have a cough, had a temperature of 38 C or more, and had an elevated 
respiratory rate, above the age-specific value on a minute estimation (World Health 
Organization 1990). The children admitted with diarrhoea were considered to ready for 
discharge when they had passed stools of normal consistency or no stools in the past 24 h and 
were well hydrated. Children with pneumonia were also considered for discharge when the 
temperature had been normal for at least
 
24 h, their
 
respiratory rate already normal (Beatty 
1998), there was no intercostal or sternal recession, and when the child is already able to drink 
and feed. On discharge, the duration of hospital stay was noted (from admission date to date 
of discharge), and the caregiver of the child was given a follow-up calendar date, written on 
an appointment card. The follow-up date was 4-8 weeks post discharge. At follow-up, the 
weight was measured; the children were assessed clinically for acute illness, by the 
investigator. Blood samples for serum zinc, iron, and ferritin and transferrin were taken in 
those who were not acutely ill. Children who were acutely ill were given another return date. 
All the caregivers of children who were 6 months or older (and were already consuming 
solids) were asked to participate with their children in the appetite-testing segment of the 
study, which required three additional follow-up days. 
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Anthropometry
 
The ages of the children were calculated in months by using their reported dates of birth.
 
The weight was measured using a single beam balance scale, without the child's shoes on and 
with the child wearing only light clothing, to the nearest 0.1 kg. The scale was calibrated to 
zero before each measurement session. The children were
 
not clinically dehydrated at the time 
of the weight measurements. The length was measured in the recumbent position to 0.1 cm, 
on a baby board, by the investigator with the help of an assistant. One examiner held the 
child's head (with the chin in the neutral position) in contact with the fixed part of the board, 
while the other examiner stretched the child to maximum length and then brought the 
movable part of the board into contact with the heels. Z-scores for weight-for-age, length-for-
age, and weight-for-length were calculated based on the National Centre for Health Statistics 
by means of the Epi-Info software version 3.2.2 (Centers for Disease Control and Prevention, 
Atlanta, Georgia, USA) (Dean et al.
 
2000).
 
Blood sampling and analysis
 
Blood samples were collected by venepuncture (puncture site cleaned with trace element-free 
alcohol). The samples for zinc were collected in trace element-free tubes with removable lids. 
All the blood samples were collected by the investigator and were sent to the laboratory 
immediately after collection, protected from light and stored at -20 C after centrifugation, 
until analysis. All the blood samples were stored at the Medunsa branch of the National 
Health Laboratory Services (NHLS) and analysed within 3 months of collection.
 
       
Serum zinc was measured by atomic absorption spectrometry in mol L- 1
 
(Perkin Elmer 
ICP/5500, Perkin Elmer Life and Analytical Sciences Inc., Waltham, Massachusetts, USA); 
separation from cells was conducted within 45 min. Serum iron was measured in mol L- 1
 
(SYNCHRON CX Systems IRON/TIBC Calibrator Kit, Beckman Instruments, Johannesburg, 
South Africa) by using rate spectrophotometry. Serum ferritin was measured using 
commercial ELISA
 
kits in g L- 1
 
(Access Ferritin assay, Access Immunoassay Systems, 
Beckman Coulter, Johannesburg, South Africa). Quality control for serum zinc, iron and 
ferritin was assessed by repeat analysis of standard reference material for low, normal and 
high values. Coefficients of variation of less than 5% were considered acceptable. Serum 
transferrin was measured in g L- 1
 
using spectrophotometry (Beckman Immage
 
Immunochemistry Systems and Beckman Calibrator 1, Beckman Instruments, Johannesburg, 
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South Africa). The C-reactive protein (CRP)
 
was measured by nephelometry using an 
international reference standard for plasma proteins. CRP levels greater than
 
10 mg L- 1
 
were 
considered to be elevated. Haemoglobin was analysed on whole blood by means of an 
electronic coulter counter in grams per decilitre.
 
Appetite testing
 
Conditions prior to testing
 
The subjects were given appointments on three non-consecutive days within a period of 2 
weeks.
 
The transport costs of the children and their caregivers were reimbursed on arrival at 
the hospital for appetite testing.
 
From the last meal of the day preceding the appetite test, the 
child was not allowed to eat any food,
 
not even breast or formula milk, until after the appetite 
test
 
(Dossa et al.
 
2002).
 
The test was conducted early in the morning. The mothers were asked 
when the last meal of the child was. If for any reason the child had been fed prior to the 
appetite test,
 
the mother was given another date for the appetite test. 
 
Test food
 
After interviewing the mothers, it was clear that the majority of the children consumed 
commercially manufactured infant cereals on a regular basis. The cereal Nestlé Nestum No 2  
[Nestlé (South Africa), South Africa was used. For each participant, 25 g of dry porridge was 
weighed on an electronic load cell scale to the nearest 0.1 g. The cereal contains wheat and 
honey. Each 100 g of the dry cereal contains 9.3 g protein, 77.9 g carbohydrates, 1.7 g fat, and 
5.2 g fibre and has 1634 kJ of energy. Fresh milk was warmed to 50 C (milk container put in 
a bowl of boiled water, until the milk temperature
 
reached 50 C, measured by using a metal 
stem thermometer), and 160ml of this milk was added to the dry porridge and mixed to a 
uniform consistency. One hundred millilitres
 
of the milk contains 3.2 g protein, 4.8 g 
carbohydrates, and 3.8 g fat and yields 260 kJ. The preparation of the test cereal was 
standardized.
 
Test-feeding procedures
 
The
 
weight of the wet cereal was measured. An empty porcelain bowl was weighed and then 
the bowl with the cereal was weighed. The test was conducted in a quiet room, with three to 
five mother-and-child pairs at a time. Each pair sat apart from the next, and the mothers were 
not allowed to communicate with each other during the test. Plastic teaspoons were used for 
feeding the children. The mothers were informed that the child was not obliged to finish the 
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test food and could stop eating at anytime. The mother helped her child such that the child 
was eating ad libitum;
 
the mother was not allowed to verbally encourage the child to eat, nor 
apply any kind of pressure on the child. The child was not allowed to drink water or breast 
milk during the appetite-testing procedure. When a child was about to complete eating, a 
second bowl was prepared in the same manner, and this was offered to the child to eat. When 
the child stopped eating, the amount eaten and the duration of the eating episode was noted. A 
5-min break was then given, after which the child was invited to continue eating. The total 
amount eaten and the total eating duration of the eating episode were noted. The investigator 
supervised the feeding episodes to ensure compliance. The eating environment and utensils 
for each mother and child pair were standard. 
 
 
Ethical considerations
 
The Medunsa Research Ethics and Publications Committee approved the study; the 
permission of the Dr George Mukhari hospital authorities was obtained, and the parents 
provided signed informed consent. 
 
Statistical analysis 
Anthropometric parameters, biochemical indices, duration of hospital stay and appetite test 
measurements were studied by means of analysis of variance (ANOVA). Among the children 
admitted with pneumonia there was
 
interaction between the variables  "HIV status" and
"admission diagnosis" in relation to "age". Consequently, the ages of HIV-infected children 
with pneumonia were compared to uninfected children with pneumonia by using independent-
samples t-test. 
 
       
Correlation between weight-for-length Z-scores and chronological age, and between 
serum ferritin and CRP were assessed by the Pearson correlation coefficient. Correlation 
between anthropometric values, serum zinc and iron concentrations, and duration of 
hospitalization and amount eaten per kilogram body weight were also assessed using the same 
method (Pearson). All statistical tests were two tailed, and P-values less than 0.05 were 
considered statistically significant. 
 
       
All data analyses were performed using SPSS (SPSS Inc., Chicago, Illinois, USA) 
statistical package for Windows version 11.0. 
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RESULTS
 
 
In total 210 children were enrolled, but 18 refused consent for HIV testing, leaving 192 (106 
HIV-infected and 86 HIV-uninfected) children.
 
Of
 
the 106 HIV-infected,
 
71 were admitted 
with pneumonia and 35 with diarrhoea (see Table 1). The proportion of children admitted 
with pneumonia was 67%, and it was 33% for those admitted with diarrhoea. Similarly, two-
thirds of the HIV-infected children had
 
pneumonia as the admission diagnosis. The overall 
male to female ratio was 9:10. This ratio was independent of whether the children were HIV-
infected group or not and whether they were admitted with diarrhoea or with pneumonia. Of 
the full study population, 69% were younger than 1 year of age. ANOVA revealed a 
significant interaction between HIV status and admission diagnosis in relation to the subjects?  
ages. Age was therefore used as a covariant in the ANOVA . It appeared that among children 
admitted with
 
pneumonia, the mean age was significantly higher in those who were HIV-
infected compared with
 
the non-infected group (Table 1). The children were followed up 4-8
 
weeks after discharge for blood sampling and analysis,  and the number of the children in the 
four subgroups is shown in Table 2. The data of appetite measurements was available for 50  
children (Table 3). 
 
Anthropometry
 
The anthropometric indices of the subjects are shown in Table 1. ANOVA showed that for all 
the anthropometric measurements, there was no significant interaction between HIV infection 
and admission diagnosis. Weight -for-age and length-for-age Z-scores were significantly lower 
among HIV-infected children compared with
 
HIV-uninfected children. The admission 
diagnosis (i.e. pneumonia or diarrhoea) did not seem to significantly affect weight-for-age or 
length-for-age Z-scores. There was no significant difference in the weight-for-length Z-scores 
between HIV-infected and HIV-uninfected children. However, ANOVA showed a significant 
interaction between the subjects ages and weight -for-length Z-scores. Pearson's correlation 
coefficient showed a significant negative correlation between age and weight-for-length Z-
scores (P
 
< 0.001). 
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Table 1.  Anthropometric characteristics and duration of hospitalization of all the study 
children
 
 
Pneumonia
 
Diarrhoea
 
All HIV-
uninfected
 
All HIV-
infected
  
HIV-uninfected
 
HIV-infected
 
HIV-uninfected
 
HIV-infected
 
n
 
58
 
71
 
28
 
35
 
86
 
106
 
Gender (M/F)
 
35/23
 
30/41
 
10/18
 
16/19
 
45/41
 
46/60
 
Age (months)
 
7.4 ± 5.7*
 
11.1 ± 6.4
 
11.4 ± 7.6
 
9.1 ± 6.8
 
8.7 ± 6.3
 
10.4 ± 6.5
 
WAZ
 
-1.02 ±  0.97*
 
-1.88 ± 0.83
 
-0.89 ± 1.02†
 
-1.46 ± 0.76
 
-0.97 ± 0.99*
 
-1.74 ± 1.20
 
HAZ
 
-0.65 ± 1.31*
 
-1.72 ± 0.85
 
-0.71 ± 1.10*
 
-1.62 ± 0.88
 
-0.67 ± 1.24*
 
-1.68 ± 0.86
 
WHZ
 
-0.61 ± 1.11
 
-0.78 ± 0.88
 
-0.59 ± 1.12
 
-0.46 ± 0.95
 
-0.60 ± 1.11
 
-0.67 ± 0.90
 
Duration (days)
 
6.1 ± 2.1*
 
9.3 ± 3.0
 
3.8 ± 1.5*
 
5.9 ± 1.9
 
5.4 ± 1.9*
 
8.2 ± 2.6
 
HIV, human immunodeficiency virus; WAZ, weight -for-age Z-score; HAZ, length-for
 
-age Z-
score; WHZ, weight-for-length Z-score.
 
Mean ± standard deviation (n). *Significantly 
different from HIV-infected group (P <0.01). †Significantly different from HIV-infected 
group (P <0.05)
 
 
Duration of hospitalization 
Table 1 also provides the results of the comparison of the duration of hospitalization of HIV-
infected children with that of uninfected children.  The duration of hospitalization was 52% 
longer (9.3 days compared with
 
6.1 days) in HIV-infected children admitted with pneumonia 
as compared with
 
non-HIV-infected children with pneumonia; this difference was significant 
(P
 
<
 
0.001). Among children admitted with diarrhoea, the duration of hospital stay was 55% 
longer (5.9 days compared with
 
3.8 days) in HIV-infected children (P <0.001). Children 
admitted with pneumonia had a significantly longer hospital stay (53% longer) compared with
 
those admitted with diarrhoea (P
 
< 0.001).
 
The Pearson correlation coefficient also revealed a 
significant negative correlation between serum zinc concentrations and duration of 
hospitalization, and between weight-for-age Z-scores (WAZ), length-for-age Z-scores (HAZ) 
and duration of hospitalization.
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Table 2.
 
Biochemical indices 4 to 8 weeks after hospital discharge
 
 
Pneumonia
 
Diarrhoea
 
 
HIV-uninfected 
 
HIV-infected 
 
HIV-uninfected 
 
HIV-infected 
 
Serum zinc (µmol L- 1)
 
5.8  2.9 (48)*±
 
4.7 ± 2.8 (50)
 
67 * ±  3.1 (24)
 
5.3 ±  2.9 (28)
 
Serum iron ( mol Lµ - 1)
 
7.0 ± 4.3 (48)†
 
5.2 ± 3.23 (51)
 
7.5 ± 4.4 (24) †
 
6.5 ± 4.6 (28)
 
Serum ferritin ( g Lµ - 1)
 
76.5  72.9 (43)±
 
90.3 ±  83.8(44)
 
67.3 * ± 54.6 (25)
 
143.0 ±  105.0 (26)
 
Transferrin (g L- 1)
 
2.4   0.9 (43)*±
  
2.1 ± 1.1 (41)
 
2.7 ± 0.9 (19)*
  
2.1 ± 1.0 (25)
 
Haemoglobin (g dL- 1)
 
10.8 *± 1.9 (50)
  
9.5 ± 2.1 (47)
 
10.5 ± 2.0 (25)*
  
9.9 ± 2.0 (28)
 
CRP >10 mg L- 1
 
(%)
 
26% (26)*
  
35% (35)
 
12% (12)
 
*
 
19% (19)
 
HIV, human immunodeficiency virus ; CRP, C-reactive protein.
 
Mean ± standard
 
deviation 
(n). *Significantly different from HIV-infected group (P
 
<0.01), †Significantly different from 
HIV-infected group (P
 
=
 
0.05)
 
 
Biochemical indices
 
The biochemical indices of the subjects are shown in Table 2. ANOVA showed no significant 
interaction between HIV status and admission diagnosis with respect to the concentrations of 
serum zinc, iron and transferrin, and the haemoglobin levels. Serum zinc, iron and transferrin 
concentrations, and haemoglobin levels were significantly lower in HIV-infected children 
compared with the uninfected children. ANOVA revealed a significant interaction between 
HIV status and admission diagnosis in relation to serum ferritin concentrations. Independent 
samples t-test done subsequently showed no significant difference in serum ferritin 
concentrations of HIV-infected and non-HIV-infected children with pneumonia; however, 
HIV-infected children with diarrhoea had significantly higher serum ferritin concentrations 
compared with non-infected children with diarrhoea. A large proportion of both HIV -infected 
and non-infected children were anaemic (Hb < 11g d
 
L- 1), 75% in HIV-infected children and 
58% in HIV-uninfected children. ANOVA revealed that HIV -infected children had 
significantly higher CRP levels independent of admission diagnosis (P
 
< 0.05). The 
percentage of children with CRP levels less than 10mg L- 1
 
among HIV-infected and HIV-
uninfected children was 30% and 21% respectively. Pearson's correlation coefficient showed 
a significant positive correlation between serum ferritin and CRP levels (P
 
< 0.01).
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Table 3.
 
Appetite test 4 to 8 weeks after hospital discharge
  
 
Pneumonia
 
Diarrhoea
 
All HIV-
uninfected
 
 
All HIV-
infected
 
 
 
HIV-
uninfected
 
HIV-
infected
 
HIV-
uninfected
 
HIV-
infected
 
n
 
13
 
17
 
11
 
9
 
24
 
26
 
Gender (M/F) 
 
6/7
 
6/11
 
3/8
 
5/4
 
9/15
 
11/15
 
Age (months)
 
11.9 ± 4.1
  
14.1 ± 5.3
 
14.2 ± 6.3
 
12.0 ± 4.2
 
13.0 ± 5.1
 
13.4 ± 4.9
 
Weight (kg)
 
8.6 ±
 
1.8
 
7.9 ± 1.4
 
9.2 ± 1.7
 
8.1 ± 1.0
 
8.9 ± 1.8*
 
8.0 ± 1.3
 
Amount eaten (g)
 
190 ± 53*
 
153 ± 54
 
230 ± 99†
 
148 ± 47 208 ± 74*
 
148 ± 47
 
Amount eaten (g kg- 1
 
Bwt)
 
21.8 ± 7.1
  
18.8 ± 6.2
 
29.3 ± 7.8
 
*
 
18.1 ± 4.9
 
25.2 ± 7.4*
 
18.6 ± 5.8
 
Duration of eating (min)
 
12.1 ± 3.2
 
*
 
15.6 ± 3.0
 
14.9 ± 4.7
 
15.6 ± 3.1
 
13.4 ± 3.9†
 
15.6 ± 3.0
 
Eating rate (g min- 1)
 
16.5 ± 5.0*
  
10.3 ± 3.8
 
18.8 ± 7.7*
  
9.8 ± 3.4
 
17.6 ± 6.2*
 
10.1 ± 3.7
 
HIV, human immunodeficiency virus. Mean ± standard deviation (n). *Significantly different 
from HIV-infected group (P
 
<0.01). †Significantly different from HIV-infected group (P
 
=0.05).
 
 
Appetite test 
The total intake of the test food eaten, the amount of test food per kilogram body weight, the 
eating duration and the eating rates are shown in Table 3. The amount of test food eaten was 
significantly lower in HIV-infected children compared with
 
those who
 
were uninfected. The 
duration of eating was significantly longer in children who were HIV-infected than in the 
uninfected ones. ANOVA revealed that the amount of test food eaten per kilogram was 2 6% 
lower (statistically significant),
 
and the eating rate was significantly lower in HIV-infected 
children compared with
 
uninfected children, independent of the admission diagnosis. The 
admission diagnosis (pneumonia or diarrhoea) did not significantly affect the eating duration, 
eating rate or the amount eaten per kilogram body weight.
 
The Pearson correlation coefficient 
also revealed a negative correlation between serum zinc concentrations and amount eaten per 
kilogram body weight, and between WAZ, HAZ and amount eaten per kilogram body weight, 
but these were not
 
statistically significant.
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DISCUSSION
 
 
The objective of this study was to study the duration of hospital stay, appetites and nutritional 
status of HIV-infected South African children compared with
 
uninfected children. The length 
of hospital stay was significantly longer in children infected with HIV compared with
 
those 
who were not infected. The appetites of HIV-infected children were significantly poorer than 
the non-infected children.  The children with HIV infection were significantly more stunted, 
but not more wasted,
 
compared with
 
the uninfected ones. The micronutrient status of children 
infected with HIV was poor compared to those who were uninfected.
 
       
Considering the objectives of the study, it was important to adequately define HIV-
infected children in distinction to HIV-uninfected children, and this was done by the ELISA 
test and PCR as described in the Subjects and Methods section. However, within the group of 
children who were HIV-infected, clinical and immunological staging of the HIV disease was 
not done. It is recognised that the outcome of the study could have been affected by the stage 
of HIV. 
       Approximately 55% of the study children were HIV-infected; this is in keeping with the 
proportions observed at the hospital. There were more females than males among the subjects, 
and in the HIV-infected group of children, the proportion of females was also higher. 
However,
 
there was no significant association between the gender of the child and whether 
the child was HIV-infected or not. There was also no association between the gender of the 
children and whether they were admitted with diarrhoea or pneumonia, therefore the results of 
boys and girls were combined. HIV-infected children admitted with pneumonia were 
significantly older than the uninfected children. This is thought to be as a result of the fact that 
diarrhoea and pneumonia occur more commonly in infants than in older children (Kosek et al. 
2003; Zar et al. 2005). However, HIV-infected children remain vulnerable to these diseases 
for a longer period than the uninfected children, such that HIV-infected children with 
pneumonia or diarrhoea may on average be older than uninfected children. This may explain 
the age difference that we noted in the current study. Certainly, other authors have made a 
similar observation; a study performed on Ugandan children younger than 18 months 
admitted with sepsis noted that the median age of HIV-infected subjects was higher than that 
of uninfected subjects (Bakaki et al. 2001).  This was also noted in a group of HIV-infected 
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children (aged
 
2
 
months-5
 
years) admitted with severe lower respiratory tract infection to a 
hospital in Johannesburg, South Africa, where the median age of HIV-infected children was 
significantly higher than that of uninfected children (Madhi et al. 2000a).
 
The duration of hospital stay was approximately 53% longer among HIV-infected children, 
compared to uninfected ones. Among children admitted with diarrhoea those with HIV 
infection had a 55% longer hospital stay. Similarly,
 
in the group of children admitted with 
pneumonia it was 53% longer. The difference in duration of hospitalization of 2-3 days is also 
considered clinically significant. The longer duration of hospitalization among HIV-infected 
children is consistent with the findings of a number of studies. A study conducted in the 
United States
 
which evaluated a database that accounted for approximately 73% of  all US 
hospital discharges of children in 2000, revealed that HIV-infected children had longer mean 
hospital stays (7.8 days versus 3.9 days), when compared with
 
HIV-uninfected children 
(Kourtis et al. 2006). South African studies have reported similar results. In Johannesburg, 
HIV-infected children admitted to a tertiary hospital had a 33% longer hospital stay (Meyers 
et al. 2000). Likewise, HIV-infected who were admitted to hospitals in Cape Town and 
Johannesburg with lower respiratory tract infection had a longer duration of hospitalization 
than HIV-uninfected children (7-14 days compared with 6-10 days)  (Madhi et al. 2000b;  Zar 
et al. 2001). In the same way, the median duration of hospital stay was 8  days for HIV-
infected children admitted to a hospital in Johannesburg with diarrhoea, as opposed to 3
 
days 
for HIV-uninfected children
 
with diarrhoea
 
(Johnson et al. 2000).
 
       
Children with HIV infection had significantly lower appetites compared with
 
uninfected 
children in this study. This was in terms of total amount eaten, duration of eating episodes and 
eating rate,
 
and was independent of the admission diagnosis. The total amount of test food 
eaten was 26% lower in the group of children who were HIV-infected, compared with
 
those 
who were uninfected. The children who were infected with HIV also ate significantly less per 
kilogram
 
body
 
weight
 
than the uninfected children. The amount eaten per kilogram
 
body 
weight was 15%-20% lower in the HIV-infected group of children. The HIV-infected children 
took longer to complete eating the smaller amount of test food, and this resulted in an eating 
rate that was 60% slower than that of the HIV-uninfected children. The ad libitum 
consumption of the test food was used as a proxy for measuring appetite in this study. This 
appetite test has been validated as an appropriate tool in appetite evaluations (Dossa et al. 
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2002). However,
 
it is recognised that there may be other reasons contributing to reduced food 
intake in HIV-infected children. Oro-pharyngeal candidiasis is known to be common in HIV-
infected children (Pol et al. 2007), and this may lead to painful swallowing and thus reduced 
food intake. The proportion of children with oro-pharyngeal candidiasis was not assessed in 
this study. Reduced energy intake is thought to be common in HIV-infected children, and this 
reduced energy intake is thought to play a major role in the poor growth of HIV-infected 
people (Macallan et al.
 
1995). A s tudy comparing HIV-infected American children with 
growth failure (growth velocity  5th percentile for age) with HIV= -infected children without 
growth failure noted that the mean age-adjusted energy intake per day was significantly lower 
in the group of children with growth failure (Arpadi et al. 2000). Because of
 
a lack of similar 
studies in young HIV-infected children, the results of the appetite test cannot be compared. 
Nonetheless, we believe that the poor appetites in HIV-infected children in our study
 
were 
adequately demonstrated.  
 
       
The weight-for-age and length-for-age Z-scores of the HIV-infected children were 
significantly poorer than that of uninfected children. However, there was no significant 
difference in the weight-for-length Z-scores. Our finding that length-for-age Z-scores were 
significantly lower among HIV-infected children compared to the non-infected children was 
consistent with other studies that have suggested that stunting is frequently an early finding in 
perinatal HIV infection. Bobat et al. (2001) observed a cohort of children born to HIV-
infected South African women and noted that by 3
 
months of age, the children who were 
HIV-infected were significantly more stunted, but not more wasted than those who were not 
HIV-infected. The poor weight-for-age Z-scores and stunting that occurs in these infants may 
be
 
related to poor intra uterine growth as a result of poor maternal nutrition. Nonetheless, 
there are post-natal causes of stunting as well, including decreased energy intake (Arpadi et 
al.
 
2000), nutrient malabsorption (Knox et al.
 
2000) and increased resting energy expenditure 
per kilogram of fat-free mass (Batterham 2005). We may assume that the weights and lengths 
will be similarly affected by the poor maternal nutritional status, such that wasting is not 
evident in the first few months of life. However, as the child's own immunological status 
deteriorates, wasting may then ensue. Maternal nutritional status before and during gestation 
is thought to be one of the strongest determinants of pregnancy outcomes (Villamor et al. 
2002). Pregnant HIV-infected women have been observed to be at higher risk than those who 
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are not infected of intrauterine growth retardation and having low birth weight babies (Iroha 
et al. 2007). Poor maternal weight, advanced-stage HIV disease and intrauterine HIV 
transmission were identified as significant determinants of having a low birth weight baby in 
a group of pregnant HIV-infected Tanzanian women (Dreyfuss et al. 2001). The assertion that 
wasting is likely to be a late finding among children with HIV infection is supported by a 
study conducted among pregnant HIV-infected women in the Democratic Republic of Congo 
(DRC). In this study from the DRC, it was shown that when compared with
 
pregnant HIV-
uninfected women, the children of the HIV-infected women were significantly more stunted 
by 3
 
months of age, while they only became significantly more wasted by 12 months of age 
(Bailey et al. 1999). In our study,
 
there was no significant difference in weight-for-length Z 
scores between HIV-infected and uninfected children.
 
       
In the current study, the zinc and iron status of HIV-infected children was significantly 
poorer than that of uninfected children. Similar findings have been observed in a number of 
studies. Low concentrations of plasma zinc have been noted to be highly prevalent in HIV-
infected female drug users (Baum et al. 2003). Micronutrient deficiencies were also noted to 
widespread in stable HIV-infected South African children (Eley et al. 2002a). Anaemia has 
also been shown to be common in HIV-infected  children; another study from Cape Town, 
South Africa, indicated that 72% of HIV-infected children were anaemic (Eley et al. 2002b). 
The factors that result in micronutrient deficiencies in HIV-infected subjects include the 
following: (1) decreased intake of micronutrients as a result of poor appetite, central nervous 
system disease and dysphagia;
 
and (2) diarrhoea and malabsorption of micronutrients,
 
and 
altered metabolism with increased utilization of the micronutrients. These factors have been 
well described in the review by Semba & Tang (1999).   
 
       
Micronutrient deficiencies are known to be associated with increased severity of 
infectious diseases, especially diarrhoea and respiratory tract infections (Bloem et al. 1990; 
Bahl et al. 1998). Deficiencies of micronutrients have also been observed to be associated 
with poor growth. This has been elucidated by a review by Rivera et al. (2003), which noted 
that there is strong evidence for the contribution of micronutrients to growth faltering, in 
particular deficiencies of zinc, vitamin A and iron. The longer duration of hospitali zation 
observed in the current study is thought to be in part related to
 
the poor nutritional status 
(anthropometry and micronutrient status) of the HIV-infected children.
 
Indeed, we did show a 
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significant negative correlation between anthropometric data (WAZ and HAZ), serum zinc 
concentrations and the duration of hospital stay. Micronutrient deficiencies, in particular zinc 
deficiency, have been associated with poor appetite (Baum et al. 2000). Moreover, zinc 
supplementation has been shown to significantly improve appetite in infants (Umeta et al. 
2000). The poor growth observed in these children is thought to be partly related to reduced 
energy intake, which is influenced by appetite.
 
       
Results from this study show that children with HIV infection have a longer duration of 
hospitalization
 
and
 
were noted to have poorer appetites
 
than the control group. The nutritional 
status of HIV-infected children as measured by growth and micronutrient status was 
significantly poorer than that of non-infected children.
  
       
A holistic approach is needed in the potential interventions in HIV-infected children. 
Potential interventions include early introduction and scaling up of antiretroviral therapy, 
focusing on appetite and food intake and possibly micronutrient supplementation. Future 
research will indicate whether improving the dietary intake of HIV-infected children and/or 
supplementation with multi-micronutrients will improve the nutritional status of these 
children.   
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Abstract
 
The duration of pneumonia and of diarrhea is reported to be longer in HIV-infected children 
than in uninfected children. We assessed the effect of a multi -micronutrient supplement on the 
duration of hospitalization in HIV-infected children. In a double-blind randomized trial, HIV-
infected children (4-24 mo) who were hospitalized with diarrhea or pneumonia were enrolled 
(n = 118) and given a daily dose of a multi-micronutrient supplement (containing vitamins A, 
B complex, C, D, E and folic acid, as well as copper, iron and zinc at levels based on 
recommended daily allowances) or a placebo until discharge from the hospital. Children's 
weights and heights were measured after enrollment and micronutrient concentrations were 
measured before discharge. On recovery from diarrhea or pneumonia,
 
the children were 
discharged and
 
the
 
duration of hospitalization was noted. Anthropometric indices and 
micronutrient concentrations did not differ between children who received supplements and 
those who received placebos. Overall, the duration of hospitalization was significantly shorter 
(P < 0.05) among children who were receiving
 
supplements (7.3 ± 3.9 d) (mean ± SD) than in 
children who were receiving placebos (9.0 ± 4.9); this was independent of admission 
diagnosis. In children admitted with diarrhea, the duration of hospitalization was 1.6 d (19%) 
shorter among children receiving supplements than in those receiving placebos, and 
hospitalization for pneumonia was 1.9 d (20%) shorter among children receiving 
supplements. Short-term multi-micronutrient supplementation significantly reduced the 
duration of pneumonia or diarrhea in HIV-infected children who were not yet receiving 
antiretroviral therapy and who remained alive during hospitalization.
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INTRODUCTION
 
 
There were ~2.5 million children living with HIV worldwide in 2007 and 90% of them were 
in sub-Saharan Africa (1). In South Africa ,
 
there are ~300 000 children up to the age of 14 y 
infected with HIV (2). In sub-Saharan Africa, the HIV epidemic has resulted in a marked 
increase in childhood respiratory and diarrheal disease-related morbidity and mortality (3-5). 
In a South African academic hospital, the most common admission diagnosis among HIV-
infected children was pneumonia, followed by diarrhea; these diseases were also noted to be 
more common in HIV-infected children than in uninfected children (6).     
 
       
A survey in the USA showed that the duration of hospital stays was longer in HIV -
infected children than in uninfected children (7). HIV-infected South African children 
hospitalized with diarrhea or pneumonia also need longer periods of hospitalization (8, 9, 6, 
10). In a cross-sectional study at our hospital in Pretoria, we detected that duration of 
hospitalization was significantly longer (2.5 d) and that the
 
micronutrient status was 
significantly poorer (our unpublished data). Micronutrient deficiencies are indeed known to 
be common in HIV-infected children (11, 12). The severity of the micronutrient deficiencies 
may be partly related to the stage of the HIV disease (13) and to the severity of the pneumonia 
and/or diarrheal illness (14).  
       
Studies assessing the effect of micronutrient supplementation on the duration of episodes 
of diarrhea or pneumonia reveal conflicting results. Zinc supplementation was
 
shown to be 
beneficial in reducing the duration of diarrhea in South Asian children (15-18) but not in 
Bangladeshi male infants aged 1-6 mo (19). Analyses of pooled data from trials of acute 
diarrhea have concluded that zinc therapy is beneficial in the treatment of acute diarrhea (20, 
21). Although it has been found that zinc supplementation may reduce the duration of 
pneumonia (22), other studies failed to confirm this effect (23, 24). The addition of vitamin A 
to the zinc supplement may have a synergistic effect on reducing diarrhea (25), partly due to 
the fact that zinc is essential for both intra-
 
and intercellular transport of vitamin A (26, 27). 
However, other studies do not show this effect (18, 16). Vitamin A supplementation was 
shown to significantly reduce the duration of hospitalization among Mozambican children 
who were admitted with non-measles acute lower respiratory infections (28). Nonetheless, a 
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metaanalysis revealed that there is no evidence that high-dose vitamin A improves recovery 
from pneumonia in developing countries (29). 
 
       
Given that micronutrient supplements might be more effective in children who are 
malnourished (15, 30, 31), supplementation might be beneficial in children who are HIV-
infected. However, studies on the effects of micronutrient supplementation on the duration of 
hospitalization of HIV-infected children are scarce. 
 
       
Because micronutrient deficiencies rarely occur as single nutrient problems but rather as 
simultaneous deficiencies of more micronutrients, it is considered that the deficiencies should 
be addressed concurrently  (32, 33). The proportion of HIV-infected South African children 
receiving antiretroviral therapy (ART) in 2007 was estimated to be 10% according to 
UNAIDS (1). We therefore performed a
 
randomized controlled trial to test our hypothesis that 
a multi-micronutrient supplement would significantly reduce the duration of hospitalization in 
HIV-infected children admitted with acute diarrhea and pneumonia who are not receiving 
ART. 
 
 
PARTICIPANTS AND METHODS 
 
 
Participants and study area 
 The participants were HIV-infected children with ages between 4 mo and 2 y (overall number 
of children assessed for eligibility = 389; number of enrolled children = 118). These children 
had been admitted with diarrhea or pneumonia to the pediatric wards of
 
Dr George Mukhari 
hospital, the academic hospital for the Medunsa campus of the University of Limpopo. This 
public hospital is the second largest in the republic of South Africa with ~1800 beds. It is 
located ~35 km north-west of Pretoria, the capital city of South Africa. All the children were 
from the townships surrounding the hospital. The study was conducted between November 
2005 and May 2007. 
 
       
Diarrhea was defined as the passing of   3 loose stools/d in the previous 24 h as reported =
by the parent or guardian. Pneumonia was defined as an illness during which a child is 
reported to have a cough, has a temperature of 38 C or more, and has an elevated respiratory 
rate above the age specific value on a minute estimation (50 breaths/min) (34). Because we 
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intended to assess the effects of supplements on acute diarrhea, it was decided that children 
whose diarrheal episode was already longer than 72 h on admission should be excluded. 
Children admitted with pneumonia complicated by respiratory failure, i.e.
 
hypoxia (saturation 
<90% on optimum amount of supplemental oxygen) and/or hypercarbia (Pco2 > 50 mmHg),
 
were also not included, because these children were eligible for transfer to the intensive care 
unit. To assess the effects of the supplements as such,
 
children who were on ART or those 
who had received vitamin or micronutrient supplementation in the previous 2 mo were 
considered not eligible for inclusion. The proportion of HIV-infected South African children 
(<14 y) receiving ART in 2007 was estimated to be 10% according to UNAIDS (1). The 
proportion of HIV-infected children aged 4-24 mo who were on ART is not known, but it was 
probably below 10% (Dr M.C. Moshe, personal communication).
 
       
Children who had a chronic illness unrelated to HIV were also excluded (total number 
excluded = 271; 258 because of not meeting inclusion criteria and 13 because of refusing to 
participate).
 
       The Medunsa Research Ethics and Publications Committee approved the study; the 
permission of the GaRankuwa (now Dr George Mukhari) hospital authorities was obtained. 
The parents or guardians of all participants provided signed informed consent prior to 
commencing the study. 
 Study design
 A randomized, double-blind, placebo-controlled study was performed. A simple 
randomization schedule (computer-generated random numbers) was used to assign the 
children to 1 of 2 groups to receive a multi-micronutrient supplement or a placebo, stratified 
by admission diagnosis (pneumonia or diarrhea).    
 
       
The HIV status of the children was confirmed by laboratory analysis. HIV-infected 
children whose parents agreed to participate in the study were enrolled within 24 h after 
admission. The assessment for eligibility (including obtaining consent for participation in the 
study) was conducted in the pediatric admission ward of the hospital in the morning (around 
breakfast time); this process lasted ~2h. The supplement was then given to children who met 
the inclusion criteria and were willing to participate. The timing of the subsequent daily dose 
of supplement or placebo was standardized and was scheduled to be given at breakfast. Thus, 
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the administration of supplement or placebo started on the morning of enrolment. The body 
weights and lengths of the children were measured when the child was fully rehydrated, 
usually within 24 h of enrolment. 
 
       
The principal investigator monitored the progress of the children in the ward and when 
the attending physicians were of the opinion that the child was likely to be discharged (in line 
with discharge criteria) within 1 or 2 d, then blood samples were taken from fasting children 
for serum zinc, serum retinol, iron, and ferritin, plasma C-reactive protein (CRP), and 
hemoglobin (Hb) analyses. On the day of discharge, the duration of hospitalization was noted. 
Blood samples were also taken for CD4 and CD8 counts (within 24 h of admission) and these 
were used to classify the severity of HIV according to the CDC classification (35). 
 
 
Treatment 
 
The supplements and placebos used were crushable tablets provided by the pharmaceutical 
company Adminicle Trading. The multi -micronutrient supplements contained 300 ìg retinol, 
0.6 mg thiamine, 0.6 mg riboflavin, 8 mg niacin, 0.6 mg pyridoxine, 1 ìg cobalamin, 70 ìg 
folic acid, 25 mg ascorbic acid, 5 ìg 1,25-dihydrocholecalciferol, 7 mg d,l á-tocopherol, 700 
ìg copper, 8 mg iron, 30 ìg selenium and 8 mg zinc at amounts based on recommended 
dietary allowances for a 1-y-old child (36). The amounts in the supplement were 
independently confirmed and certified by the Medicines Control Council of South Africa. The 
placebo and supplement tablets were identical in appearance and taste; the containers were 
also identical and were labeled only by study serial number. The supplements or placebos 
were crushed using a pill crusher and mixed with water and were administered by the nurse in 
the ward.
 
Methods
 
Clinical evaluation.
 
The children were all examined by the principal investigator to look for 
any chronic illnesses. All the children were treated according to standard hospital protocols 
for diarrhea and pneumonia. The children with pneumonia were all given first-line antibiotics 
for community-acquired pneumonia. The children were ready for discharge when they passed 
two consecutive formed stools or no stools passed in the previous 24 h,
 
as reported by the 
nurses in the hospital records. A child was considered to have recovered from pneumonia
 
when the temperature and respiratory rate had been normal for at least 24 h, when there was 
Chapter 3
                                                              
Short-term micronutrient effect on diarrhea and pneumonia 
 
 
                                   
                                                                                                                                                                                                    
61
 
 
 
no intercostal or sternal recession, and the
 
child was able to drink and eat. The attending 
physicians discussed with the principal investigator prior to discharge to ensure adherence to 
the discharge criteria. 
 
HIV tests.
 
HIV-1 and HIV-2 serostatus was ascertained using 2 ELISA tests (Abbot 
Diagnostics) in children older than 15 mo (37). In children younger than 15 mo, a PCR test 
was performed in addition to the 2 ELISA (37). The PCR test (Gene Amp 2400, Applied 
Biosystems) was performed in the Virology laboratory of the National Health Laboratory 
Services (NHLS) at the Medunsa campus of the University of Limpopo. 
 
Anthropometry.
 
The ages of the children were calculated in months by using the dates of 
birth, as given by the mothers. The weight was measured to the nearest 0.1 kg without shoes 
and with
 
the child wearing only light clothing using a single beam balance scale. The scale 
was calibrated before each measurement session using a standard weight of 10 kg. The 
children were not clinically dehydrated at the time of the weight measurements. The length 
was measured in the recumbent position to 0.1 cm, on a baby board, by the investigator with 
the help of an assistant. One examiner held the child's head (with the chin in the neutral 
position) in contact with the fixed part of the board while the other  examiner stretched the 
child to maximum length and then brought the movable part of the board into contact with the 
heels. Z-scores for weight-for-age (WAZ), length -for-age (HAZ), and weight-for-length 
(WHZ) were calculated based on the National Centre for Health Statistics (NCHS) reference 
values by means of the Epi-Info software version 3.2.2 (38).
 Blood sampling and analysis.
 
Blood samples were collected by venipuncture (puncture site 
cleaned with trace element-free alcohol). The samples for zinc were collected in trace 
element-free
 
tubes, with removable lids. 
 
       
All blood samples were collected after an overnight fast and were sent to the laboratory 
immediately after collection, protected from light, and stored at -20 C after centrifugation, 
until analysis. All the blood samples were stored at the Medunsa branch of the NHLS.
 
       
The serum zinc, serum iron, and ferritin measurements were performed at the Medunsa 
branch of the NHLS, while the retinol samples were batched and sent frozen to the main
 
branch of the NHLS in Johannesburg and were analyzed within 10 d of sampling. Serum zinc 
was measured by atomic absorption spectrometry (Perken Elmer ICP/550) (39), serum retinol 
by a fluorometric method (40), serum iron by rate spectrophotometry (39) (SynchronCX 
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System, Beckman Coulter), and serum ferritin by using commercial ELISA kits (Beckman 
Access 2, Beckman Coulter) (41). Quality control for serum zinc, iron,
 
and ferritin was 
assessed by repeat analysis of standard reference material for low, normal,
 
and high values. 
The source of the reference material was Bio-Rad Laboratories for serum zinc and iron and 
the material for the serum ferritin was obtained from Beckman Coulter. The intra-assay and 
inter-assay CV for serum zinc, retinol, iron,
 
and ferritin were all < 5%.
 
       
The Hb concentration was analyzed spectrophotometrically in whole blood (ABX Pentra 
DX 120, Horiba ABX Diagnostics). It was measured to test for anemia, defined as Hb of less 
than 110 g/L (42).  
 
       
Plasma concentrations of CRP
 
were measured by nephelometry, using an international 
reference standard for plasma proteins. CRP levels > 10 mg/L were considered to be high, and 
indicative of inflammation. The CD4 lymphocyte counts were measured using a Coulter flow 
cytometer (Coulter Epics XL-MCL, Beckman Coulter) to assess the immunological stage of 
HIV infection. The CD4 were reported as CD4 T-cell percentage (percent of total T-
lymphocyte that is of the CD4 lineage) rather than absolute CD4 counts, because the CD4 
percentages are commonly used in clinical pediatric practice and have less age-related 
variability (43). 
 
Statistical analysis
 Anthropometric Z-scores were calculated with Epi-Info software (version 3.2.2). Data 
elaboration and analysis was performed using SPSS 13.0 for Windows. Statistical analyses 
were 2-tailed where appropriate and significance was set at 5%.  
 
       
The sample size calculation was based on a cross-sectional study conducted at the same 
hospital (our unpublished data) that revealed a mean duration of hospitalization of 5.9 ± 1.9 
and 9.0 ± 2.5 d for HIV-infected children admitted with diarrhea and pneumonia respectively. 
The calculations were based on a 5% level of significance and 80% power for a 2-tailed test, 
designed to be able to detect 1.5 d in the duration of diarrhea and of pneumonia. The required 
sample sizes per treatment group were 26 and 29 for diarrhea and pneumonia, respectively 
(44). In the present study, we ended up with slightly lower numbers than were calculated, but 
these lower numbers hardly affected the power of the tests. However, the power of the tests 
was strongly influenced by the much larger actual between-child duration of hospitalization 
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(twice as much as we used in our a priori power calculations). Therefore, the actual power 
with
 
which a relevant difference of 1.5 d in duration of hospitalization could be tested 
between treatment and placebo groups for all children was only 40%. Nevertheless, we did 
observe a significant treatment effect. However, in future studies, power calculat ions should 
be based on larger between-child variation in duration of hospitalization.
 
       
Analyses were conducted using coded treatment groups with the analysts blinded to the 
actual treatment. 
 
       
Data were assessed for normality by visual examination of distribution plots followed by 
normality tests, and were normalized where appropriate by log transformation. 
 
       
Anthropometric measurements, serum zinc, retinol, iron, ferritin, and CD4 lymphocyte 
percentages and Hb concentrations, were compared using ANOVA with treatment group and 
gender as between-subject factors. The proportion of children with anemia and with CRP 
levels > 10 mg/L was compared between the 2 groups by the chi-square test.
 
       
The differences in the duration of hospitalization of the 2 treatment groups were also 
contrasted by means of ANOVA, with admission diagnosis as a cofactor and age and gender 
as covariates. The effect of a covariate on the dependent variable was used to assess the 
interaction effect. ANOVA with or with out the inclusion of data of children who died (i.e. 
intention to treat analysis) did not differ significantly from each other.   
 RESULTS
 
 A total of 389 children were screened, of whom 118 children were enrolled. Out of the 118 
enrolled children,
 
50 were
 
admitted with diarrhea and 68 with pneumonia (Fig. 1). In total,
 
12 
(10%) children died during the period of hospitalization: 4 from the diarrhea group and 8 from 
with pneumonia group. In relation to treatment, 7 out of the 12 children who died were from 
the placebo group and 5 from the supplement group. The children who died were slightly 
younger and had lower weights and lengths than those who completed the study,
 
but the 
WAZ, HAZ and WHZ did not differ ( Supplemental Table 1 ).  
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Table 1.
 
Anthropometric data of HIV-infected children with diarrhea or pneumonia   
 
              
administered a supplement or placebo who completed the study
 
1
 
 
Diarrhea
 
Pneumonia
 
All children who completed
 
 
Placebo
 
Supplement
 
Placebo
 
Supplement
 
Placebo
 
Supplement
 
n
 
24
 
22
 
28
 
32
 
52
 
54
 
Male/Female
 
11/13
 
11/11
 
14/14
 
20/12
 
25/27
 
31/23 
 
Age (months)
 
12.4 ± 5.3
 
14.2 ± 6.7
 
9.0 ± 3.6
 
12.5 ± 5.7#
 
10.6 ± 4.8
 
13.2 ± 6.1#
 
Weight (kg)
 
6.6 ± 1.4
 
6.8 ± 1.7
 
5.8 ± 1.6
 
6.8 ± 1.6#
 
6.2 ± 1.5
 
6.8 ± 1.6#
 
Height (cm)
 
68.2 ± 7.1
 
69.5 ± 7.4
 
64.4 ± 7.1
 
68.4 ± 6.9#
 
66.1 ± 7.3
 
68.8 ± 7.1
 
WAZ
 
-2.71 ± 1.31
 
-2.83 ± 1.16
 
-2.83 ± 1.24
 
-2.57 ± 1.43
 
-2.77 ±  1.26 -2.68 ± 1.32
 
HAZ
 
-2.34 ± 1.59
 
-2.42 ± 1.72
 
-2.31 ± 1.62
 
-2.22 ± 1.55
 
-2.32 ± 1.59
 
-2.30 ± 1.61
 
WHZ
 
-1.63 ± 1.41
 
-1.73 ± 1.38
 
-1.45 ± 1.21
 
-1.52 ± 1.34
 
-1.53 ± 1.30
 
-1.61 ± 1.35
 
1Values are the mean ± SD. #Different from placebo group, P  <0.05.  
       
       The male:female ratio was similar among the children randomized into the 2 treatment 
groups as well as for children admitted with diarrhea and with pneumonia. Among children 
admitted with pneumonia, those who were receiving the supplement were older than those 
receiving the placebo (P < 0.05). However, among those admitted with diarrhea age did not 
differ. WAZ, HAZ, and
 
WHZ of the children did not differ between treatment groups, or 
between the children admitted with diarrhea or pneumonia (Table 1).
 
       
The serum zinc, vitamin A, iron, and ferritin concentrations and the CD4 lymphocyte 
percentages did not differ significantly between the 2 treatment groups and did not differ by 
diagnosis at admission (Supplemental Table 2 ). With respect to Hb levels,
 
we found a 
significant interaction between admission diagnosis and the age of the children, but there was 
no treatment effect. The mean Hb levels were lower in the group of children admitted with 
pneumonia (89 ± 18 g/L) than those in children admitted with diarrhea, (100 ± 15 g/L) (P < 
0.05) (Supplemental Table 2). The number of children with inflammation (CRP >10 mg/L) 
was
 
similar among children who received placebos (32) and supplements (28) (Supplemental 
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Table 2). The proportion of children admitted with diarrhea exhibiting inflammation was 43% 
less than the proportion of those admitted with pneumonia with inflammation (73%) (P < 
0.05). 
 
       
The duration of hospitalization was shorter in children who were receiving supplements 
than in those who were receiving placebos (P < 0.05) (Table 2). When the data of the 
children who died were included (intention to treat analysis), the duration of hospitalization 
was also shorter among children who received the supplement (7.0 ± 3.8 d) than in those 
taking the placebo (8.6 ± 4.8 d) (P < 0.05). This reduction in the period of hospitalization was 
independent of the children?s ages. There was no significant interaction between admission 
diagnosis and treatment group with respect to duration of hospitalization. The duration of 
hospitalization among children admitted with diarrhea was 1.6 d (19%) shorter in the 
supplement group.
 
Similarly,
 
among children admitted with pneumonia,
 
the duration of 
hospital stay was 1.9 d (20%) shorter in the group of children on supplements.
 
Table 2.
 
Duration of hospitalization in HIV-infected children with diarrhea or pneumonia 
 
              administered a supplement or placebo who completed the study
 
1  
 Diarrhea Pneumonia  All children who completed  
 
Placebo
 
Supplement
 
Placebo
 
Supplement
 
Placebo
 
Supplement
 
n
 
24
 
22
 
28
 
32
 
52
 
54
 
Hospitalization 
duration, d
 
8.6 ± 5.0
 
7.0 ± 4.5
 
9.4 ± 4.9
 
7.5 ± 3.5
 
9.0 ± 4.9
 
7.3 ± 3.9#
 
1
 
Values are the mean ± SD. #Different from placebo group, P <0.05
 
 
DISCUSSION
 
 
Our main objective in this study was to assess the effect of a commercially available multi-
micronutrient supplement on the duration of acute diarrhea and of pneumonia in HIV-infected 
children who were not yet receiving ART. Duration of hospital stay was u sed as a 
measurement of the duration of acute diarrhea and of pneumonia. Supplementation indeed 
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reduced the length of hospitalization significantly by ~20%, (1.5 d), independent of admission 
diagnosis; a reduction that might be considered as clinically meaningful.
 
       
The nutritional status of the study children as measured by anthropometry and 
micronutrient status was poor. Mean values for WHZ indicate that a large portion of the 
children should be classified as wasted and mean values for HAZ demonstrate that most of the 
children were stunted (Table 1). Growth failure is common among HIV-infected children. The 
WAZ were significantly lower in HIV -infected children admitted with diarrhea to a South 
African academic hospital than in the uninfected control group (8). Stunting is said to be the 
growth problem most frequently seen in HIV-infected children (45). 
 
       
The micronutrient status of the study children was poor as assessed by the absolute values 
of serum micronutrient concentrations compared to the local laboratory reference values (46), 
but there were no significant differences between the micronutrient concentrations of the 
supplement and placebo groups. Possibly the duration of the supplementation (only during 
hospitalization) was too short, but we did not collect serum samples before commencing 
treatment. The absence of such baseline serum concentrations hampers a valid interpretation 
of the lack of difference in micronutrient concentrations between the 2 treatment groups just 
before discharge. Anemia and low serum concentrations of micronutrients have been shown 
to be common among HIV-infected children (11, 12).   
       
The percentage of children with anemia was significantly higher among children admitted 
with pneumonia than in children admitted with diarrhea.
 
This is consistent with our 
observation that the proportion of children with inflammation (CRP >10 mg/L) was 
significantly higher among children admitted with pneumonia. Systemic infectious diseases 
(with resultant inflammation) are known to cause acute hemolytic anemia (47) and elevated 
CRP levels have shown to be highly correlated with anemia (48). 
 
       
The proportion of children who died during hospitalization was 8% in the group of 
children admitted with diarrhea, whereas among those admitted with pneumonia it was 12%. 
This mortality rate of ~10% is similar to that observed among HIV-infected children in the 
general wards of our hospital. The anthropometry data suggests that the children who died 
were more stunted and underweight than the children who completed the study.
 
       
Despite a careful randomization, the children who were hospitalized with pneumonia and 
received the placebo treatment were 3.5 mo younger than those who received the supplement. 
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However, ANOVA revealed that age was not signifi cantly associated with duration of 
hospitalization. Therefore, it is unlikely that the difference in ages between the treatment 
groups might have confounded the treatment effect on the duration of hospitalization. 
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Supplemental Table 1 .
 
Anthropometric data of all enrolled HIV-infected children with diarrhea or pneumonia administered a  
 
                                           
supplement or placebo
 
1 
 
 
Placebo
 
Supplement
 
All enrolled children 
 
 
Completed study
 
Died
 
Completed study
 
Died
 
Placebo
 
Supplement
 
n
 
52
 
7
 
54
 
5
 
59
 
59
 
Age (mo) 10.5 ± 4.8 10.8 ± 3.3 13.2 ± 6.1  10.1 ± 4.8  10.6 ± 4.6  12.7 ± 6.0*  
Weight (kg) 6.2 ± 1.5 5.5 ± 1.3 6.8 ± 1.6 5.4 ± 1.5  6.1 ± 1.5  6.7 ± 1.6*  
Height (cm) 66.1 ± 7.3 62.1 ± 7.2 68.8 ± 7.1  65.0 ± 6.9  65.7 ± 7.3  68.5 ± 7.1*  
WAZ
 
-2.77 ± 1.26
 
-3.47 ± 1.78
 
-2.68 ± 1.32
 
-3.50 ± 0.98
 
-2.85 ±  1.33
 
-2.75 ± 1.31
 
HAZ
 
-2.32 ± 1.59
 
-2.99 ± 2.93
 
-2.30 ± 1.61
 
-2.56 ± 1.98
 
-2.40 ± 1.78
 
-2.32 ± 1.63
 WHZ
 
-1.53 ± 1.30
 
-1.69 ± 1.68
 
-1.61 ± 1.35
 
-2.31 ± 0.47#
 
-1.55 ± 1.33
 
-1.67 ± 1.31
 1
 
Values are the mean ± SD. * Different from placebo group. # Different from children who completed study
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Supplemental Table 2 .
 
Biochemical indices of HIV-infected children with diarrhea or pneumonia administered a supplement or  
 
                                      
placebo who completed the study
 
1*
 
 
Diarrhea
 
Pneumonia
 
All children who completed 
 
 
Placebo 
 
Supplement
 
Placebo
 
Supplement
 
Placebo
 
Supplement
 
Serum zinc (µmol/L) 7.6 ± 2.7 (23)  7.6 ± 2.5 (21) 7.7 ± 2.7 (28)  8.6 ± 3.3 (32)  7.7 ± 2.7  (51)  8.2 ±  3.0 (53)  
Serum retinol (µmol/L) 0.59 ± 0.29 (22) 0.76 ± 0.43 (21) 0.78 ± 0.39 (25)  0.76 ± 0.36 (31)  0.69 ± 0.36 (47)  0.76 ± 0.39 (52)  
Serum iron (µmol/L) 7.6 ± 6.6 (23) 6.8 ± 3.3 (21) 7.6 ± 5.6 (28)  7.9 ± 5.4 (32)  7.6 ± 6.0   (51)  7.5 ± 4.7 (53)  
Log serum ferritin (log 
[ìg/L])
 
1.75  0.56 (23)±  1.75 ± 0.48 (21) 1.95 ± 0.66 (28)  1.85 ± 0.48 (32)  1.86 ± 0.62 (51)  1.81 ± 0.48 (53)  
Hemoglobin (g/L)
 
98 ± 15 (22)
 
102 ± 16 (16)
 
88 ± 18 (28)
 
90 ± 18 (31)
 
93 ± 17 (50)
 
94 ± 18 (47)
Plasma CRP> [10 mg/L (%)
 
50 % (11)
 
40% (6)
 
75%(21))
 
71% (22)
 
64%(22)
 
61%(28)
 CD4 percent
 
21.4 – 14.8 (22)
 
19.7 ± 10.1 (17)
 
19.9 ± 12.3 (27)
 
20.1 ± 13.0 (22)
 
20.1 ±13.0 (22)
 
20.6 ± 11.7 (39)
 1
 
Values are the mean ± SD (n) * No difference between the two treatment groups
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As mentioned before, the duration of hospitalization was ~20% shorter in the treatment 
group and this was independent of the admission diagnosis. Unfortunately, there are hardly 
any studies that assess the effect of micronutrients in hospitalized HIV-infected children. 
Therefore, comparisons can only made with studies in hospitalized children from developing 
countries, where the nutritional status of the children might be similar to that found in HIV-
infected children. Zinc supplements (combined with vitamin B complex) significantly reduced 
the stool output and duration of diarrhea in hospitalized Indian children compared with 
children given B complex vitamins only (49). Supplementation with a combination of zinc 
and copper to Indian children admitted with diarrhea did not significantly reduce the duration 
of hospitalization (50). Evidence suggests that zinc supplements have a beneficial effect on 
the duration of diarrhea, but the evidence for other micronutrients is equivocal. Analysis of 
pooled data indicated that zinc supplementation significantly reduces the duration of acute 
diarrhea (20). It is possible that the effects of the multi-micronutrient supplement (on the 
duration of diarrhea) that were observed in the current study are partly related to the zinc 
component. Nonetheless, the use of a multi-micronutrient supplement is likely to improve the 
overall micronutrient status of the children and may thus have greater benefits.  
       Among children admitted with pneumonia in the current study, those who received the 
supplement had a 20% shorter duration of hospitalization. In a group of children from India 
who were hospitalized with severe acute lower respiratory infection (ALRI), supplementation 
with zinc reduced the duration of symptoms of severity, but this effect was only noted in 
boys; vitamin A on the other had no effect on the symptoms (23). Some studies have shown 
no effect on the duration of hospitalization among children who were given zinc and/or 
vitamin A supplements (51), or only zinc supplements (24). A metaanalysis revealed that 
there is no evidence that high-dose vitamin A improves recovery from pneumonia in 
developing countries (29). Studies on the efficacy of zinc supplements in reducing the 
duration of pneumonia has shown conflicting results and as far as we know, no metaanalysis 
has been conducted on the effect of zinc on acute pneumonia. The use of the antioxidant 
vitamins
 
E and C as adjunct therapy in children with severe ALRI has also been shown to 
have no benefit (52). While the benefits of a single micronutrient may be equivocal, a multi-
micronutrient supplement as used in the current study may be more beneficial in HIV-infected 
children.     
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We consider the reduction in duration of hospitalization of 1.5 d as clinically meaningful. 
A longer duration of hospitalization has an impact on hospital bed occupancy and the risks of 
acquiring a nosocomial infection are also increased with longer hospitalization. Apart from 
the clinical importance there is also the health care relevance. In an academic hospital in 
South Africa, the total daily cost to the hospital of caring for an inpatient HIV-infected child 
in 2005 was estimated at $1007 (calculated by using mid-2005 South African Rand to US 
dollars exchange rates) (53), and the costs of the multi-micronutrient supplement are around 
$0.10 per day. We surmise that a reduction of 1.5 d in the duration of hospitalization wou ld 
result in significant cost savings per patient.
 
       
The major finding of our study is that short-term multi-micronutrient supplementation 
will significantly reduce the duration of hospitalization in HIV-infected children admitted 
with diarrhea or with pneumonia who are not yet treated with ART and who do not die during 
hospitalization. Whether supplementation with the multi-micronutrient for a longer period 
may also reduce the number of episodes of diarrhea and of pneumonia in HIV-infected 
children should be investigated.         
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ABSTRACT
 
Background: Poor growth, micronutrient deficiencies and episodes of diarrhea and 
respiratory infections occur frequently in HIV-infected children. Deficiencies of 
micronutrients are associated with poor growth and increased risk of diarrhea and respiratory 
infections. The diarrhea and respiratory infections and poor growth in HIV-infected children 
may be partly related to the micronutrient deficiencies. Our objectives were to determine 
whether multi-micronutrient supplementation would
 
improve the growth performance and 
reduce the number of episodes of diarrhea and/or of respiratory symptoms in HIV-infected 
children.
 
Methods: In a double-blind randomized trial, HIV-infected South African children aged 4-24 
months (n = 201) were assigned to receive a multi-micronutrient supplement or placebo daily 
for six months. The children were assessed for respiratory symptoms or diarrhea bi-weekly; 
weights and heights were measured monthly.  
Results: In total, 121 children completed the study (40% dropout). Dropouts were excluded 
from further analysis. Weight -for-height Z-scores improved significantly (p<0.05) among 
children given supplements compared to those given placebo (0.40 ± 1.22 versus -0.04 ± 
1.40) (mean ± SD). Height-for-age Z-scores did not improve in both treatment groups. The 
number of monthly episodes of diarrhea in the placebo group (0.36 ± 0.36) was
 
higher 
(p=0.09) than in the supplement group (0.25 ± 0.31) and the number of monthly episodes of 
respiratory symptoms was
 
significantly higher (p<0.05) among children on placebos (1.01 ± 
0.67) than those on supplements (0.66 ± 0.51).
 
Conclusion: Multi-micronutrient supplements significantly improved wasting but not 
stunting. Supplementation reduced the number of episodes of diarrhea and respiratory 
symptoms by about 30%.
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INTRODUCTION
 
 
In 2008
 
there were
 
430 000 children younger than 15 years worldwide who were newly 
infected with HIV and 90% of whom were in Sub-Saharan Africa (1). Children who are 
infected with HIV are known to be at high risk for poor nutritional status, infections and poor 
growth performance (2, 3). Growth failure in HIV-infected children is associated with an 
increased risk of mortality (4, 5). Episodes of diarrhea and of respiratory symptoms appear
 
more common in HIV-infected than in uninfected children (6).  
 
       
Deficiencies of micronutrients, especially of vitamin A and zinc a re associated with 
diarrhea and respiratory diseases (7, 8).
 
Micronutrient status also influences growth. 
Deficiencies of zinc and of iron have been associated with impaired growth (9, 10). Vitamin 
A and carotenoid status were demonstrated to be independent predictors of growth failure in
 
Malawian children (11). Micronutrient deficiencies seem to be common with HIV infection, 
and these deficiencies tend to be more severe in HIV-infected children (12, 13).
 
       Studies on the effect of micronutrient supplementation on growth and morbidity in 
malnourished children have not always resulted in undeniably positive outcomes. Vitamin A 
supplementation has been shown to be beneficial in reducing the risk of diarrhea, but may be 
detrimental against respiratory infections (14). Zinc supplementation may improve growth (9) 
and reduce the incidence of diarrhea and respiratory infections in young children (15). Other 
studies indicate that zinc supplementation increases respiratory infections
 
(16), although 
adding vitamin A seems to reduce the adverse effects of zinc on respiratory infections (17). 
Micronutrient deficiencies are seldom limited to a single micronutrient, therefore it has been 
suggested that supplements that contain an array of micronutrients should be provided (18).  
 
       
Since HIV-infected children might be severely malnourished, they might profit most 
from beneficial effects of multi-micronutrient administration. Unfortunately, such studies are 
scarce.
 
The aim of the present study was to investigate whether daily multi-micronutrient 
supplementation might improve the growth performance and might reduce the number of 
episodes of diarrhea or pneumonia in HIV-infected young South African children who were 
not yet on antiretroviral
 
therapy
 
(ART). 
 
METHODS
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The study was conducted from the Doctor George Mukhari Hospital in GaRankuwa, near 
Pretoria, the capital city of the Republic of South Africa.
 
       
HIV-infected children aged 4 to 24 months were enrolled into the study from the pediatric 
outpatient department
 
of the hospital
 
from November 2005 to November 2006. 
 
       
Children who were on ART, or had received micronutrient supplementation or children 
with a chronic illness were not eligible for enrolment.
  
       
The Medunsa Research Ethics and Publications Committee approved the study; the 
permission of the hospital authorities was obtained, and the parents or guardians provided 
signed informed consent. The children were referred to the ART
 
clinic when necessary as per 
standard hospital procedure (immunological and clinical staging was used) and taken off the 
study when ART was
 
commenced. 
 
       
In a double-blind, placebo controlled study,
 
children were assigned to one of two 
intervention groups by computer randomization. The manufacturer prepared packs of tablets 
corresponding to the subject's number according to the randomization schedule. The 
investigators, field workers and participants were blinded to the treatment assignments, which 
were revealed after completing data analysis. The children had monthly appointments at the 
hospital for follow up weight and height measurements, collection of tablets, and evaluation 
of side-effects of micronutrients.   
       
At enrolment and at the third and sixth monthly hospital visits, blood samples were taken 
for serum zinc, retinol, iron and ferritin and CD4 T-lymphocyte counts. 
 
       
The tablets were prepared by the pharmaceutical company Adminicle Trading (Edenvale, 
South Africa). The multi-micronutrient supplement was a crushable tablet which contained 
300 µg retinol, 0.6 mg thiamin,
 
0.6 mg riboflavin, 8 mg niacin, 0.6 mg pyridoxine, 1 µg
 cobalamin, 70 µg folic acid, 25 mg ascorbic acid, 5 µg
 
1,25-dihydrocholecalciferol, 7 mg d,l-
tocopherol, 700 µg
 
copper, 8 mg iron, 30 µg selenium, and 8 mg zinc at amounts
 
based on 
recommended dietary allowances for a 1
 
year old child (19). The placebo and supplement 
tablets were identical in appearance and taste. The caregiver crushed the tablet using a pill 
crusher and mixed it with a small portion of the breakfast cereal which was fed to the child 
before the rest of the meal.
 
HIV tests: In children older than 15 months HIV-1 and HIV-2 serostatus was ascertained with 
ELISA tests (20); in younger children a PCR was performed additionally. The CD4 T-
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lymphocyte counts were measured by means of a Coulter flow cytometer (Coulter Epics XL-
MCL, Beckman Coulter) to stage the HIV infection.
 
Anthropometry: The subject's age was calculated from the date of
 
birth. The weight was 
measured with the child wearing only light clothing to the nearest 0.1 kg, using one digital 
scale, calibrated using a standard weight of 10 kg. The length was measured on a baby board 
in the recumbent position to 0.1 cm. Z scores for weight-for-age (WAZ), height -for-age 
(HAZ), and weight-for-height (WHZ) were calculated based on the National Centre for 
Health Statistics reference values using
 
the Epi-Info software version 3.2.2 (21).                                                   
Blood sampling and analysis: Blood samples (8 ml) were collected after an overnight fast by 
venipuncture (site cleaned with trace element-free alcohol) from the cubital fossa or external 
jugular vein. Samples were collected in eight separate trace element-free tubes, with a 
removable non-rubber lid protected from light, sent to the laboratory immediately after 
collection, and stored at -20 C after centrifugation, until analysis. They were evaluated for 
hemolysis.  
 
       Serum zinc samples were measured by atomic absorption spectrometry (Perkin Elmer 
ICP/5500), serum retinol measurements by the fluorometric method (22), serum iron levels 
were measured by using rate spectrophotometry (SYNCHRON CX Systems IRON/TIBC 
Calibrator Kit, Beckman Instruments) and serum ferritin levels using commercial enzyme-
linked immunoassay kits (Access Ferritin assay, Access Immunoassay Systems, Beckman 
Coulter). Quality control was performed by repeat analysis of standard reference material for 
low, normal and high values. The intra-assay and inter-assay coefficients of variation
 
for 
serum zinc, retinol, iron and ferritin were
 
all
 
less than 5%.                        
 Morbidity: The children were visited at home twice a week by a field worker who assessed 
whether the
 
child was suffering from diarrhea or symptoms of acute respiratory tract 
infection, and when the symptoms resolved. Compliance was evaluated by pill count. The 
children were referred to hospital when necessary. Diarrhea was present on any day when the 
child passed three or more loose stools per day (23). Acute respiratory symptoms were 
defined as
 
the history of cough and fever. 
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Statistical analysis:
 
Data entry and analyses were performed on SPSS 13.0 for Windows. Statistical analyses were 
two-tailed where appropriate and statistical significance was set at 5%. Data were assessed for 
normality and normalized by log transformation for serum ferritin.
 
       
The differences in anthropometric indices, and male to female ratios between the children 
who completed the study and those who dropped out were assessed by analysis of variance 
(ANOVA) and chi -square respectively.  
 
       
Anthropometric indices, micronutrient concentrations and immunological parameters 
were studied by means of ANOVA for repeated mea sures with treatment group and gender as 
between subjects' factors. Changes in these measurements over 3
 
months and 6
 
months and 
differences between the two treatment groups in the number of diarrheal and pneumonia 
episodes per month were assessed using ANOVA by treatment group, age and gender.
 
 
RESULTS
 
 
A total of 201 children aged 4 to 24 months were enrolled  (Figure 1); 121 completed the 
study. Among the 80 children who dropped out (40%), 43 died, 11 received treatment with 
ART, 13 relocated to another area and 13 dropped out for other reasons. Among the children 
who died, 80% died within the first month of follow up. The number of children who died and 
those who relocated was higher in the supplement group, while the number who received 
ART
 
was higher in
 
the placebo group, but none of these differences reached statistical 
significance. 
 
       
The anthropometric indices and CD4 T-lymphocytes (at enrolment) of the study children 
who dropped out and those who completed the study are compared in Table 1; there were no 
differences in the ages and the ratio of males to females. The children who dropped out were 
significantly more stunted and underweight and marginally more wasted than those who 
completed the study, in both treatment groups. The percentages of CD4 T-lymphocytes of the 
children who dropped out were lower than those who completed the study; this was only 
significant in the placebo group.
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Figure 1. Profile of study participants
 
Assessed for eligibility 
(n=837)
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Not meeting inclusion criteria (524)
 
Refused to participate (112)
 
Analyzed (n= 62)
 Excluded from analysis (n= 35)  
 
          
Lost to follow-up (n= 35)
 
          
Died (n= 16)
 
          
Received ARV    (n= 8)
 
          
Relocated (n= 4)    
 
          Other (n= 7) 
                 
Placebo (97)
 
Lost to follow-up (n= 45)
 
 
Died (n= 27)  
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Other (n= 6)  
 
 
Supplement
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Analyzed (n= 59)
 Excluded from analysis (n= 45) 
 
Allocation
 
Analysis
 
Follow-Up
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Table 1:
 
Anthropometric indices and CD4 T-lymphocytes of children at enrolment
 
 
Placebo
 
Supplement
 
All enrolled children
 
 
Children who 
completed
 Children who 
dropped out
 Children who 
completed
 Children who 
dropped out
 Children who 
completed
 Children who 
dropped out
 
n
 
62
 
35
 
59
 
45
 
121
 
80
 
Male/Female 
 
28/34
 
15/20
 
32/27
 
24/21
 
60/61
 
39/41
 
Age (months)
 
12.3 ± 6.5
 
11.7 ± 6.1
 
13.9 ± 6.1
 
12.8 ± 7.0
 
13.1 ± 6.4
 
12.3 ± 6.6
 
Weight (kg) 7.49 ± 1.86 6.37 ± 1.6# 7.89 ± 1.91  6.29 ± 1.7#  7.7 ± 1.9  6.3 ± 1.7#  
Height (cm) 70.31 ± 7.59 66.06 ± 7.8# 72.92 ± 6.86$  67.59 ± 7.1#  71.6 ± 7.3  67.0 ± 7.4#  
WAZ -1.67 ± 1.61 -2.91 ± 1.27#  -1.98 ± 1.51   -3.00 ± 1.18#   -1.82  ± 1.56  -2.97 ± 1.21#  
HAZ
 
-1.30 ± 1.66  
-2.76 ± 1.68#
 
-1.23 ± 1.56
 
-2.43 ± 1.54#
 
-1.27 ± 1.61
 
-2.54 ± 1.57#
 
WHZ
 
-1.13 ± 1.24 
 
-1.37 ± 1.36
 
-1.48 ± 1.27 
 
-2.00 ± 1.32*
 
-1.30 ± 1.26
 
-1.46 ± 1.31#
 CD4 percent (n)
 
28.0 ± 11.9 (48)
 
14.0 ± 8.9 (15)#
 
25.0 ± 12.5 (41)
 
21.1 ±  14.9 (16)
 
26.6 ± 12.2 (89)
 
17.7 ± 12.6 (31)#
 Values presented as mean ± SD
 $ Marginally different from subjects who completed study in placebo group (p=0.051)
 #Significantly different from subjects who completed study (p<0.05)
 
*Marginally different from subjects who completed study (p=0.06)
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Table 3:
 
Micronutrient status of the children over intervention period
 
 
Placebo
 
Supplement
 
 
Zinc 
(µmol/L)    
 Retinol 
(µmol/L) 
 Iron 
(µmol/L)
 Log ferritin 
(log[µg/L])     
 Zinc 
(µmol/L) 
 Retinol 
(µmol/L)
 Iron 
(µmol/L) 
 Log ferritin 
(log[µg/L])      
 
n
 
53
 
34
 
52
 
52
 
51
 
32
 
49
 
49
 
Enrolment
 
9.9 ± 2.9 
 
0.77 ± 0.44 
 
7.5 ± 4.0 
 
1.60 ± 0.50 
 
9.2 ± 2.8 
 
0.85 ± 0.43 
 
8.8 ± 4.5 
 
1.52 ± 0.36 
 
3 mo 10.0 ± 3.7  0.72 ± 0.23  9.1 ± 4.7  1.52 ± 0.45  10.6 ± 2.8  0.82 ± 0.37  11.3 ± 8.1  1.65 ± 0.33  
6 mo 10.4 ± 3.4  0.72 ± 0.20  8.2 ± 5.7  1.54 ± 0.53  10.5 ± 3.3  0.85 ± 0.43  9.9 ± 5.6  1.61 ± 0.37  
? 3mo 0.07 ± 4.1  -0.05 ± 0.40  1.55 ± 4.8$ -0.08 ± 0.39$  1.37 ± 3.5$*  -0.03 ± 0.46  2.46 ± 9.22^  0.13 ± 0.4$#  
? 6 mo
 
0.41 ± 4.0 
 
-0.05 ± 0.48 
 
0.67 ± 6.1
 
-0.06 ± 0.39 
 
1.26 ± 4.1$ 
 
-0.01 ± 0.67 
 
1.08 ± 7.23
 
0.10 ± 0.4* 
 
Values presented as mean ± SD 
 
$Significantly different from zero 
 ^Marginally different from zero (p=0.07)
 #Significantly different from placebo group (p<0.05)
 * Marginally different from placebo group (p=0.09)
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The immunological status of the children who completed the 6
 
months follow-up
 
was 
poor as denoted by the CD4 T-lymphocyte percentage (Table 2). At enrolment about 50% of 
the children in the placebo and supplement groups had CD4 T-lymphocyte proportions below 
25%. The CD4 T-lymphocyte percentage did not improve within both treatment
 
groups and 
there was no significant difference between the two groups.
 
       
The concentrations of serum zinc, retinol, iron and ferritin over the 6
 
month period are 
presented in Table 3 . There were no significant differences in the zinc and retinol 
concentrations between the two treatment groups at enrolment. The zinc concentrations 
improved significantly (by 14%) through
 
the
 
study period within the supplement group, but 
not significantly within the placebo group. Nonetheless,
 
there was no significant difference in 
the absolute change of serum zinc concentrations between the two treatment groups. The 
retinol concentrations did not differ significantly through
 
the 6
 
month
 
intervention
 
period 
within each treatment group and between the two treatment groups.
 
The serum iron 
concentrations increased by 12.5% and the log ferritin by 0.1 in the supplement group. On the 
other hand, among children on placebos, the serum iron concentrations increased by 9% while 
the log ferritin value deteriorated significantly over  the 6  months.   
       Weights and heights of the children who completed the follow-up period are shown in 
Table 4 and their derived anthropometric indices in Table 5 . The weights of the children 
increased significantly by 1.35 kg in the placebo group and
 
by 1.66 kg in supplement group. 
Through the
 
period of follow-up, there was a significant increase in height of 5.95 cm in the 
placebo group and 5.98 cm in the supplement group. Neither weight gain nor height increase 
was different between the two groups. There were no significant differences at enrolment 
between the two treatment groups in WAZ, HAZ and WHZ ( Table 5), but the absolute low 
values of the Z-scores indicate that a large proportion of the children should be classified as 
wasted and stunted. WHZ as indicator for wasting and HAZ as indicator for stunting are 
graphically presented in Figure 2. Over the 6
 
month intervention there was a significant 
improvement in WAZ and WHZ values among the children in the supplement group but not 
in the placebo group. The change in HAZ did not differ between the groups. 
 
       
The episodes of respiratory symptoms and of diarrhea were analyzed for children who 
had been followed up for 3
 
or more months. The number of episodes was then divided by the 
number of months of follow-up; these are presented in Table 6 . The ages of these children 
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were similar in the two treatment groups. The children who received the supplements had 
fewer episodes of diarrhea per month (0.25 ± 0.31) (mean ± SD) compared to those who were 
given placebos (0.36 ± 0.36) (p = 0.09) and substantially lower number of episodes of 
respiratory symptoms: 0.66 ± 0.51 versus 1.01 ± 0.67 (p<0.05); the latter difference was 
independent of the children's ages. 
 
 
DISCUSSION
 
 
The objective of the study was to assess the impact of 6
 
month multi-micronutrient 
supplementation on growth performance and number of episodes of diarrhea and respiratory 
symptoms of HIV-infected children. 
 
       
There was a high dropout rate among the children in the study (40%), and among
 
the 
children who dropped out the mortality was high at 54% (21% of all enrolled children). 
Although the number of children who died was higher in the group that received the 
supplements, 80% of children died within the first month of follow up in both treatment 
groups. It is therefore unlikely that the supplement was associated with the mortality. A 
pooled analysis of studies conducted in West, East and South Africa estimated that by two 
years of age 53% of HIV-infected children would have died (24). A survey that reviewed the 
mortality in a number of South African hospitals noted that approximately 48% of the deaths 
of children admitted to these hospitals were related to HIV infection (25). Only 11 (14% of 
the total number of dropouts) children were commenced on ART
 
in the current study. The 
ART
 
program was only rolled out in South Africa in 2004. The relatively low proportion of 
children who received ART
 
in the study may be related to the fact that the rollout of the ART
 
program was still at an early stage.
 
       
Children who dropped out were significantly more stunted and more wasted at enrolment 
than those who completed the study
 
in both groups but
 
the difference in wasting approached
 
significance only
 
among children who received the supplement. This chance finding occurred 
in spite of careful randomization procedures. Poor growth has been linked with increased 
mortality in HIV-infected children. This is supported by a study which indicated that wasting 
and stunting in HIV-infected children are associated with increased mortality (5). The 
immunological status (as measured by the percentage of CD4 T-lymphocytes) of the children 
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who dropped out in the current study was significantly worse than that of those who 
completed the study. This finding is in line
 
with a
 
meta-analysis of 10 studies that suggested 
that CD4 measurements are the most important indicator of mortality in HIV-infected 
children not receiving ART
 
(26).
 
       
Supplementation with micronutrients over a period of six months did not have an effect 
on the immunological status as measured by the CD4 T-lymphocytes in the current study. 
This is in keeping with a study in which zinc supplementation in HIV-infected young South 
African children had no effect on the percentage of CD4 lymphocytes when compared to a 
placebo (27). In pregnant HIV-infected Tanzanian women, however, multivitamin 
supplementation significantly improved the women? s CD4 counts, compared to women who 
received a placebo (28). 
 
       
The concentrations of serum zinc improved significantly over the study period among 
children who received the multi-micronutrient supplement. However, the absolute change in 
serum zinc and retinol concentrations was not significantly different between the two 
treatment groups. On the other hand there was a significant difference in the change in log 
ferritin (it was higher in the supplement group). Unfortunately blood samples for acute phase 
reactants (e.g. C-reactive protein) were not taken; this might have  hampered  the assessment of 
the difference in micronutrient concentrations. 
       
In the current study, the improvement in WAZ and WHZ over the six months period was 
significantly greater among children who were given the supplements. However the 
supplements had no effect on stunting. In Peru (an area with low HIV prevalence) no 
improvement was noted in WAZ and HAZ in children
 
(age 6-35 months)
 
who were given 
multi-micronutrients (29). Supplementation with vitamin A in HIV -infected Tanzanian 
children
 
(6-60 months of age)
 
significantly improved height, but not in uninfected children 
(30). It has been suggested that micronutrient supplements are more effective in children who 
have poor anthropometric indices. The children in the current study were more wasted and 
stunted than the children in the above noted studies, and all the supplements were given for 
six months except in the Tanzanian study where the duration was 12 months. A meta -analysis 
that assessed the effects of zinc supplementation on growth concluded that the effect was 
greatest in children older than six months whose initial HAZ were < -2.0 (9). 
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In the current study, children who received the micronutrient supplement had 
significantly fewer episodes of respiratory symptoms and fewer episodes of diarrhea than 
those who were on the placebo; the difference in diarrheal episodes did not reach statistical 
significance. In young
 
(6-24 months of age)
 
South African children who were born to HIV-
infected mothers, receipt of a multi-micronutrient supplement (that included vitamin A) did 
not reduce the prevalence of diarrhea or respiratory symptoms when compared with
 
children 
who were given vitamin A only irrespective of HIV status ( 2). However, multi-micronutrients 
supplementation reduced the incidence of diarrhea in rural South African children compared 
with those who received vitamin A only; the reduction was only noted in stunted HIV -
uninfected children (31).
 
Similarly, zinc supplements significantly reduced episodes of 
diarrhea in HIV-infected South African children; episodes of pneumonia however, were 
marginally reduced (27). A meta -analysis of 17 studies (from areas with low HIV prevalence) 
concluded that zinc supplementation significantly reduced the risk of diarrhea and respiratory 
illnesses (32).
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Table 4:
 
Weights and heights of the children over intervention period 
 
 
Placebo
 
Supplement
 
 
n
 
Age
 
(months)    
 
Weight
 
(kg) 
 
Height
 
(cm) 
 
n
 
Age 
(months) 
 
Weight 
 
(kg) 
 
Height 
 
(cm) 
 
Enrolment
 
62
 
12.3 ± 6.5
 
7.5 ± 1.9
 
70.3 ± 7.6
 
59
 
14.0 ± 6.1
 
7.9 ± 1.9
 
72.9 ± 6.9~ 
 
1 mo
 
62
 
13.3 ± 6.5
 
7.7 ± 1.9
 
71.1 ± 7.4
 
59
 
15.2 ± 6.4
 
8.3 ± 1.8
 
73.9 ± 6.9#
 
2 mo
 
62
 
14.2 ± 6.5
 
8.0 ± 1.9
 
72.1 ± 7.2
 
59
 
16.1 ± 6.4
 
8.5 ± 1.9
 
74.8 ± 6.9#
 
3 mo
 
62
 
15.1 ± 6.5
 
8.3 ± 1.9
 
73.1 ± 7.1
 
59
 
17.1 ± 6.4
 
8.8 ± 2.0
 
75.8 ± 7.0#
 
4 mo 62 16.1 ± 6.5 8.5 ± 2.0 74.2 ± 7.1  59  18.0 ± 6.4  9.0 ± 2.0  76.9 ± 7.0#  
5 mo 62 17.0 ± 6.6 8.6 ± 2.1 75.1 ± 7.1  59  19.0 ± 6.4  9.3 ± 1.9*  77.8 ± 7.0#  
6 mo 62 17.9 ± 6.6 8.8 ± 2.1 76.3 ± 7.2  59  19.9 ± 6.4  9.6 ± 2.0^  78.9 ± 7.1#  
? 3 mo 
62 2.9 ± 0.4$   0.80 ± 0.60$ 2.83 ± 1.54$  59  3.0 ± 0.4$  0.89± 0.75$  2.89 ± 1.59$  
? 6 mo
 
62
 
5.6 ± 0.5$
 
1.35 ± 0.96$
 
5.95 ± 2.24$
 
59
 
5.8 ± 0.5$
 
1.66 ± 1.10$
 
5.98 ± 2.31$
 Values presented as mean ± SD
 $Significantly different from zero (p<0.001)
 #Significantly different from placebo group (p<0.05)
 ~Marginally different from placebo group (p=0.051)
 
*Marginally different from placebo group (p=0.09)
 
^Marginally different from placebo group (p=0.06) 
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Table 5:
 
Anthropometric indices of the children over intervention period 
 
 
Placebo
 
Supplement
 
Follow up  
phase
 n
 
Age 
(months)    
 WAZ 
 
HAZ 
 
WHZ 
 
n
 
Age 
(months) 
 WAZ 
 
HAZ 
 
WHZ 
 
Enrolment
 
62
 
12.3 ± 6.5
 
-1.67 ± 1.61
 
-1.30 ± 1.66
 
-1.12 ± 1.24
 
59
 
14.0 ± 6.1
 
-1.98 ± 1.51 
 
-1.23 ± 1.56
 
-1.48 ± 1.27
 
1 mo
 
62
 
13.3± 6.5
 
-1.75 ± 1.57
 
-1.40 ± 1.70
 
-1.10 ± 1.13
 
59
 
15.2 ± 6.4
 
-1.86 ± 1.41
 
-1.34 ± 1.46
 
-1.30 ± 1.15
 
2 mo
 
62
 
14.2 ± 6.5
 
-1.79 ± 1.60
 
-1.48 ± 1.69
 
-1.07 ± 1.19
 
59
 
16.1 ± 6.4
 
-1.83 ± 1.44
 
-1.41 ± 1.47
 
-1.22 ± 1.18
 
3 mo 62 15.2 ± 6.5 -1.76 ± 1.58 -1.50 ± 1.64 -1.00 ± 1.17  59  17.1 ± 6.4  -1.79 ± 1.49  -1.38  ± 1.46  -1.18 ± 1.25  
4 mo 62 16.1 ± 6.5 -1.80 ± 1.59 -1.46 ± 1.62 -1.10 ± 1.23  59  18.0 ± 6.4  -1.77 ± 1.45  -1.31 ± 1.46  -1.23 ± 1.15  
5 mo 62 17.0 ± 6.6 -1.84 ± 1.64 -1.45 ± 1.71 -1.17 ± 1.25  62  19.0 ± 6.4  -1.70 ± 1.42  -1.28 ± 1.53  -1.15 ± 1.11  
6 mo 62 18.5 ± 7.1 -1.85 ± 1.69 -1.26 ± 1.66 -1.27 ± 1.18  59  20.0 ± 6.5  -1.58 ± 1.52  -1.14 ± 1.59  -1.08 ± 1.24  
? 3 mo
 
62
 
2.9 ± 0.4$  
 
-0.11 ± 0.69
 
-0.20 ± 0.55$
 
0.08 ± 0.92
 
59
 
3.0 ± 0.4$
 
0.11 ± 0.80^#
 
-0.18 ± 0.84
 
0.21 ± 0.91$
 ? 6 mo
 
62
 
5.6 ± 0.5$
 
-0.19 ± 1.10
 
0.03 ± 0.88
 
-0.04 ± 1.40
 
59
 
5.8 ± 0.5$
 
0.39 ± 1.07$#
 
0.09 ± 0.95
 
0.40 ± 1.22$#
 Values presented as mean ± SD
 $Significantly different from zero (p<0.05)
 ^Marginally different from zero (p=0.07)
 #Significantly different from placebo group (p<0.05)
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Figure 2: Anthropometric Z-scores of children who completed study
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Table 6: Diarrhea and respiratory symptom episodes per month of follow up
 
  
n
 
Age at 
enrolment  
(months)
 
Number of 
diarrheal 
episodes        
per month       
 Number of episodes 
of respiratory 
symptoms per month         
 
Placebo
 
53
 
12.0 ± 6.3
 
0.36 ± 0.36
  
1.01 ± 0.67
 
Supplement
 
52
 
13.7 ± 6.0
 
0.25 ± 0.31*
 
0.66 ± 0.51#
 
Values presented as mean ± SD
 
*Marginally different from placebo group (p=0.087)
 
#Significantly different from placebo group (p<0.05)
 
 
       
The improvement in growth performance and reduction in morbidity that was observed in 
this study suggests that micronutrient supplements are useful as adjunct therapy in HIV-
infected children. While there was no effect on CD4 lymphocytes, there were  no deleterious 
effects. At the time of conducting the study, AR T  was  not widely available at the local 
hospital, but has since become available to an increasing number of children in sub-Saharan 
African countries. However, because ART
 
are given to children with advanced HIV disease, 
micronutrient supplementation may be useful in those children who are as yet not eligible for 
ART. The effect of micronutrient supplementation in children in children who are on ART
 should also be investigated.
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Abstract
 
 
The aim of the study was to assess the effect of multi-micronutrient supplementation on the 
appetite of HIV-infected children. HIV-infected children (6-24 months) who had previously 
been hospitalized were enrolled into a double-blind randomized trial, and given daily multi-
micronutrient supplements or placebos for six months. Appetite tests were performed at 
enrolment and after three and six months. Appetite was measured as ad libitum
 
intake of a 
commercial cereal test food served after an overnight fast according to standardized 
procedures. Body weights and total amount of test food eaten were measured. In total,
 
99 
children completed the study (50 on supplements and 49 on placebos). Amounts eaten per 
kilogram body weight in the supplement group at enrolment and after six months were 36.7 ± 
17.7 g/kg (mean ± SD) and 41.3 ± 15.0 g/kg respectively, while the amounts in the placebo 
group were 47.1 ± 14.9 g/kg and 45.7 ± 13.1 g/kg respectively. The change in amount eaten 
per kilogram body weight over six months was significantly higher in the supplement group 
(4.7 ± 14.7 g/kg) than in the placebo group (-1.4 ± 15.1 g/kg). Multi-micronutrient 
supplementation for six months seems to significantly improve the appetite of HIV-infected 
children. 
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INTRODUCTION
 
  
Severe malnutrition is a frequent finding in children who are infected with HIV (Kessler, 
Daley, Malenga & Graham, 2000). Undernutrition has indeed been found to be a major 
problem in HIV-infected children in South Africa as illustrated by a study that revealed that 
more than 65% of these children were stunted before starting antiretroviral (ARV) therapy 
(Eley et al., 2006).
 
       
The origin of malnutrition in HIV infection is considered multi-factorial, and the 
mechanisms are thought to include decreased energy intake (Arpadi et al., 2000), nutrient 
malabsorption (Knox, Spiegelman, Skinner & Gorbach, 2000) and increased resting energy 
expenditure per kilogram of fat-free mass (Batterham, 2005). Reduced energy intake is 
considered to be a primary contributing factor to the pathogenesis of HIV-associated wasting 
(Mulligan et al., 2007). Asymptomatic HIV-infected children have been shown to have lower 
dietary energy and protein intakes compared to uninfected children who were born to HIV-
infected mothers (Jahoor, Abramson & Heird, 2003). Decreased nutrient intake in HIV -
infected children may result from anorexia (loss of appetite), central nervous system disease 
and dysphagia; these have been summarized in the review by Semba and Tang (1999). In a 
group of HIV-infected Indian children loss of appetite was a common symptom, with 59% of 
the children reported to have this symptom (Pol, Shepur & Ratageri, 2007). Loss of appetite 
was reported to be common among HIV-infected adults in Côte D? Ivoire (Castetbon et al., 
1997). Oesophageal candidiasis is common with HIV infection and will often result in 
dysphagia (difficulty in swallowing) and odynophagia (painful swallowing) and these in turn 
may also contribute to reduced energy and nutrient intake (Semba & Tang, 1999). 
Malnutrition in HIV-infected children is therefore likely to be related at least partly to the 
poor appetite of these children.
 
       
Poor appetite might be caused by micronutrient deficiency (Lawless, Latham, 
Stephenson, Kinoti, & Pertet, 1994; Umeta, West, Haidar, Deurenberg, & Hautvast, 2000), 
and since micronutrient deficiencies are common among HIV-infected children (Eley, Sive, 
Abelse et al., 2002; Eley, Sive, Shuttleworth, & Hussey, 2002), it is possible that the poor 
appetite in these children is to a degree influenced by these deficiencies. Zinc deficiency has 
been associated with disturbances in taste perception and appetite (Chen, Song, & Lin, 2000; 
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Ueda et al., 2006). A strong association between anorexia nervosa and zinc deficiency has 
been established (Shay & Mangian, 2000). Zinc supplements given to stunted Ethiopian 
children significantly improved appetite compared to children who were given a placebo 
(Umeta et al., 2000). Iron deficiency is also known to be associated with poor appetite. It has 
been reported
 
that iron supplementation improved appetite and growth in anaemic
 
Kenyan 
children (Lawless et al., 1994).
 
       
Another cause of poor appetite might be inadequate hormonal regulation of appetite. 
Insulin and leptin, for example, are involved in appetite regulation. The hormone leptin is 
primarily produced in the adipose tissue and is positively associated with body fat mass and 
recent energy intake. Circulating leptin levels signal to the brain that body fat stores and 
energy intake are adequate and this will result in appetite suppression. Insulin stimulates 
leptin production and secretion (Arsenault et al., 2007). Whether the effect of these hormones 
on appetite is influenced by micronutrient levels is unclear. Some studies have suggested that 
zinc may be involved in the regulation of serum leptin concentrations (Chen et al., 2000; 
Mantzoros et al., 1998).   
       Since micronutrient deficiencies might result in lowered appetite of HIV-infected 
children possibly through appetite regulating hormones, we conducted a randomized placebo-
controlled trial to assess the effect of multi-micronutrient supplementation on the appetite of 
these children and their levels of appetite regulating hormones. 
 
 SUBJECTS AND METHODS
 
 Subjects and study area
 
The study was conducted from the Doctor George Mukhari hospital which is located about 30 
km northwest of Pretoria, the capital city of the Republic of South Africa. This academic 
public hospital is attached to the Medunsa campus of the University of Limpopo and serves 
an area of approximately 2600 square km, including the township of Soshanguve where about 
one million people live. 
 
       
HIV-infected children aged 6 to 24 months who had been previously admitted to the 
paediatric wards of the hospital with pneumonia or diarrhoea were enrolled into the study. 
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The children were recruited either on discharge from the wards or at the follow up visit (post 
discharge) to the paediatric outpatient department (POPD) of the hospital. 
 
       
Children who were on anti-retroviral (ARV) therapy or had received micronutrient 
supplementation in the previous two months were not eligible for enrolment into the study. 
Similarly, children who had been diagnosed with a chronic illness unrelated to HIV infection 
were excluded. The children were enrolled from November 2005 until November 2006. 
 
 
Ethical considerations: 
 
The Research Ethics and Publications Committee of the Faculty of Medicine at Medunsa 
approved the study, and the permission of the hospital authorities was obtained. The parents 
or guardians provided signed informed consent. The children were referred to the anti-
retroviral (ARV) clinic when required in line with standard hospital procedures by using 
immunological and clinical staging. A child was only removed from the study when the 
physicians at the ARV clinic decided to commence ARV therapy (this was the case in eight of 
the children, see Fig. 1). 
 
 
                                               
                                               
Figure 1: Profile of enrolled children
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50 completed 
intervention
25 dropped 
out
16 died
2 received 
ARV
5 relocated
2 other
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Study design  
 
A double-blind, placebo controlled study was performed. Children were randomly assigned to 
one of two intervention groups using a simple randomization schedule by means of computer 
generated numbers. A staff member of the university attached to the hospital and who was not 
involved with the study did the randomization. The manufacturer prepared numbered packs of 
tablet corresponding to the subject's number according to the randomization schedule. The 
investigators, field workers and participants were all blinded to the treatment assignments.
 
       
The tablets were given to the children's caregivers to administer to the children dai ly for 
six months. The study children were also given appointments for monthly hospital follow up 
visits, during which weight and height measurements were performed.  
 
       
At enrolment, and at the third and sixth monthly hospital visits, appetite tests were 
performed and blood samples were taken for serum zinc, iron, ferritin, as well as plasma 
insulin and leptin. 
 
                
Intervention    
The multi-micronutrient supplement and placebo were prepared by the pharmaceutical 
company Adminicle Trading (Edenvale, South Africa). The multi-micronutrient supplement 
contained vitamin A 300 µg, vitamin B1 0.6 mg, vitamin B2 0.6 mg, vitamin B3 8 mg, 
vitamin B6 0.6 mg, vitamin B12 1 µg, folic acid 70 µg, vitamin C 25 mg, vitamin D 5 µg, 
vitamin E 7 mg, copper 700 µg, iron 8 mg, selenium 30 µg and zinc 8mg. These values are 
based on the recommended daily allowances for a one year old child (Food and Nutrition 
Board-Institute of Medicine, 2000). The placebo and supplement tablets were identical in 
appearance and were administered by crushing (using a pill crusher) and dissolving in a small 
amount of water. 
 
 
Methods
 
HIV tests
  
HIV-1 and HIV-2 serostatus was ascertained with the use of ELISA tests in children older 
than 15 months (Urassa, Matunda, Bredberg-Raden, Mhalu & Biberfeld, 1994). In children 
younger than 15 months a PCR test was performed in addition to the ELISA tests (van der 
Weert et al., 2006). The CD4 T -lymphocyte counts were measured by means of a Coulter 
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flow cytometer (Coulter Epics XL-MCL, Beckman Coulter) to assess immunological stage of 
HIV infection.
 
 
Table 1
 
Weights and heights of the children throughout the intervention
 
 
 
Age
 
(months)
 
Weight
 
(kg)
 
Height
 
(cm)
 
Placebo
 
(n = 49)
 
 
Enrolment
 
13.6 ± 5.7
 
7.9 ± 1.7
 
72.2 ± 6.3
 
3 mo
 
16.4 ± 5.7
 
8.7 ± 1.7
 
74.8 ± 6.1
 
6 mo
 
19.3 ± 5.7
 
9.3 ± 1.9
 
77.9 ± 5.9
 
    
Ä 3 mo O.V – M.4A   M.UP – M.SMA O.SO – 1.4PA  
Ä 6 mo R.T – M.SA 1.PR – M.VSA  R.VR – O.O4A  
 
Supplement (n = 50) 
 Enrolment
 
15.1 ± 5.4
 
8.1 ± 1.9
 
74.3 ± 6.0
 3 mo
 
18.2 ± 5.7
 
9.0 ± 2.0
 
77.1 ± 6.5*
 6 mo
 
21.1 ± 5.6
 
9.8 ± 2.1
 
80.0 ± 6.8
 
 
Ä 3 mo
 
3.1 ± 0.7$ 
 
0.89 ± 0.78$
 
2.78 ± 1.61$
 
Ä 6 mo
 
6.0 ± 0.7$
 
1.66 ± 1.10$
 
5.98 ± 2.31$
 
Values presented as mean ± SD. $Significantly different from zero ( P < 0.001)
 
*Marginally different from placebo group (P =
 
0.08)
 
 
Anthropometry 
 
The subject's age was calculated in months from the date of birth as given by the mother. The 
weight was measured without shoes, and with the child wearing only light clothing to the 
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nearest 0.1 kg using the same single digital scale for all children. The scale was placed on a 
table and was calibrated before each measurement session using a standard weight of 10 kg.                                   
       
The length was measured in the recumbent position to 0.1cm, on a baby board, by the 
investigator (SM) with the help of an assistant. One examiner held the child's head (with the 
chin in the neutral position) in contact with the fixed part of the board while the other 
examiner stretched the child to maximum length and then brought the movable part of the 
board into contact with the heels. 
 
       
Z scores for weight-for-age, height-for-age, and weight-for-height were calculated based 
on the National Centre for Health Statistics (NCHS) reference values by means of the Epi-
Info software version 3.2.2 (Dean et al., 2000).
 
 
Blood sampling and analysis
 
All blood samples were collected after an overnight
 
fast by venipuncture (puncture site 
cleaned with trace element free alcohol). Approximately 8 ml of blood was collected from 
each child. When the cubital fossa veins were not easily accessible, blood was obtained from 
the external jugular vein using a stainless steel needle and a plastic syringe. The samples were 
collected in eight separate trace element free tubes, with a removable non-rubber lid. The 
needle was removed from the syringe prior to injecting the blood into tubes in order to limit 
haemolysis.
 
The samples were evaluated for haemolysis. All the blood samples were collected 
and sent to the laboratory immediately after collection, protected from light, and stored at -
20°C after centrifugation, until analysis. The samples were analyzed within three
 
months of 
collection at the Medunsa branch of the national Health Laboratory Service NHLS).
 
       
Serum zinc samples were measured by atomic absorption spectrometry in mol/ (Perkin 
Elmer ICP/5500), separation from cell was conducted within 45 minutes. Quality control was 
assessed by repeat analysis of standard reference material. Coefficients of variation of less 
than 5% were considered acceptable. Serum iron concentrations were measured in mol/l by 
using rate spectrophotometry (SYNCHRON CX Systems IRON/TIBC Calibrator Kit, 
Beckman Instruments). Quality control was assessed by repeat analysis of standard reference 
material for low, normal and high values. Serum ferritin was measured by using commercial 
ELISA kits in g/l (Access Ferritin assay, Access Im munoassay Systems, Beckman Coulter). 
Similarly quality control was assessed by repeat analysis of standard reference material for 
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low, normal and high values. Coefficients of variation of less than 5% were considered 
acceptable. Plasma insulin concentrations were measured using enzyme labelled 
immunometric assays in mU/L, and plasma leptin concentrations were measured with the use 
of radioimmunoassay in ng/ml. 
 
 
Table 2
 
Anthropometric indices of the children throughout the intervention
 
 
 
Age
 
(months)
 
WAZ
 
HAZ
 
WHZ
 
Placebo
 
(n = 49)
     
     
Enrolment
 
13.6 ± 5.7
 
-1.76 ± 1.63
 
-1.27 ± 1.65
 
-1.30 ± 1.28
 
3 mo
 
16.4 ± 5.7
 
-1.68 ± 1.52
 
-1.42 ± 1.62
 
-1.03 ± 1.21
 
6 mo 19.3 ± 5.7 -1.67 ± 1.65  -1.09 ± 1.53  -1.22 ± 1.27  
     
Ä 3 mo 2.9 ± 0.4$ 0.08 ± 0.61  -0.15 ± 0.53^  0.27 ± 0.86$  
Ä 6 mo 5.7 ± 0.6$ 0.10 ± 1.00  0.18 ± 0.80  0.08 ± 1.16  
     Supplement
 
(n = 50)
     
     Enrolment
 
15.1 ± 5.4
 
-2.11 ± 1.50
 
-1.27 ± 1.56
 
-1.63 ± 1.19
 3 mo
 
18.2 ± 5.7
 
-1.84 ± 1.50
 
-1.38 ± 1.50
 
-1.28 ± 1.23
 
6 mo
 
21.1 ± 5.6
 
-1.59 ± 1.52
 
-1.13 ± 1.63
 
-1.11 ± 1.22
 
     
Ä 3 mo
 
3.1 ± 0.7$
 
0.27 ± 0.78$
 
-0.11 ± 0.90
 
0.36 ± 0.90$
 
Ä 6 mo
 
6.0 ± 0.7$
 
0.52 ± 1.00$#
 
0.14 ± 0.95
 
0.53 ± 1.22$*
 
Values presented as mean ± SD. $Significantly different from zero ( P < 0.05). ^Marginally 
different from zero (P = 0.06). #Significantly different from placebo group (P < 0.05). * 
Marginally different from placebo group (P = 0.06)
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Appetite testing
                                                                                                                
Conditions prior to testing: The children were given appointments on two separate days 
within a period of two weeks. The child was not allowed to eat any food (not even breast or 
formula milk) from the last meal of the day preceding the day of the appetite test, until after 
the appetite test. The test was conducted early in the morning. Compliance with these 
conditions was ascertained and if for any reason the mother had fed the child prior to the 
appetite test, another date for appetite testing was set.                                                                                                                   
Test food : A honey and wheat cereal, Nestlé Nestum® No 2 was used; in each case 75 gm of 
dry porridge was weighed on an electronic load cell scale to the nearest 0.1 gm. The 
preparation of the test cereal was standardised. Fresh full fat milk in a 2 litre milk container 
was put in a bowl of boiled water, until the milk T
 
reached 50 C, (measured by using a metal 
stem thermometer) 480 ml of this milk was then added to the dry porridge and mixed to a 
uniform consistency. Each 100 gm of the dry cereal contains 9.3 gm protein, 77.9 gm 
carbohydrates, 1.7 gm fat, and 5.2 gm fibre and have 1634 kJ of energy. One hundred 
millilitres of the milk contains 3.2 gm protein, 4.8 gm carbohydrates and 3.8 gm fat and yields 
260 kJ.                                                                                                                                                                              
Test feeding procedure : A porcelain bowl that easily accommodates a 700 ml volume was 
used. Plastic teaspoons were used to feed the children. The weight of the wet                   
cereal was measured.
 
An empty bowl was measured first and then the bowl with the cereal 
was measured. The test was conducted in a quiet room, with three to five mother 
and child pairs at a time. Each pair sat apart from the next, separated from the other 
participants by a curtain. The mothers were not allowed to communicate with each other 
during the test and they could not see how the other children were eating. The mother helped 
her child such that the child was eating ad libitum; the mother was not allowed
 
to verbally 
encourage the child to eat, nor to apply any kind of pressure on the child. The mothers were 
informed that the child was not obliged to finish the cereal. When the child stopped eating, the 
amount eaten and the duration of the eating episode were noted. A five minute break was then 
given, after which the child was invited to continue eating. The bowl with the leftover cereal 
was then weighed. An observer was on hand to ensure strict adherence to the procedures. The 
observer also recorded the duration of each eating episode. The total amount eaten and the 
total duration of the eating episode were used for further analysis.
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Statistical analysis
 
Data elaboration and analysis was performed by SPSS 13.0 for Windows. Statistical 
significance was set at 5%. 
 
       
Data were assessed for normality by visual examination of distribution plots, followed by 
normality tests. Where appropriate data were normalized by log transformation and these log 
transformed values were used for analysis. Serum ferritin and plasma insulin concentrations 
were log transformed.
 
       
The differences in baseline anthropometric indices, and ratio of males to females between 
the children who completed the study and those who dropped out were compared by 
univariate analysis of variance (ANOVA) and the chi -square test respectively.  
 
       
ANOVA revealed that there was no systematic difference between appetite measurements 
done on the first and second day of appetite testing within the two week period. Consequently 
mean values were calculated for each subject, and these mean values were utilized in the 
analysis. Changes in appetite measurements, anthropometric parameters, micronutrient 
concentrations and hormone levels were assessed by using ANOVA for repeated measures 
with treatment group and gender as between subjects factors. The changes in the parameters 
over three months and over six months were also tested by means of univariate ANOVA.  
 
RESULTS
 
 A total of 140 children aged 6-24 months were enrolled. Ninety-nine children completed the 
study (29% dropout). Among the 41 children who dropped out, 22 died, eight were started on 
anti-retroviral (ARV) therapy, seven relocated to another area, and the ot her four dropped out 
for other reasons (Fig. 1). Although the number of children who died and the number who 
relocated was higher in the group of children who received the supplement, these differences 
did not reach statistical significance. The number of the ones who were started on ARVs was 
higher in the placebo group and this too was not statistically significant. The children who 
dropped out and those who completed the study were not significantly different in terms of 
age (14.4 ± 6.4 months compared to
 
14.3 ± 5.5 months) (mean ± SD) and the ratio of males to 
females (0.77 as opposed to 0.86). 
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The weights and heights of the subjects who completed the six month follow up period 
are shown in Table 1 and their derived anthropometric indices in Table 2. The male to female 
ratio among the children who completed the six month intervention was not significantly 
different between the two treatment groups (0.81 and 0.72 in the placebo and supplement 
groups respectively). There were no significant differences at enrolment between the two 
treatment groups in terms of weight and height. The increase of the weights of the children of 
1.4 kg in the placebo group and 1.7 kg in the supplement group was not significantly different 
between the two groups. Over the six-month period of follow up the height increased by 5.95 
cm and 5.98 cm in the placebo and supplement groups respectively. There were no significant 
differences at enrolment between the two treatment groups in the weight-for-age Z-score 
(WAZ), height -for-age Z-score (HAZ) and weight-for-height Z-score (WHZ). However, a 
large proportion (46%) of the enrolled children were wasted and/or stunted. A total of 32 of 
these children were stunted (HAZ < -2SD) and 33 were wasted (WHZ < -2 SD), with 19 of 
them found to be both wasted and stunted. During the six-month intervention there was a 
significant improvement in the WAZ and WHZ among the children in the supplement group, 
and this improvement was significantly better than that in the placebo group. There were no 
significant changes in the HAZ over the six-month period in both treatment groups.  
       The serum concentrations of zinc, iron and ferritin over the six month period are 
presented in Table 3. There were no significant differences in these serum concentrations 
between the two groups at enrolment. Over the six month period the serum zinc 
concentrations improved significantly (by 12%) within the supplement group, but not within 
the placebo group. However, there was no significant difference in the absolute change of 
serum zinc concentrations over six months between the two treatment groups. The log ferritin 
values improved over the intervention period in the supplement group, and this improvement 
reached statistical significance within the first three months. On the other hand, the log ferritin 
value in the placebo group deteriorated significantly over the first three months, and did not 
change in the next three months.
 
       
The plasma leptin and the log transformed insulin concentrations over the study period 
are shown in Table 4. There were no significant changes in these values, either within each
 
group or between the two groups.          
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Table 3
 
Micronutrient status of the children throughout the intervention
 
 
 
Zinc
 
(µmol/L)
 
Iron
 
(µmol/L)
 
Log ferritin
 
(log[µg/L])
 
Placebo
    
    
n
 
43
 
43
 
43
 
Enrolment
 
9.7 ± 2.8
 
7.0 ± 4.1
 
1.49 ± 0.44
 
3 mo
 
9.4 ±
 
3.1
 
9.0 ± 4.8
 
1.41 ± 0.36
 
6 mo
 
10.1 ± 3.0
 
8.3 ± 5.8
 
1.41 ± 0.41
 
    
Ä 3 mo
 
-0.25  ± 3.84
 
2.08  ± 4.86$
 
-0.08  ± 0.42
Ä 6 mo
 
0.45 ± 3.80
 
1.36  ±5.99
  
 
Supplement 
   
    
n
 
44
 
42
 
42
 
Enrolment
 
9.4 ± 2.8
 
8.6 ± 4.3
 
1.49 ± 0.33
 3 mo
 
10.6 ± 2.8
 
11.8 ± 8.4
 
1.64 ± 0.34
 6 mo
 
10.5 ± 3.1
 
9.9 ± 5.6
 
1.61 ± 0.39
 
    Ä 3 mo
 
1.19 ±3.46$*
 
3.23 ± 9.21$
 
0.15 ±0.37$#
 
Ä 6 mo
 
1.15 ± 3.76$
 
1.30 ± 7.44
 
0.11 – 0.40^#
 
    
NHLS reference values
 
(NHLS, 2007)
 
8.2 –
 
23.0
 
9.0- 21.5
  
0.85 - 2.15
Values presented as mean . $ Significantly different from zero. ^Marginally different ± SD
from zero (P = 0.07). #Significantly different from placebo group (P < 0.05)
 
* Marginally different from placebo group (P = 0.07)
 
           
-0.08  ± 0.51
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The amounts of test food eaten (in grams and in grams/kg body weight), eating duration 
and eating rate are presented in Table 5. The amount of test food eaten at enrolment (in grams 
and in amount per kg body weight) was significantly (p<0.05) higher in the placebo group 
compared to that in the supplement group. The change in amount of test food eaten (either 
expressed in grams or in grams/kg body weight) over the six months follow up period was 
significantly higher in the supplement group (p<0.05).
 
 
DISCUSSION
 
 
The main objective of the study was to investigate whether a six month multi-micronutrient 
supplementation would improve the appetite of HIV-infected young South African children. 
We indeed observed a significant improvement in appetite as measured by the amount of test 
food eaten.
 
       
In the current study appetite was measured by ad libitum
 
consumption of a commercial 
cereal test food after an overnight fast. This technique of appetite testing has been validated in 
young Beninese children as an appropriate tool for testing and evaluating appetite (Dossa, 
Ategbo, van Raaij, de Graaf, & Hautvast, 2002a). Even though the children in the current 
study were younger and more malnourished than the Beninese children, the standardization of 
the testing procedures was successfully implemented.
 
       
The improved appetite was observed in a group of children who were poorly nourished at 
enrolment, as signified by the anthropometric indices which showed that 46% of them were 
malnourished (stunted and/or wasted), and also indicated by the serum values of the 
micronutrients relative to the local laboratory reference values (NHLS, 2007). 
 
       
The improvements in appetite were not associated with changes in the hormones leptin 
and insulin. It should, however, be realized that the leptin concentrations were tested in a 
small number of children and thus there was insufficient power to arrive at a definite 
conclusion. Nonetheless a study conducted in young Peruvian children indicated that zinc 
supplementation over six months had no effect on the leptin, ghrelin and insulin 
concentrations of the children (Arsenault et al., 2007).
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Table 4
 
Hormone levels of the children throughout the intervention
 
 
Log Insulin
 
(log[mU/L])
 
Leptin
 
(ng/ml)
 
Placebo
    
   
n
 
42
 
14
 
Enrolment
 
0.10 ± 0.34
 
1.60 ± 1.06
 
3 mo
 
0.22 ± 0.47
 
2.55 ± 0.75
 
6 mo
 
0.11 ± 0.41
 
1.84 ± 0.66
 
   
Ä 3 mo
 
0.12 .± 0.64
 
0.95 ± 0.96$
 
Ä 6 mo
 
0.01 ± 0.58
 
0.24 ± 1.36
 
   
Supplement    
   
n 41 17  
Enrolment 0.06 ± 0.44 1.74 ± 1.43  
3 mo
 
0.25 ± 0.54
 
2.00 ± 0.94*
 6 mo
 
0.09 ± 0.51
 
1.81 ± 1.14
 
   Ä 3 mo
 
0.19 ± 0.73
 
0.26 ± 1.24
 Ä 6 mo
 
0.03 ± 0.64
 
0.06 ± 1.73
 
Values presented as mean . * Marginally different from placebo group (±SD P = 0.08). 
$Significantly different from zero
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Table 5
 
Appetite of the children throughout the intervention
 
 
 
Age
 
(months)
 
Amount eaten 
(g)
 
Eating duration 
(min)
 
Eating rate 
(g/min)
 
Amount eaten 
(g/kg Bwt)
 
Placebo 
     
(n = 49)
 
     
Enrolment
 
13.6 ± 5.7
 
362 ± 124
 
25.4 ± 7.3
 
15.3 ± 6.5
 
47.1 ± 14.9 
 
3 mo
 
16.4 ± 5.7
 
405 ± 129
 
26.4 ± 8.1
 
16.5 ± 7.2
 
47.6 ± 15.5
 
6 mo
 
19.3 ± 5.7
 
419 ± 137
 
26.0 ± 9.2
 
17.8 ± 8.3
 
45.7 ± 13.1
 
      
Ä 3 mo
 
2.9 ± 0.4$
  
1.1± 6.4
 
1.2 ± 5.6
 
0.5 ± 13.1
 
Ä 6 mo
 
5.7 ± 0.6$
  
0.7 ± 9.1
 
2.5 ± 7.6$
 
-1.4 ± 15.1
 
      
Supplement 
(n = 50) 
     
Enrolment 15.1 ± 5.4  286 ± 130# 24.2 ± 9.0  12.4 ± 5.7#  36.7 ± 17.7#  
3 mo 18.2 ± 5.7 364 ± 141 25.3 ± 7.5  15.5 ± 8.3  42.0 ± 17.4  
6 mo
 
21.1 ± 5.6
 
394 ± 139
 
25.6 ± 8.8
 
16.9 ± 7.6
 
41.3 ± 15.0
 
      Ä 3 mo
 
3.1 ± 0.7$
 
79 ^± 120$
 
1.1  11.3±
 
3.1  7.8$±
 
5.3 ± 14.9$
 Ä 6 mo
 
6.0 ± 07.7$
 
108 ± 112 #
 
1.4  11± .6
 
4.5  7.2$±
 
4.7 ±14.7$
 Values presented as mean   Significantly different from zero (p<0.05).                             ± SD. $
^ Marginally different from placebo group (p=0.08). * Marginally different from placebo 
group (p=0.09). # Significantly different from placebo group (p<0.05).
 
 
       
Children who received the supplements achieved significant improvements in their 
appetites over the six month period. This was in relation to amount of test food eaten, both in 
terms of absolute amounts, and amounts per kg body weight. A number of published studies 
have demonstrated that appetite stimulants (like megestrol acetate) can improve the appetite 
of HIV-infected subjects (Mulligan et al., 2007). While there have been trials that have 
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evaluated the effect of micronutrients on appetite, these have been in areas with a low 
prevalence of HIV (Dossa, Ategbo, van Raaij, de Graaf, & Hautvast, 2001; Dossa, Ategbo, 
van Raaij, de Graaf, & Hautvast, 2002b; Umeta et al., 2000; UNAIDS, 2007). There are 
hardly any studies that have assessed the effect of multi-micronutrients on the appetites of 
HIV-infected children. Multi-micronutrient supplements with and without iron did not 
improve the appetites (as assessed by ad libitum
 
intake of test food) of apparently stable 
young children from Benin, however the supplements were only given for 14 weeks (Dossa et 
al., 2001, 2002b). It is possible that the 14-week period of supplementation in stable children 
was too short. Single micronutrient supplementation has
 
also been used to improve appetite. 
In a group of stunted Ethiopian children supplementation with zinc only (over six months), 
significantly reduced the incidence of anorexia, compared to a placebo (Umeta et al., 2000). 
Iron supplementation (over 12 months) together with anti-helminthic drugs was also reported 
to have improved the appetites of Zanzibari school children (Stoltzfus et al., 2004). In the 
Ethiopian and Zanzibari studies poor appetite was assessed by interviewing the mother. 
Supplementation with iron over 14 weeks improved the appetites (assessed by ad libitum  
intake of test food) of anaemic Kenyan primary school (Lawless et al., 1994). As already 
noted, these children were anaemic and thus iron is likely to have a noticeable effect 
compared to placebo.  
       
The results of our study indicate that multi-micronutrient supplementation might be 
useful in improving appetite in HIV-infected children, and this may improve the nutritional 
status of these children and thus reduce their susceptibility to infections. 
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The studies in this thesis addressed two main aims. The first was to assess the effects of short-
term and long-term multi-micronutrient supplementation on episodes of diarrhoea and of 
respiratory infections in HIV-infected children who were not yet on antiretroviral therapy 
(ART). The second aim was to assess the impact of long-term multi-micronutrient 
supplementation on the appetite and growth performance of HIV-infected children who were 
not yet on ART. A cross -sectional study was performed prior to these intervention studies to 
compare the appetite, nutritional status and duration of diarrhoea and pneumonia in HIV-
infected children (not on ART) with HIV-uninfected children in order to confirm the need for 
these supplementation studies. 
 
       
We noted that the appetite and nutritional status of HIV-infected children were
 
poorer 
than those
 
of uninfected children (Chapter 2). HIV-infected children admitted with diarrhoea 
or pneumonia were also noted to have a longer duration of hospitalization than those who 
were not infected (Chapter 2).  It was also observed that short-term multi-micronutrient 
supplementation reduced the duration of acute episodes of diarrhoea and pneumonia (Chapter 
3); while long-term supplementation significantly reduced the frequency of episodes of 
respiratory symptoms and marginally reduced the frequency of episodes of diarrhoea (Chapter 
4). Long-term supplementation with the multi-micronutrient  supplement  also improved the 
appetite and growth performance of HIV-infected children (Chapters 4 & 5).  
       
In this chapter the following topics will be discussed:
 
methodological issues related to the 
studies performed, the main findings of these studies, the important role of antiretroviral 
therapy (ART) in the current treatment of children infected with HIV, the interrelationship 
between ART and nutritional status and the policy implications arising from the findings of 
the studies.
 
                 
Methodological issues related to research performed
 
 
This section deals with some of the methodological aspects of the studies that are relevant for 
the validity of our findings. These aspects relate to the study population, choice of 
micronutrient supplement and assessment of micronutrient status.
 
 
Study population in short and long-term intervention studies  
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Rationale for enrolment of only HIV-infected children in intervention studies
      
In the intervention studies that are described in this thesis, the effect of the supplement was 
assessed
 
only in children who were HIV-infected; HIV-uninfected children were not included. 
It might be argued that the effects of micronutrient supplementation should have been 
assessed simultaneously in both HIV-infected and uninfected children, in order to evaluate the 
magnitude of the effect in HIV-infected children. However, our objective was to assess 
whether multi-micronutrient supplements were beneficial in HIV-infected children. It was not 
to compare the magnitude of the effect of the supplements in HIV-infected
 
children with that 
in uninfected ones. Studies evaluating the effect of multi-micronutrient supplements in HIV-
uninfected children from developing countries had been previously conducted by other 
researchers. These studies indicated that supplementation is beneficial in these children (see 
Chapter 1). We initially conducted a cross-sectional study that was intended to confirm 
whether the duration of hospitalization, appetite and nutritional status of HIV-infected 
children were
 
significantly worse than those
 
of uninfected children. The results of the cross-
sectional study suggested that there was a need to assess the effects of multi-micronutrient 
supplementation specifically in HIV-infected children. We therefore decided to limit the 
subjects in the intervention studies to HIV-infected children.  
Hospital outpatient department based trial versus community based trial  
The children who participated in the long-term supplementation study were enrolled from the 
outpatient department (OPD) of the hospital. Indeed
 
these were children who had previously 
presented with an illness at the hospital. One might wonder whether children from the OPD 
are representative of children in their age group in the community. Children who have had 
previous hospital visits may conceivably have a poorer nutritional status than those who have 
not required a prior visit to hospital (Lima et al.
 
2004). The results of the study may thus be 
relevant to children who have already had an illness related to the HIV disease. However, 
without ART mortality is very high amongst HIV-infected African children; approximately 
35% die in the first year and 53% by the second year (Newell et al.
 
2004). There is evidence 
that a large proportion of ART naïve HIV -infected children who die have had previous 
hospital admissions (Walker et al. 2006). During the period when the study was conducted, 
ART in the public sector of South Africa was only initiated in hospitals. There are therefore 
probably not many HIV-infected South African children younger than two years who have
 
not
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had a visit to hospital. In view of these facts it is unlikely that there would have been a high 
number of HIV-infected children without previous hospital visits in a group of children 
enrolled from the community. We thus consider HIV-infected children enrolled from the OPD 
as representative of HIV-infected children in their age group in the community.
 
Appropriate age group for multi-micronutrient supplementation 
 
In the studies of this thesis the supplement was given to HIV-infected children aged 4-24 
months at enrolment. One might wonder if this is the appropriate age of giving the 
supplement in order to ensure the optimal outcomes in HIV-infected children. There are a 
number of reasons why supplementing to children at this age is a sound idea. HIV-infected 
children often require hospitalization at
 
this age. South African studies that have assessed the 
impact of HIV on paediatric hospital admissions have confirmed that the majority of 
hospitalized HIV-infected children are younger
 
than two years of age (Pillay
 
et al.
 
2001; 
Meyers et al.
 
2000). It is also estimated that 30% of infants born to HIV-infected
 
mothers
 
get 
infected; of these 5% are infected in utero, 15% during labour, and 10% in the postpartum 
period (Merchant and Lala, 2005). It is clear from this that the majority of HIV-infected  
children are infected during and after birth. The effects of the HIV infection are thus likely to 
start manifesting in infancy. Therefore giving an intervention to HIV-infected children during 
infancy seems to be appropriate.                   
       
An alternative strategy that has been used is to give micronutrient supplements to 
pregnant HIV-infected women in order to improve the growth and morbidity of their HIV-
infected infants. Studies from Tanzania in particular have shown a beneficial effect in 
improving the weight-for-length and weight-for-age Z-scores, reducing the risk of acute 
diarrhoea and improving the CD4 T-lymphocyte counts of children born to these women 
(Villamor et al. 2005; Fawzi et al.
 
2003). In the minority of children who are infected in 
utero, the mechanisms leading to growth delay are likely to start in utero and to continue after 
birth (Villamor et al. 2005). Indeed HIV-infected pregnant women have a higher risk of 
delivering low birth weight babies (Fawzi et al.
 
1998). Multi-micronutrient supplementation 
to pregnant HIV-infected women is therefore
 
a
 
viable alternative to supplementing infants and 
young children. On the other hand, it might be more practical to give the supplement to HIV-
infected infants and young children as they are more likely to present to healthcare facilities at 
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this age. The administration of supplements to HIV-infected infants and young children when 
compared to pregnant mothers is probably a more appropriate and practical tool.
 
Severity of HIV disease in enrolled children                                                                                 
                                                                     
In the studies that are reported in this thesis the clinical stage (WHO, 2005) of the HIV-
infected children was not described. It may be considered that the severity of the HIV disease 
may play a role in children? s response to micronutrients, in which case then the severity of the 
HIV should be described. The severity of HIV disease can be assessed by clinical or 
immunological staging (using CD4 lymphocyte counts) (CDC, 1994). Certainly, CD4 
lymphocytes were assessed in the children who took part in the long-term supplementation 
studies. We were thus able to assess the proportion of children with severe immune 
suppression in these studies (see Chapter 4).   
 
        
Multi-micronutrient supplementation 
 
Methodological issues relevant to micronutrient supplementation include composition of the 
supplement and recommended dose of micronutrients.   
 Composition and dose of the multi-micronutrient supplement  
Since multiple micronutrients seem to be of more benefit than a single micronutrient, we 
decided to use a multi-micronutrient supplement in the short-term and long-term intervention 
studies. The most prevalent micronutrient deficiencies include iron, zinc,
 
vitamins A, B2, 
B12, D and E, and these usually occur together (Allen et al.
 
2009). The following 
micronutrients have also been shown to play a role in the human immune system; zinc, iron, 
vitamins A, B6, B12, folic acid, C, D and E (Mehta & Fawzi, 2007).
 
As a result we felt that 
the multi-micronutrient supplement should at least contain the micronutrients that commonly 
cause
 
deficiencies as
 
well as those that
 
have immunological actions.
 
       
The multi-micronutrient supplement that was used in the intervention studies is 
commercially available and it contains 300 ìg retinol, 0.6 mg thiamin, 0.6 mg riboflavin, 8 
mg niacin, 0.6 mg pyridoxine, 1 ìg cobalamin, 70 ìg folic acid, 25 mg ascorbic acid, 5 ìg 
1,25-dihydrocholecalciferol, 7 mg d,l á-tocopherol, 700 mg copper, 8 mg iron, 30 ìg 
selenium, and 8 mg zinc. The amounts in the supplement were independently tested and 
confirmed by the Medicines Control Council of South Africa. These amounts are equal to the 
recommended dietary intake levels for a one year old
 
child. This is line with WHO guidelines 
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which recommend that micronutrient supplements should be given according to RDA (WHO, 
2003). In light of the evidence that high intakes of some micronutrients may produce adverse 
outcomes in HIV-infected persons (WHO, 2003), it was prudent to supplement at RDA levels 
as per WHO guidelines. It should be noted that the dose of zinc (8 mg) that was also given in 
the short-term supplementation study was lower than the recommended 20 mg for acute 
diarrhoea in children older than six months (WHO & UNICEF, 2004). Still, safe upper limits 
for micronutrients in children infected with HIV have not been established, thus it was 
considered that using the RDA levels was appropriate.
 
       
Some questions have been raised about the
 
possible pitfalls of supplementing 
micronutrients to HIV-infected children. These questions relate in particular to zinc, vitamin 
A and iron, and are partly related to the structure of the virus. The nucleocapsid protein of the 
human immunodeficiency virus has zinc fingers which have a high affinity for zinc cations 
and are involved in viral replication. The HIV genome is also known to have a retinoic acid 
receptor element, thus vitamin A may increase HIV replication (Mehta & Fawzi, 2007). Zinc 
has also been shown to induce the proliferation of CD4 lymphocytes and activated CD4 
lymphocytes are a major target for HIV replication. Vitamin A is known to increase lymphoid 
cell differentiation, which leads to an increase in CCR5 receptors which are essential for  
attachment of HIV to lymphocytes (Mehta & Fawzi, 2007). It has also been argued that iron 
supplementation could have deleterious consequences for HIV-infected people; these adverse 
effects could include enhanced oxidative stress, increased viral replication and increased 
mortality (Boelaert et al. 1996; Savarino
 
et al. 1999). Notwithstanding these concerns, 
supplementation with the afore-mentioned micronutrients appears to be safe. Zinc 
supplementation for six months to HIV-infected South African children did not increase 
plasma HIV viral loads or decrease the percentage of CD4 lymphocytes (Bobat et al. 2005). A 
review by Clark and Semba (2001) indicated that iron supplementation for HIV-infected 
pregnant women, and for anaemic infants and children as is currently practiced in most 
developing countries is not contraindicated by available data. Encouragingly, another study 
noted that while vitamin A supplementation increased the risk of respiratory infection among 
HIV-uninfected Tanzanian children, it was actually protective among those who were HIV-
infected (Fawzi et al. 2000).
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Adequate assessment of micronutrient status
 
There is a lack of adequate biomarkers of micronutrient status. Serum concentrations of 
micronutrients are not considered as accurate indicators of total body micronutrient status.
 
Zinc status:
 
There are a number of techniques that can be used to assess zinc status; of these 
the most promising for field application are dietary assessment and plasma/serum zinc 
concentration measurement (Gibson
 
et al. 2008). Despite its limitations, analysis of plasma or 
serum zinc concentration remains the most practical method currently available to assess zinc 
status of populations (Hess et al. 2007). Consumption of a meal may induce a postprandial 
reduction in plasma zinc, even if dietary intakes of zinc and tissue reserves are normal 
(Hambidge et al. 1989). To avoid the latter problem it is advisable to obtain
 
fasting serum 
zinc samples. This
 
was obviously done in the studies reported in this thesis.
 
Vitamin A status : Vitamin A status can be best expressed in terms of total body reserves of 
vitamin A, or alternatively of liver concentrations of the vitamin (Tanumihardjo, 2004). In 
well-nourished persons, the liver contains more than 80% of the total-body stores (Senoo et 
al. 2007). Direct measurement of liver retinol stores by liver biopsy is considered to be the 
“gold standard”, but this is invasive and is thus rarely an option (Tanumihardjo, 2004). While 
measurement of serum retinol concentration is less sensitive than the techniques used to 
measure retinol liver stores (Furr et al. 1989), it is thought to be adequate for estimating 
vitamin A status when the levels are very low (< 0.35 ìmol/L)
 
or very high (> 3.5 ìmol/L) 
(Furr et al. 1989).
   Iron status: The measurement of body iron stores through bone marrow staining is considered 
to be the “gold standard” for determining iron status (Erhardt et al. 2004). However, this 
requires bone marrow aspiration which is an invasive procedure. Serum ferritin and soluble 
transferrin receptor are considered to be the two best parameters for assessing iron status 
(Erhardt et al. 2004). The high cost and lack of standardisation of the soluble transferrin 
receptor assay tends to limit its applicability (Yang et al. 2008). It is thought that for most 
programmatically relevant purposes serum ferritin is an effective measure of iron status (Yang 
et al. 2008).
 
       
Although the biomarkers for assessing micronutrient status are not adequately developed,
 
the methods used in the studies are suitable for assessing micronutrient status in populations.   
 
                                                                                                                                     
 
130
 
 
 
       
Concentrations of serum zinc, retinol and ferritin are adversely affected by inflammation; 
concentrations of
 
serum zinc and retinol are lower, while those of serum ferritin are high with 
elevated C-reactive protein (CRP) concentrations (Brown et al. 1993; Erhardt et al. 2004). 
Unfortunately, for practical reasons CRP concentrations were not measured in the 
intervention studies of this thesis. The CRP concentrations
 
would
 
have enhanced the
 
interpretation
 
of the micronutrient concentrations. 
 
   
Main research outcomes 
 
 
Differences between HIV-infected and uninfected children (Chapter 2)
 
We observed that the duration of hospitalization was significantly longer among HIV -infected 
children than that in those who were uninfected. The nutritional status of children infected 
with HIV was also shown to be poorer than that of uninfected children.
 
The weight-for-age 
and length-for-age Z-scores of the children who were HIV-infected with HIV were 
significantly lower than those of the uninfected children. However, there was no difference in 
the weight-for-length Z-scores between these two groups of children. HIV-infected children 
were observed to have significantly poorer appetites than HIV-uninfected children. This was 
in terms of total amount eaten, duration of eating episodes and eating rate.  
       
The finding of increased duration of hospitalization and a poorer nutritional status among 
HIV-infected children compared to HIV-uninfected children was consistent with findings of 
other researchers (Kourtis et al. 2006; Heikens
 
et al. 2008). The finding of reduced appetite in 
HIV-infected children as opposed to that in uninfected ones is also in keeping with 
observations by other authors (Pol
 
et al. 2007; Heikens
 
et al. 2008). However, other studies 
had used caregiver reported assessment of appetite, while we used a more objective means of 
appetite measurement. The comparison with other studies is more extensively reported in 
Chapter 2.
 
       
The duration of hospitalization of HIV-infected was longer and their appetite and 
nutritional status poorer than that of uninfected children.             
 
       
We
 
would thus recommend that in communities with high HIV prevalence all children 
with severe malnutrition should be investigated for
 
HIV infection. 
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Short-term and long-term multi-micronutrient supplementation and its effects on diarrhoea 
and respiratory infections in HIV-infected South African children (Chapters 3 and 4)
        
Our finding was that short-term multi-micronutrient supplementation reduced the duration of 
episodes of diarrhoea and pneumonia and long-term multi-micronutrient supplementation 
decreased the frequency of episodes of diarrhoea and respiratory symptoms. 
 
       
Supplementation with micronutrients during an episode of diarrhoea or respiratory 
infection has resulted in variable outcomes. Zinc supplementation has been clearly shown to 
reduce the duration of diarrhoea, but does not seem to be beneficial in acute respiratory 
infections (Fischer Walker & Black, 2007; Mathew, 2010a) While there is some evidence of 
the benefits of vitamin A in acute diarrhoea (Mahalanabis & Bhan, 2001) ,
 
a review
 
by Fischer 
Walker & Black
 
(2007) suggested that neither vitamin A nor folic acid has an effect on the 
duration of diarrhoea. Vitamin A does not seem to be useful in non -measles pneumonia, and a 
systematic review suggested that vitamin A has no benefit in the treatment of childhood 
pneumonia (Mathew, 2010b). However, multi -micronutrient supplementation reduced the 
duration of respiratory-related illness in Chinese preschool children compared to children who 
were only given vitamin A or vitamin A plus iron (Chen et al. 2010).   
       We believe that the decreased duration of hospitalization that we observed is clinically 
significant. A longer duration of hospitalization has an impact on hospital bed occupancy and 
may result in the exclusion of other patients who require hospitalization. The risks of 
acquiring a nosocomial infection are also increased with longer hospitalization. In addition to 
these,
 
there are financial costs related to hospitalization. The costs of hospitalization include 
the actual cost of hospital care, as well as the cost of days lost from work by the 
parents/caregivers and the transport costs of visiting the child in hospital. While calculations 
of inpatient costs were not done in the current study, it has been estimated that the mean total 
direct medical cost of hospitalization for a child admitted with diarrhoea at Dr George 
Mukhari hospital (where the current study was conducted) in 2005 was $1123 (MacIntyre & 
de Villiers, 2010). We can thus conclude that a reduction of 1.5 days in the duration of 
hospitalization
 
would result in significant cost savings per patient.
 
       
Studies assessing the effect of multi-micronutrient supplementation on the frequency of 
episodes of diarrhoea and respiratory infections have shown varying results. A study 
conducted among Peruvian children indicated that while zinc supplementation alone seemed 
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to reduce the number of episodes of diarrhoea and respiratory illness, a multiple micronutrient 
supplement (including zinc) actually increased the number of episodes of these diseases 
(Penny et al. 2004). In rural South African children multiple micronutrient supplementation 
decreased the episodes of diarrhoea and respiratory symptoms, but only among stunted HIV-
uninfected children (Chhagan et al. 2009). Multi-micronutrient sprinkles (including zinc) also 
significantly reduced the prevalence of diarrhoea compared to placebo (Sharieff et al. 2006). 
Supplementation with a multi-micronutrient seasoning powder also reduced the incidence of 
diarrhoea and respiratory related illness in Chinese pre-school children compared to children 
who were only given vitamin A or vitamin A plus iron (Chen et al. 2010).     
 
       
Our observations were that short-term multi-micronutrient supplementation decreases the 
duration of hospitalization in HIV-infected children admitted with diarrhoea or with 
pneumonia. Long-term multi-micronutrient supplementation seems to reduce the number of 
episodes of diarrhoea and those of respiratory symptoms.
 
       
The implementation of multi-micronutrient supplementation in HIV-infected children 
with an acute episode of diarrhoea or pneumonia should be considered in the clinical setting 
as this seems to reduce the duration of illness. Long-term multi-micronutrient 
supplementation in HIV-infected children should also be considered  for application as it 
apparently decreases the frequency of episodes of diarrhoea and respiratory symptoms.  
 Impact of multi-micronutrient supplementation on growth performance of HIV-infected 
South African children (Chapter 4)
 We noted that while the supplement significantly improved the weight-for-age and weight-
for-height Z-scores of these children, it seemed to have no effect on the height-for-age Z-
scores. It is possible that supplementation for six months was too short to observe 
improvement in height. A meta-analysis assessing the effects of vitamin A, iron and multi -
micronutrients indicated that neither vitamin A nor iron alone improved either ponderal or 
linear growth, but multi-micronutrient supplementation improved linear growth 
(Ramakrishnan et al. 2004). A systematic review showed that while the efficacy of multi -
micronutrient supplementation varied across trials, there is substantial evidence that growth 
(in terms of length and weight) is improved, and that the benefits are greater with a multi-
micronutrient than with two or fewer micronutrients (Allen et al. 2009). Studies that evaluate 
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the effect of multi-micronutrient supplementation on growth of HIV-infected children are 
few, and as far as we know no meta-analysis has been performed. 
 
       
A study such as the one we performed showing improvement in wasting strengthens the 
case for recommending supplementation to all HIV-infected children.  
 
 
Effect of multi-micronutrient supplementation on appetite of HIV-infected South African 
children (Chapter 5)
 
The multi-micronutrient supplement resulted in a significant improvement in appetite of 
children when compared with that of children who were on the placebo. This was observed in 
relation to the absolute amount eaten and amount eaten per kilogram body weight, but not in 
terms of the duration of eating episodes and the eating rate. 
 
       
Supplementation with zinc and with iron was noted to improve the appetite (as reported 
by the mother) of Ethiopian and Zanzibari children respectively (Umeta et al.
 
2000; Stoltzfus 
et al. 2004). However, multivitamin-multimineral supplementation with or without additional 
iron did not improve the appetite (measured by ad libitum  intake of test food) of Beninese 
children (Dossa et al. 2001; Dossa et al. 2002). It is worth noting that the multivitamin-
multimineral supplementation in the Beninese studies was given for six weeks while the zinc 
and iron supplements were given for six and 12 months respectively. It thus possible that 
supplementation for a longer period may have yielded positive results. 
 
       
Our findings were that multi-micronutrient supplementation improves the appetite of 
HIV-infected children.
 
       
We believe that the improvement in the appetite of HIV-infected children that we 
observed is a meaningful result that would further support a recommendation to give multi-
micronutrient supplements to HIV-infected children at a population level.
 
          
                   
Pivotal role of antiretroviral therapy in treatment of HIV-infected children
 
                   
In the first 15 years (1981-1995) of the HIV pandemic, HIV disease was a universally fatal 
and catastrophic illness (Delaney, 2006). Most HIV programmes at the time focused
 
on 
prevention of further infections, surveillance of HIV infection and supportive treatment for 
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the infected people. The supportive treatment was mainly related to treatment of opportunistic 
infections (UNAIDS, 2000). The development of multi-drug combination therapy for 
treatment of HIV disease (which became available in 1996) is considered as one of the 
successes of modern medicine (Delaney, 2006). This combination therapy, where successfully 
implemented has changed HIV from an almost inevitably fatal disease to a chronic illness 
(Delaney, 2006). However, ART
 
remained largely unavailable to HIV-infected persons in 
developing countries until 2002 (WHO, 2002).
 
       
In 2000, the United Nations adopted the millennium development goals, which include 
combating HIV/AIDS, malaria and other infectious diseases (goal
 
number six). One of the 
targets of this goal was to achieve by 2010, universal access to treatment (ART) for 
HIV/AIDS for all those who need it (United Nations, 2000). Subsequently WHO released 
guidelines for scaling up ART in resource limited settings; t hese guidelines included 
recommendations for starting ART in infants and children with advanced HIV disease (WHO, 
2002). However, subsequent evidence revealed that mortality is high in infancy and that early 
initiation of ART dramatically reduces this mort ality. The guidelines now state that ART 
should be initiated in all HIV-infected infants, regardless of the CD4 count or whether the 
infant is sick (WHO, 2010). It is stated that ART should be commenced in children between 
12 and 24 months irrespective of clinical and immunological stage, but this is a conditional 
recommendation; eligibility for ART in children older than 2 years is based on clinical and 
immunological severity (WHO, 2010).
 
       
WHO currently has a number of recommendations relating to nutrition for HIV-infected 
children, but the quality of evidence supporting a number of them is low. A number of these 
recommendations state that guidelines that are in place for HIV-uninfected should apply to 
HIV-infected children as well. These include six monthly high dose vitamin A to children 
aged 6-59 months, zinc supplementation for acute diarrhoea, and exclusive breastfeeding for 6 
months and then continuation until two years and beyond (WHO, 2010). These guidelines 
also add a conditional recommendation that children who are infected with HIV should 
receive one RDA of micronutrients daily, and that if this cannot be given through the diet or 
there is evidence of deficiency, then supplements should be given (WHO, 2010). This is put 
forward as a conditional recommendation, as there is inadequate and very low quality 
evidence to support it. 
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In South Africa, the policies relating to the treatment of HIV infection have not always 
been in line with WHO guidelines. In 1998, WHO recommended that prevention of mother-
to-child transmission should be part of the minimum standard of care for HIV-infected 
women and that this should include ART to the pregnant mother (WHO, 1998). This was not 
implemented in South Africa, and it was only after a successful court
 
action by South African 
NGOs in 2002, that a limited programme of giving ART to pregnant women to reduce HIV 
transmission to their infants was started. As mentioned before WHO guidelines in 2002 were 
to give ART to infants and children with advanced HIV d isease (WHO, 2002). This again was 
not implemented and it was only in November 2003 that the South African government 
published its plan to provide public access to ART in 2004 (many years after the effectiveness 
of ART in reducing mortality had been repor ted) (Department of Health, South Africa, 2003). 
By then some sub-Saharan countries that have less resources than South Africa had already 
begun to make ART available. The latest South African guidelines (2010) on provision of 
ART to infants and children are largely in line with WHO recommendations, except that the 
conditional recommendation of providing ART to children aged 12 -24 months regardless of 
HIV severity is not followed. Similarly, the WHO conditional recommendation of giving 
multi-micronutrients to all HIV-infected children is also not adhered to (Department of 
Health, South Africa, 2010).   
       
The clinical efficacy of ART in children in developed countries has been well 
documented. A study conducted in the United States indicated that the ini tiation of 
combination ART was associated with an estimated reduction of 67% in the risk of death 
(Gortmaker
 
et al. 2001). This reduction in risk of death was regardless of age, sex, percentage 
of CD4 lymphocytes, race and educational level of the parents.
 
Mortality was also markedly 
reduced in a group of children from California (United States) after the introduction of ART; 
the hospitalization rate was also markedly reduced (from 6.49 to 0.6 admissions per 100 
person-years) (Viani et al. 2004) Studies from less developed countries have also showed that 
excellent clinical response to ART. In a group of South African children, survival after one 
year post introduction of ART was 84%; this was in spite of the fact that 77% of the children 
had advanced immune suppression (Eley et al. 2006). Another study conducted in Côte 
d'Ivoire also exhibited a low mortality rate after 42 months of treatment; a good immune 
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recovery and a sustained viral suppression were also obtained (Rouet et al. 2006). Yet the 
coverage of ART in children in Africa remains low.      
 
       
Children under one year are among those who are most vulnerable to HIV but are often 
among the least served (UNAIDS, 2008). Studies from Cambodia and South Africa have 
indicated that the median age at which ART is commenced is around 6 years (Janssens et al. 
2007; Reddi et al. 2007). A retrospective review of post neonatal mortality in South Africa 
revealed a peak at 2-3 months of age in HIV-related mortality (Bourne et al. 2009). Indeed 
early initiation of ART has been shown to significantly reduce mortality when compared with 
ART initiated according to clinical progression of HIV or CD4 counts (Violari et al. 2008). 
Encouragingly the number of children initiated on ART has increased dramatically over the 
past few years and it is reported that from the end of 2007 to the end of 2008 there was a 39% 
increase in the number of children initiated on ART (WHO, 2009). 
 
 
Interrelationship between antiretroviral therapy and nutritional status
 
 
It is important to note that the results that reported  in this thesis apply to HIV-infected 
children who are not yet on ART. It is quite conceivable that the response of children who are 
on ART may not be similar. Nonetheless, failure to address nutritional deficiencies that a re 
there even in HIV-infected children who are on ART, may limit the potential of ART. 
Malnutrition at the time of commencing ART has been associated with increased mortality 
(Paton et al.
 
2006). Indeed, a study in Malawi indicated that adults with severe malnutrition 
(body mass index < 16.0 kg/m2) had a six times higher risk of dying in the first three months 
of commencing ART when compared to those with normal nutritional status (Zachariah
 
et al.
 
2006). The association between undernutrition and increased
 
mortality on starting ART has 
also been seen in children. In a group of HIV-infected Kenyan children who commenced 
ART, wasting and anaemia were associated with increased early mortality (Wamalwa et al.
 
2010).
 
       
Treatment with ART has been shown to h ave beneficial effects on the nutritional status of 
HIV-infected children. A multi -centre study conducted in the Netherlands showed 
improvements in weight-for-age and height-for-age Z-scores after the children had received 
ART for 96 weeks; the improvement
 
was only significant in virologic responders (Verweel et 
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al.
 
2002). A significant improvement in weight -for-age and height-for-age Z-scores was also 
observed in Thai children within the first year after ART initiation (Aurpibul et al.
 
2009). 
Likewise, HIV-infected children from Malawi had significant improvements in WAZ and 
HAZ, two years after starting ART (Weigel et al.
 
2010). Treatment with ART also 
significantly improved WAZ and HAZ in Ugandan children within 48 weeks of ART 
initiation (Musoke et al.
 
2010). It is worth noting that while the mean WAZ returned to -1.5 
or greater at 48 weeks among the Thai children, it was not until
 
144 weeks that the mean HAZ 
reached -1.5 or greater (Aurpibul et al.
 
2009). Among the Malawian children neither
 
the 
median WA Z nor
 
the median HAZ reached
 
normal values after two years on ART among 
children who were underweight or stunted at baseline (Weigel et al.
 
2010).         
 
       
It seems that ART may also influence the concentrations of some micronutrients.              
         
A systematic review of observational studies of micronutrients in HIV-infected persons 
receiving ART suggested that some micronutrients may increase after ART initiation (Drain 
et al.
 
2007). Treatment with ART increased the concentrations of á -carotene, â-carotene, á-
tocopherol, vitamin B-12 and folate, but not of vitamin A, selenium or zinc (Drain et al.  
2007). Conversely, a study that compared serum zinc concentrations of HIV-infected children 
on ART with that of HIV -infected children who were not on ART revealed that children on 
ART were significantly less likely to be zinc deficient (Ndeezi et al.  2010).   
       
Micronutrient supplementation may be of benefit to HIV-infected individuals on ART as 
well. Zinc supplementation for 18 months reduced
 
the rate of diarrhoea and the likelihood of 
immunological failure in zinc deficient HIV-infected adults (Baum et al. 2010). 
Supplementation with multi-micronutrients improved the CD4 counts of adults infected with 
HIV who were on ART (Kaiser et al. 2006).
 
On the other hand some studies have not shown 
an effect of micronutrient supplementation on viral load or CD4 counts (Semba et al. 2007; 
Batterham et al. 2001).
 
       
It is important to note that there are adverse nutritional and metabolic consequences of 
ART use; these include dyslipidaemia (elevated circulating concentrations of total cholesterol 
and triglycerides), lipodystrophy, glucose intolerance and insulin resistance (Raiten et al.
 
2005). Other nutritional abnormalities include lactic acidaemia, osteopaenia and osteoporosis 
(Raiten et al.
 
2005).  
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Treatment of dyslipidaemia as a consequence of ART is the same as when it results from 
other causes.
 
The treatment includes a low-fat diet, exercise and medical therapy (fibrates and 
statins) when required (Dubé et al.
 
2003). There is also some evidence that micronutrients 
may be of some benefit in ART related dyslipidaemia. Extended release niacin was noted to 
significantly improve total cholesterol (decreased), triglycerides (decreased), VLDL 
(decreased) and HDL (increased) in non-diabetic HIV-infected adult males who were on ART 
and had confirmed dyslipidaemia (Dubé et al.
 
2006). An earlier trial had also shown that 
extended release niacin had a beneficial effect in HIV-infected adults on ART with
 
dyslipidaemia (Gerber et al.
 
2004). Both these trials indicated that extended release niacin 
was safe in these patients, especially in relation to concerns about insulin resistance (Dubé et 
al.
 
2006; Gerber et al.
 
2004). Thiamine and riboflavin may be of benefit in treating the lactic 
acidosis that may be caused by the nucleoside reverse transcriptase class of ART; some case 
report studies on HIV-infected adults have also suggested this beneficial effect (Dalton & 
Rahimi, 2001; Arici et al.
 
2001). There seems to be evidence of the contribution of ART to 
the reduced bone mineral density that is observed in HIV-infected patients; the role of vitamin 
D and calcium supplementation needs further investigation (Stone et al.  2010).                 
        
Implications for Public Health Policies arising from research described in thesis  
 
Current WHO/UNICEF recommendations for the treatment of acute diarrhoea are for the 
provision of 10 mg (in children younger than 6 months) or 20 mg of zinc (in children who are 
6 months or older) daily for 14 days (WHO and UNICEF, 2004). This dose has been worked 
out for HIV-uninfected children, and it has not been demonstrated to be safe in HIV-infected 
children. However, it is thought that short-term zinc supplementation is
 
unlikely to have 
deleterious effects. There are no current recommendations relating to micronutrient 
supplementation in children with acute non-measles pneumonia, outside the neonatal period. 
We showed that multi-micronutrient supplementation reduces the duration of diarrhoea and 
pneumonia in HIV-infected children (Chapter 3). While further studies may be needed to 
confirm these findings, serious consideration should be given to supplementing HIV-infected 
children suffering from acute diarrhoea or pneumonia with multi-micronutrients.         
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Our finding that long-term multi-micronutrient supplementation improves appetite, 
reduces wasting and decreases the number of episodes of diarrhoea and respiratory symptoms 
serves to strengthen the current conditional recommendation by WHO that HIV-infected 
children should receive micronutrients
 
at RDA levels
 
daily. Relationships that are observed in 
randomised controlled trials provide
 
a high quality form of evidence. Studies like the ones we 
performed
 
may
 
add to the data that the WHO requires to strengthen the level of 
recommendation from conditional into strong.    
 
    
Recommendations for future research
 
 
As noted previously ART does improve nutritional status, but improvement in some of the 
parameters like height may take as long as two years. Provision of ART seems to have a 
variable effect on micronutrients, and deficiency of micronutrients increases the risk of 
diarrhoea and respiratory infections (see Chapter 1). Whether the addition of multi-
micronutrient supplements to ART results in greater and quicker improvement in growth and 
reduction in episodes of diarrhoea and respiratory infections in HIV-infected children who are 
on ART needs to be assessed.  
       There is some evidence (as mentioned above) that micronutrients may be helpful in 
improving the immunological status of HIV-infected adults on ART. Studies need to be 
conducted to see if these benefits extend to HIV-infected children on ART. 
 
       
The role of micronutrient supplements in alleviating the adverse nutritional and metabolic 
effects of ART in children infected with HIV also needs elucidation.
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Summary
 
The nutritional status of HIV-infected children
 
as established by
 
weight, height and 
micronutrient status has been observed to be poor. Diarrhoea and respiratory infections have 
been shown to be
 
more
 
common
 
and more severe in these children than
 
in HIV-uninfected 
children.
 
       
Deficiencies of micronutrients are associated with poor growth and immune suppression. 
The suppressed immunity results in increased risk of infections, among others, diarrhoea and 
respiratory infections. There is evidence that micronutrient supplementation may improve 
growth and may reduce infections in children who are not HIV-infected. Micronutrient 
deficiencies
 
seldom occur as a deficiency of a single micronutrient,
 
but rather as a 
simultaneous
 
deficiency of several micronutrients: a
 
multi-micronutrient deficiency. 
Supplementation
 
with
 
a
 
multi-micronutrient
 
supplement should therefore be advised above 
supplementation with a single micronutrient.
 
       
The studies that are reported in this thesis aimed to assess the short-term and long-term 
effects of multi-micronutrient supplementation on diarrhoea and respiratory infections, and on  
appetite and growth, of HIV-infected children who are not yet on antiretroviral therapy 
(ART). We have conducted four studies.  
       The first study performed was a cross-sectional study in which the duration of 
hospitalization, nutritional status and appetite of HIV-infected children hospitalized with 
diarrhoea or pneumonia were
 
compared with those of HIV-uninfected children
 
(Chapter 2). In 
total 192 children aged 4-24 months were enrolled within 24 hours of admission and their 
HIV status was determined and their weights and lengths were measured. On discharge the 
duration of hospitalization was recorded and they returned to hospital
 
4-8 weeks later for 
appetite testing and assessment of serum micronutrient status. Appetite was tested by ad 
libitum
 
consumption of a commercial baby cereal on three separate days using a standardized 
protocol. HIV-infected children were observed to be more wasted but not more stunted than 
those who were uninfected. The duration of hospitalization was 52% longer in HIV-infected 
children compared with those who were uninfected. Serum zinc, iron and transferrin 
concentrations and haemoglobin levels were significantly lower in HIV-infected children 
compared with those who were not infected. The appetite of
 
HIV-infected children as
 
established as
 
amount of test food eaten and
 
as
 
eating rate,
 
was also poor compared with that 
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in uninfected children.
 
In literature much has been reported on the effects of micronutrient 
supplementation in HIV-uninfected children,
 
but hardly on effects in HIV-infected children. 
Since we observed in our study that the starting position with respect to hospitalization 
duration, nutritional status and appetite was worse in HIV-infected children compared with 
HIV-uninfected children, we decided to investigate the effects of multi-micronutrient 
supplementation in HIV-infected children. The supplement used in the short-term and long-
term intervention studies contained vitamins A, B complex, C, D, E and folic acid, and
 
the 
minerals
 
iron, copper, selenium and zinc,
 
at amounts based on recommended daily allowance 
for a 1 year old child. In
 
the
 
short-term intervention study the supplement was given daily 
from enrolment until discharge
 
from the hospital, while in the long-term studies it was given 
daily for 6 months.
 
       
In chapter 3 we reported on a short-tem intervention study in which HIV-infected 
children aged 4-24 months hospitalized with diarrhoea or with pneumonia were randomized 
to receive
 
either
 
a multi-micronutrient supplement or
 
a
 
placebo until discharge from hospital. 
A total of 120 children were enrolled within 24 hours of hospitalization  (70 hospitalized with 
pneumonia and 50 with diarrhoea). Supplementation reduced the duration of hospitalization 
among children admitted with diarrhoea and with pneumonia by 1.6 and 1.9 days 
respectively. The duration of hospitalization on the  supplement  was 7.3 ± 3.5  days  and on the 
placebo
 
it was 9.0 ± 4.9
 
days
 
(P <0.05). We thus conclude that multi -micronutrient 
supplementation
 
may
 
decrease the duration of hospitalization
 
by 20%.
 
       
Subsequently
 
the effects of long-term multi-micronutrient supplementation were 
evaluated
 
in a randomized trial
 
with
 
201 HIV-infected children aged 4-24 months
 
(Chapter 4).
 The children
 
received
 
either
 
supplements or placebos daily for 6
 
months.
  
The children were 
monitored for symptoms of respiratory infection (cough and fever) or for diarrhoea twice a 
week and their weights
 
and heights were measured monthly. CD4 lymphocyte
 
counts were 
measured on enrolment and at 3
 
and 6 months.
 
Out of the 201 children who were originally 
enrolled, 121 completed the study (40% dropout).
 
Among the children who dropped out 
mortality was 54%. The children who dropped out were more wasted (-1.46 ± -1.31) vs (-1.30 
± 1.26)
 
and stunted (-2.54 ± 1.57) vs (-1.27 ± 1.61) and had lower CD4 counts (17.7 ± 12.6) 
vs (26.6 ± 12.2) when compared with those who completed the study. Supplementation 
improved the weight-for-age (0.39 ± 1.07 vs -0.19 ± 1.10) (p<0.05) and weight-for-height
 
Z-
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scores (0.40 ± 1.22 vs -0.04 ± 1.40 (p<0.05) when compared with children who received a 
placebo,
 
but supplementation
 
had no effect on the height-for-age Z-scores (0.09 ± 0.95 vs 
0.03 ± 0.88). The supplement did not result in improvement in the CD4 lymphocyte counts 
over the 6-month period in the supplement (-0.64 ± 8.3)
 
and placebo groups (-1.44 ± 7.5), but 
it did
 
result in
 
a
 
reduction in
 
the number of episodes of symptoms
 
of respiratory
 
infection
 
(0.66 ± 0.51 vs (0.66 ± 0.51) and of diarrhoea
 
(0.25 ± 0.31 vs
 
0.36 ± 0.36; p=0.09). We thus 
conclude
 
that long-term (six months) multi-micronutrient supplementation
 
will result in an 
improvement of body weight and in less episodes of respiratory infection
 
and diarrhoea.
 
The 
long-term effects of multi-micronutrient supplementation on appetite were assessed in 140 
HIV-infected children whose ages were 6-24 months (Chapter 5). The children had appetite 
tests conducted at enrolment,
 
and at 3
 
and 6
 
months. Appetite was measured as in the cross-
sectional study as ad libitum
 
intake of a commercial
 
baby
 
cereal after an overnight fast using 
a standardized protocol. A total of 99
 
of these children
 
(50 on supplements and 49 on 
placebos) completed the study. The change in appetite over six months was better in children 
who received the supplement (4.7 ± 14.7 (g of test food eaten per kg body weight)) compared 
with children who received the placebo (-1.4 ± 15.1 g/kg body weight). Our conclusion is that 
long-term supplementation with multi-micronutrients will improve the appetite of HIV-
infected children.   
       
Our
 
findings from
 
the intervention studies were obtained in HIV-infected children who 
are not yet on ART. The importance
 
of ART in the treatment of HIV -infected children cannot 
be overemphasised. However, in spite of the scaling up of access to ART, less than 50% of
 the estimated 2.3 million
 
HIV-infected sub-Saharan children currently receive ART. The 
benefits of multi-micronutrient supplementation as described in our
 
studies remain
 
therefore
 
relevant for a large number of children.  
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Samenvatting (Summary in Dutch)
 
 
De voedingstoestand van hiv-geïnfecteerde kinderen zoals vastgesteld op basis van hun
 
gewicht, lengte en micronutriëntenstatus,
 
is slecht te noemen. Diarree en luchtweginfecties 
komen in deze kinderen vaker en in ernstiger mate voor dan in kinderen die niet hiv-
geïnfecteerd
 
zijn.
 
       
Micronutriëntdeficiënties zijn geassocieerd met slechte groei en met onderdrukking van 
het immuunsysteem.  Onderdrukking van het immuunsysteem  resulteert in een toegenomen 
risico op infecties, dus ook op diarree en luchtweginfecties.  Aangetoond is dat 
micronutriëntsuppletie  bij kinderen die niet hiv-geïnfecteerd zijn de groei kan verbeteren en  
het aantal infecties kan terugbrengen.  Micronutriëntdeficiënties komen zelden voor als een 
deficiëntie aan
 
één enkel micronutriënt, in het algemeen komen meerdere deficiënties 
simultaan voor en spreekt men van multi-micronutrëntdeficiënties.  Het ligt dus meer voor de 
hand te suppleren met een multi-micronutriëntsupplement
 
dan met één enkel micronutriënt. 
 
       De studies waarover in dit proefschrift gerapporteerd wordt hadden als doel de korte-
termijn en langetermijn  effecten vast te stellen van een multi-micronutriëntsupplement  op 
diarree en luchtweginfecties, en op eetlust en groei, bij  hiv-geïnfecteerde kinderen die geen 
antiretrovirale  behandeling krijgen. We hebben vier studies uitgevoerd.  
       
De eerste
 
studie was een cross-sectioneel onderzoek waarin de hospitalisatieduur, de 
voedingstoestand  en de eetlust  van hiv-geïnfecteerde kinderen vergeleken werd met die van 
niet-hiv-geïnfecteerde kinderen
 
(Chapter 2). De kinderen waren opgenomen in het ziekenhuis 
vanwege diarree of luchtweginfecties. In totaal namen 192 kinderen in de leeftijd van 4-24 
maanden deel aan het onderzoek. Binnen 24 uur na opname in het ziekenhuis werd hun hiv-
status vastgesteld en hun lengte en gewicht gemeten. Bij ontslag uit het ziekenhuis werd de 
hospitalisatieduur genoteerd en 4-8 weken  later
 
kwamen de kinderen terug in het ziekenhuis 
voor een eetlusttest en voor vaststelling van de micronutriëntenstatus in serum.  De eetlust 
werd vastgesteld door het meten van de ad libitum
 
consumptie van een commercieel 
verkrijgbare kindervoeding op drie verschillende dagen en volgens een gestandaardiseerd 
protocol.  De hiv-geïnfecteerde kinderen waren magerder ("more wasted")
 
maar niet korter 
("not more stunted")  dan niet -hiv-geïnfecteerde kinderen.
 
De hospitalisatieduur van hiv-
geïnfecteerde kinderen was 52% langer, en hun zink, ijzer en transferrine concentraties in 
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serum alsmede
 
hun hemoglobinespiegels waren significant lager. Ook de eetlust van hiv-
geïnfecteerde kinderen uitgedrukt als hoeveelheid gegeten testvoeding en als eetsnelheid was 
lager dan die bij niet-hiv-geïnfecteerde kinderen.   In de literatuur is veel gerapporteerd over 
de effecten van micronutriëntsuppletie bij niet-hiv-geïnfecteerde kinderen, maar nauwelijks 
over effecten bij hiv-geïnfecteerde kinderen.   Aangezien wij in onze studie vonden dat de 
uitgangssituatie wat betreft hospitalisatieduur, voedingstoestand en eetlust bij hiv-
geïnfecteerde kinderen duidelijk minder
 
gunstig 
 
is dan bij niet-hiv-geïnfecteerde kinderen,
 
besloten we  de effecten van
 
multi-micronutriëntsuppletie te onderzoeken bij hiv-
geïnfecteerde kinderen.
 
       
Het supplement dat in de korte-termijn en langetermijn interventiestudies gebruikt is 
bevatte de vitamines A, B-complex, C, D, E, en foliumzuur,
 
en de mineralen  ijzer, koper, 
selenium en zink, in hoeveelheden die gebaseerd zijn op de dagelijkse aanbevolen 
hoeveelheden voor een kind van 1 jaar oud. In de korte-termijn studie werd het supplement  
tijdens de hospitalisatie dagelijks verstrekt tussen
 
de opname in het ziekenhuis en het ontslag. 
In de langetermijn studies werd het gedurende zes maanden dagelijks verstrekt.  
       In Chapter 3 wordt gerapporteerd over de korte-termijn interventiestudie bij hiv-
geïnfecteerde kinderen van 4-24 maanden oud die in het ziekenhuis opgenomen waren met 
diarree of luchtweginfecties. Deze kinderen kregen ad random óf dagelijks een multi-
micronutriëntsupplement, óf een placebo. In totaal werden 120 kinderen binnen 24 uur na 
opname in het ziekenhuis gerekruteerd: 70 waren opgenomen met luchtweginfecties en 50 
met diarree.  Suppletie verminderde de hospitalisatieduur van kinderen opgenomen voor 
diarree en voor luchtweginfecties  met respectievelijk 1,6 en 1,9 dagen. De hospitalisatieduur 
van de kinderen op het supplement was 7,3 ± 3,5 dagen en van de kinderen op de placebo 9,0 
± 4,9 dagen (p<0,05).  We kunnen dus concluderen dat multi-micronutriëntsuppletie de 
hospitalisatieduur van hiv-geïnfecteerde kinderen met circa 20% kan verlagen.
 
       
Vervolgens zijn in een int erventiestudie de effecten van langetermijn multi-
micronutriëntsuppletie geëvalueerd bij 201 hiv-geïnfecteerde kinderen in de leeftijd van 4-24 
maanden
 
(Chapter 4). De kinderen kregen ad random óf gedurende 6 maanden dagelijks het 
supplement óf gedurende 6
 
maanden dagelijks de placebo. De kinderen werden twee keer per 
week onderzocht op luchtweginfectie
 
symptomen (hoesten en koorts) en op diarree. Hun 
gewicht en lengte werd maandelijks gemeten. CD4 lymfocyten werden bepaald bij aanvang 
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van de studie en na 3
 
en 6 maanden. Van de 201 gerekruteerde kinderen hebben 121 kinderen 
de studie afgemaakt (40% uitval). De sterfte onder
 
de kinderen die uitvielen bedroeg 54%. De 
kinderen die uitvielen waren bij aanvang magerder ("more wasted") (-1,46
 
±
 
1,31 vs -1,30
 
±
 
1,26) en korter ("more stunted") (-2,54
 
±
 
1,57 vs -1,27
 
±
 
1,61) ) en hadden minder CD4 cellen 
(17,7
 
±
 
12,6 vs 26,6
 
±
 
12,2) dan de kinderen die de studie voltooiden. Vergeleken met de 
kinderen die de placebo kregen leidde suppletie tot een verbetering van de gewicht-voor-
leeftijd (0,39 ± 1,07 vs -0,19 ± 1,10) (p<0,.05) en de gewicht-voor-lengte Z-scores  (0,40 ± 
1,22 vs -0,04 ± 1,40 (p<0,05), maar het had geen effect op de lengte-voor-leeftijd Z-scores 
(0,09 ± 0,95 vs 0,03 ± 0,88). Het supplement leidde over de
 
6 maanden van interventie niet tot 
een verbetering in het aantal CD4 cellen (-0,64 ± 8,3 in de supplementgroep
 
vs -1,44 ± 7,5 in 
de placebogroep), maar wel tot een vermindering van het aantal episodes per maand van 
luchtweginfectie symptomen (0,66 ± 0,51 vs 1,01
 
± 0,67; p<0,05)
 
en van diarree (0,25 ± 0,31 
vs
 
0,36 ± 0,36; p=0,09). We concluderen dan ook dat langetermijn multi-
micronutriëntsuppletie bij hiv-geïnfecteerde kinderen zal leiden tot gewichtsverbetering en tot 
minder episodes van luchtweginfecties en diarree.  
       De langetermijn effecten van multi-micronutriëntsuppletie op eetlust werden vastgesteld 
bij 140 hiv-geïnfecteerde kinderen in de leeftijd van 6-24 maanden (Chapter 5). De kinderen 
ondergingen een eetlusttest bij aanvang van de studie en  na 3 en 6 maanden. De eetlust werd 
vastgesteld zoals in de cross-sectionele studie door het meten van de ad libitum
 
consumptie 
van een commercieel verkrijgbare kindervoeding op drie verschillende dagen en volgens een 
gestandaardiseerd protocol.  In totaal
 
voltooiden 99 kinderen de studie, 50 uit
 
de supplement 
groep en 49 uit
 
de placebogroep. De verandering in consumptie tijdens de 6 maanden durende 
interventie was in de supplementgroep gunstiger
 
dan in de placebogroep (+4,7 ± 14,7 g per kg 
lichaamsgewicht versus -1,4 ± 15,1 g/kg lichaamsgewicht). We concluderen dat langetermijn 
multi-micronutriëntsuppletie bij hiv-geïnfecteerde kinderen zal leiden tot een verbetering van 
hun eetlust.
 
       
Onze bevindingen met de interventiestudies betreffen hiv-geïnfecteerde kinderen die nog 
geen antivirale middelen toegediend kregen. Het belang van antiretrovirale behandeling van 
hiv-geïnfecteerde kinderen kan niet genoeg onderstreept worden en alle hiv-geïnfecteerde 
kinderen zouden deze middelen moeten krijgen. Echter, ondanks de toegenomen verspreiding 
van antiretrovirale middelen krijgt momenteel minder dan 50% van de geschatte 2,3 miljoen 
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hiv-geïnfecteerde kinderen in subsaharaans Afrika
 
antiretrovirale behandeling. De in onze 
studies waargenomen verbeteringen in voedingstoestand
 
en gezondheidstoestand met multi-
micronutriëntsuppletie zijn dus nog steeds relevant voor een grote groep kinderen.
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